
<html lang="en"     class="pb-page"  data-request-id="dcdb4223-7223-4d03-9d17-3d947b844189"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2020.63.issue-1;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.9b01180"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery of a Covalent Inhibitor of KRASG12C (AMG 510) for the Treatment of Solid Tumors" /></meta><meta name="dc.Creator" content="Brian A.  Lanman" /></meta><meta name="dc.Creator" content="Jennifer R.  Allen" /></meta><meta name="dc.Creator" content="John G.  Allen" /></meta><meta name="dc.Creator" content="Albert K.  Amegadzie" /></meta><meta name="dc.Creator" content="Kate S.  Ashton" /></meta><meta name="dc.Creator" content="Shon K.  Booker" /></meta><meta name="dc.Creator" content="Jian Jeffrey  Chen" /></meta><meta name="dc.Creator" content="Ning  Chen" /></meta><meta name="dc.Creator" content="Michael J.  Frohn" /></meta><meta name="dc.Creator" content="Guy  Goodman" /></meta><meta name="dc.Creator" content="David J.  Kopecky" /></meta><meta name="dc.Creator" content="Longbin  Liu" /></meta><meta name="dc.Creator" content="Patricia  Lopez" /></meta><meta name="dc.Creator" content="Jonathan D.  Low" /></meta><meta name="dc.Creator" content="Vu  Ma" /></meta><meta name="dc.Creator" content="Ana E.  Minatti" /></meta><meta name="dc.Creator" content="Thomas T.  Nguyen" /></meta><meta name="dc.Creator" content="Nobuko  Nishimura" /></meta><meta name="dc.Creator" content="Alexander J.  Pickrell" /></meta><meta name="dc.Creator" content="Anthony B.  Reed" /></meta><meta name="dc.Creator" content="Youngsook  Shin" /></meta><meta name="dc.Creator" content="Aaron C.  Siegmund" /></meta><meta name="dc.Creator" content="Nuria A.  Tamayo" /></meta><meta name="dc.Creator" content="Christopher M.  Tegley" /></meta><meta name="dc.Creator" content="Mary C.  Walton" /></meta><meta name="dc.Creator" content="Hui-Ling  Wang" /></meta><meta name="dc.Creator" content="Ryan P.  Wurz" /></meta><meta name="dc.Creator" content="May  Xue" /></meta><meta name="dc.Creator" content="Kevin C.  Yang" /></meta><meta name="dc.Creator" content="Pragathi  Achanta" /></meta><meta name="dc.Creator" content="Michael D.  Bartberger" /></meta><meta name="dc.Creator" content="Jude  Canon" /></meta><meta name="dc.Creator" content="L. Steven  Hollis" /></meta><meta name="dc.Creator" content="John D.  McCarter" /></meta><meta name="dc.Creator" content="Christopher  Mohr" /></meta><meta name="dc.Creator" content="Karen  Rex" /></meta><meta name="dc.Creator" content="Anne Y.  Saiki" /></meta><meta name="dc.Creator" content="Tisha  San Miguel" /></meta><meta name="dc.Creator" content="Laurie P.  Volak" /></meta><meta name="dc.Creator" content="Kevin H.  Wang" /></meta><meta name="dc.Creator" content="Douglas A.  Whittington" /></meta><meta name="dc.Creator" content="Stephan G.  Zech" /></meta><meta name="dc.Creator" content="J. Russell  Lipford" /></meta><meta name="dc.Creator" content="Victor J.  Cee" /></meta><meta name="dc.Description" content="KRASG12C has emerged as a promising target in the treatment of solid tumors. Covalent inhibitors targeting the mutant cysteine-12 residue have been shown to disrupt signaling by this long-“undrugga..." /></meta><meta name="Description" content="KRASG12C has emerged as a promising target in the treatment of solid tumors. Covalent inhibitors targeting the mutant cysteine-12 residue have been shown to disrupt signaling by this long-“undrugga..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 10, 2019" /></meta><meta name="dc.Type" content="news" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b01180" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01180" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b01180" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01180" /></link>
        
    
    

<title>Discovery of a Covalent Inhibitor of KRASG12C (AMG 510) for the Treatment of Solid Tumors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b01180" /></meta><meta property="og:title" content="Discovery of a Covalent Inhibitor of KRASG12C (AMG 510) for the Treatment of Solid Tumors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/large/jm9b01180_0017.jpeg" /></meta><meta property="og:description" content="KRASG12C has emerged as a promising target in the treatment of solid tumors. Covalent inhibitors targeting the mutant cysteine-12 residue have been shown to disrupt signaling by this long-“undruggable” target; however clinically viable inhibitors have yet to be identified. Here, we report efforts to exploit a cryptic pocket (H95/Y96/Q99) we identified in KRASG12C to identify inhibitors suitable for clinical development. Structure-based design efforts leading to the identification of a novel quinazolinone scaffold are described, along with optimization efforts that overcame a configurational stability issue arising from restricted rotation about an axially chiral biaryl bond. Biopharmaceutical optimization of the resulting leads culminated in the identification of AMG 510, a highly potent, selective, and well-tolerated KRASG12C inhibitor currently in phase I clinical trials (NCT03600883)." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b01180"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01180">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b01180&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b01180&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b01180&amp;href=/doi/10.1021/acs.jmedchem.9b01180" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 1</span><span class="cit-fg-pageRange">, 52-65</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/1" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b00964" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Drug Annotation</span><a href="/doi/10.1021/acs.jmedchem.9b01604" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of a Covalent Inhibitor of KRAS<sup>G12C</sup> (AMG 510) for the Treatment of Solid Tumors</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Brian A. Lanman</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Brian A. Lanman</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Medicinal Chemistry, and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: (805) 313-5777. E-mail: <a href="/cdn-cgi/l/email-protection#056769646b68646b45646862606b2b666a68"><span class="__cf_email__" data-cfemail="66040a07080b070826070b0103084805090b">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Brian+A.++Lanman">Brian A. Lanman</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8768-7188" title="Orcid link">http://orcid.org/0000-0002-8768-7188</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jennifer R. Allen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jennifer R. Allen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Medicinal Chemistry, and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jennifer+R.++Allen">Jennifer R. Allen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">John G. Allen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">John G. Allen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Medicinal Chemistry, and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=John+G.++Allen">John G. Allen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Albert K. Amegadzie</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Albert K. Amegadzie</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Medicinal Chemistry, and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Albert+K.++Amegadzie">Albert K. Amegadzie</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kate S. Ashton</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kate S. Ashton</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Medicinal Chemistry, and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kate+S.++Ashton">Kate S. Ashton</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shon K. Booker</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shon K. Booker</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Medicinal Chemistry, and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shon+K.++Booker">Shon K. Booker</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jian Jeffrey Chen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jian Jeffrey Chen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Medicinal Chemistry, and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jian+Jeffrey++Chen">Jian Jeffrey Chen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ning Chen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ning Chen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Medicinal Chemistry, and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ning++Chen">Ning Chen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michael J. Frohn</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael J. Frohn</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Medicinal Chemistry, and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael+J.++Frohn">Michael J. Frohn</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Guy Goodman</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Guy Goodman</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Medicinal Chemistry, and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Guy++Goodman">Guy Goodman</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">David J. Kopecky</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">David J. Kopecky</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Medicinal Chemistry, and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=David+J.++Kopecky">David J. Kopecky</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Longbin Liu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Longbin Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Medicinal Chemistry, and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Longbin++Liu">Longbin Liu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Patricia Lopez</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Patricia Lopez</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Medicinal Chemistry, and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Patricia++Lopez">Patricia Lopez</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jonathan D. Low</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jonathan D. Low</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Medicinal Chemistry, and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jonathan+D.++Low">Jonathan D. Low</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Vu Ma</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Vu Ma</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Medicinal Chemistry, and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Vu++Ma">Vu Ma</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ana E. Minatti</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ana E. Minatti</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Medicinal Chemistry, and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ana+E.++Minatti">Ana E. Minatti</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Thomas T. Nguyen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Thomas T. Nguyen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Medicinal Chemistry, and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Thomas+T.++Nguyen">Thomas T. Nguyen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nobuko Nishimura</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nobuko Nishimura</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Medicinal Chemistry, and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nobuko++Nishimura">Nobuko Nishimura</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Alexander J. Pickrell</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alexander J. Pickrell</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Medicinal Chemistry, and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alexander+J.++Pickrell">Alexander J. Pickrell</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Anthony B. Reed</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Anthony B. Reed</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Medicinal Chemistry, and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Anthony+B.++Reed">Anthony B. Reed</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Youngsook Shin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Youngsook Shin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Medicinal Chemistry, and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Youngsook++Shin">Youngsook Shin</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3866-354X" title="Orcid link">http://orcid.org/0000-0003-3866-354X</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Aaron C. Siegmund</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Aaron C. Siegmund</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Medicinal Chemistry, and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Aaron+C.++Siegmund">Aaron C. Siegmund</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nuria A. Tamayo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nuria A. Tamayo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Medicinal Chemistry, and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nuria+A.++Tamayo">Nuria A. Tamayo</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Christopher M. Tegley</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christopher M. Tegley</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Medicinal Chemistry, and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+M.++Tegley">Christopher M. Tegley</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mary C. Walton</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mary C. Walton</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Medicinal Chemistry, and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mary+C.++Walton">Mary C. Walton</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hui-Ling Wang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hui-Ling Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Medicinal Chemistry, and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hui-Ling++Wang">Hui-Ling Wang</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2748-5266" title="Orcid link">http://orcid.org/0000-0003-2748-5266</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ryan P. Wurz</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ryan P. Wurz</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Medicinal Chemistry, and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ryan+P.++Wurz">Ryan P. Wurz</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1413-5208" title="Orcid link">http://orcid.org/0000-0003-1413-5208</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">May Xue</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">May Xue</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Medicinal Chemistry, and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=May++Xue">May Xue</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kevin C. Yang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kevin C. Yang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Medicinal Chemistry, and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kevin+C.++Yang">Kevin C. Yang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Pragathi Achanta</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Pragathi Achanta</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Oncology Research, and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Pragathi++Achanta">Pragathi Achanta</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michael D. Bartberger</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael D. Bartberger</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Molecular Engineering, and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael+D.++Bartberger">Michael D. Bartberger</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5167-3139" title="Orcid link">http://orcid.org/0000-0002-5167-3139</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jude Canon</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jude Canon</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Oncology Research, and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jude++Canon">Jude Canon</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">L. Steven Hollis</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">L. Steven Hollis</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Discovery Attribute Sciences, Amgen Research, 360 Binney Street, Cambridge, Massachusetts 02142, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=L.+Steven++Hollis">L. Steven Hollis</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">John D. McCarter</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">John D. McCarter</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Technologies, and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=John+D.++McCarter">John D. McCarter</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Christopher Mohr</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christopher Mohr</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Molecular Engineering, and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christopher++Mohr">Christopher Mohr</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Karen Rex</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Karen Rex</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Oncology Research, and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Karen++Rex">Karen Rex</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Anne Y. Saiki</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Anne Y. Saiki</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Oncology Research, and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Anne+Y.++Saiki">Anne Y. Saiki</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tisha San Miguel</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tisha San Miguel</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Technologies, and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tisha++San+Miguel">Tisha San Miguel</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Laurie P. Volak</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Laurie P. Volak</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmacokinetics and Drug Metabolism, and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Laurie+P.++Volak">Laurie P. Volak</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kevin H. Wang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kevin H. Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Molecular Engineering, Amgen Research, 360 Binney Street, Cambridge, Massachusetts 02142, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kevin+H.++Wang">Kevin H. Wang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Douglas A. Whittington</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Douglas A. Whittington</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Molecular Engineering, Amgen Research, 360 Binney Street, Cambridge, Massachusetts 02142, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Douglas+A.++Whittington">Douglas A. Whittington</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5946-8543" title="Orcid link">http://orcid.org/0000-0002-5946-8543</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Stephan G. Zech</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stephan G. Zech</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Discovery Attribute Sciences, Amgen Research, 360 Binney Street, Cambridge, Massachusetts 02142, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stephan+G.++Zech">Stephan G. Zech</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">J. Russell Lipford</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">J. Russell Lipford</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Oncology Research, and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=J.+Russell++Lipford">J. Russell Lipford</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Victor J. Cee</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Victor J. Cee</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Medicinal Chemistry, and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Victor+J.++Cee">Victor J. Cee</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7714-397X" title="Orcid link">http://orcid.org/0000-0002-7714-397X</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01180&amp;href=/doi/10.1021%2Facs.jmedchem.9b01180" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 1</span><span class="cit-pageRange">, 52–65</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 10, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>21 July 2019</li><li><span class="item_label"><b>Published</b> online</span>10 December 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 January 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b01180" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01180</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D52%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DBrian%2BA.%2BLanman%252C%2BJennifer%2BR.%2BAllen%252C%2BJohn%2BG.%2BAllen%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D1%26contentID%3Dacs.jmedchem.9b01180%26title%3DDiscovery%2Bof%2Ba%2BCovalent%2BInhibitor%2Bof%2BKRASG12C%2B%2528AMG%2B510%2529%2Bfor%2Bthe%2BTreatment%2Bof%2BSolid%2BTumors%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D65%26publicationDate%3DJanuary%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b01180"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">29164</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">69</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b01180" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of a Covalent Inhibitor of KRASG12C (AMG 510) for the Treatment of Solid Tumors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;A. Lanman&quot;},{&quot;first_name&quot;:&quot;Jennifer&quot;,&quot;last_name&quot;:&quot;R. Allen&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;G. Allen&quot;},{&quot;first_name&quot;:&quot;Albert&quot;,&quot;last_name&quot;:&quot;K. Amegadzie&quot;},{&quot;first_name&quot;:&quot;Kate&quot;,&quot;last_name&quot;:&quot;S. Ashton&quot;},{&quot;first_name&quot;:&quot;Shon&quot;,&quot;last_name&quot;:&quot;K. Booker&quot;},{&quot;first_name&quot;:&quot;Jian&quot;,&quot;last_name&quot;:&quot;Jeffrey Chen&quot;},{&quot;first_name&quot;:&quot;Ning&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;J. Frohn&quot;},{&quot;first_name&quot;:&quot;Guy&quot;,&quot;last_name&quot;:&quot;Goodman&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;J. Kopecky&quot;},{&quot;first_name&quot;:&quot;Longbin&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Patricia&quot;,&quot;last_name&quot;:&quot;Lopez&quot;},{&quot;first_name&quot;:&quot;Jonathan&quot;,&quot;last_name&quot;:&quot;D. Low&quot;},{&quot;first_name&quot;:&quot;Vu&quot;,&quot;last_name&quot;:&quot;Ma&quot;},{&quot;first_name&quot;:&quot;Ana&quot;,&quot;last_name&quot;:&quot;E. Minatti&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;T. Nguyen&quot;},{&quot;first_name&quot;:&quot;Nobuko&quot;,&quot;last_name&quot;:&quot;Nishimura&quot;},{&quot;first_name&quot;:&quot;Alexander&quot;,&quot;last_name&quot;:&quot;J. Pickrell&quot;},{&quot;first_name&quot;:&quot;Anthony&quot;,&quot;last_name&quot;:&quot;B. Reed&quot;},{&quot;first_name&quot;:&quot;Youngsook&quot;,&quot;last_name&quot;:&quot;Shin&quot;},{&quot;first_name&quot;:&quot;Aaron&quot;,&quot;last_name&quot;:&quot;C. Siegmund&quot;},{&quot;first_name&quot;:&quot;Nuria&quot;,&quot;last_name&quot;:&quot;A. Tamayo&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;M. Tegley&quot;},{&quot;first_name&quot;:&quot;Mary&quot;,&quot;last_name&quot;:&quot;C. Walton&quot;},{&quot;first_name&quot;:&quot;Hui-Ling&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Ryan&quot;,&quot;last_name&quot;:&quot;P. Wurz&quot;},{&quot;first_name&quot;:&quot;May&quot;,&quot;last_name&quot;:&quot;Xue&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;C. Yang&quot;},{&quot;first_name&quot;:&quot;Pragathi&quot;,&quot;last_name&quot;:&quot;Achanta&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;D. Bartberger&quot;},{&quot;first_name&quot;:&quot;Jude&quot;,&quot;last_name&quot;:&quot;Canon&quot;},{&quot;first_name&quot;:&quot;L.&quot;,&quot;last_name&quot;:&quot;Steven Hollis&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;D. McCarter&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;Mohr&quot;},{&quot;first_name&quot;:&quot;Karen&quot;,&quot;last_name&quot;:&quot;Rex&quot;},{&quot;first_name&quot;:&quot;Anne&quot;,&quot;last_name&quot;:&quot;Y. Saiki&quot;},{&quot;first_name&quot;:&quot;Tisha&quot;,&quot;last_name&quot;:&quot;San Miguel&quot;},{&quot;first_name&quot;:&quot;Laurie&quot;,&quot;last_name&quot;:&quot;P. Volak&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;H. Wang&quot;},{&quot;first_name&quot;:&quot;Douglas&quot;,&quot;last_name&quot;:&quot;A. Whittington&quot;},{&quot;first_name&quot;:&quot;Stephan&quot;,&quot;last_name&quot;:&quot;G. Zech&quot;},{&quot;first_name&quot;:&quot;J.&quot;,&quot;last_name&quot;:&quot;Russell Lipford&quot;},{&quot;first_name&quot;:&quot;Victor&quot;,&quot;last_name&quot;:&quot;J. Cee&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;10&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;52-65&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b01180&quot;},&quot;abstract&quot;:&quot;KRASG12C has emerged as a promising target in the treatment of solid tumors. Covalent inhibitors targeting the mutant cysteine-12 residue have been shown to disrupt signaling by this long-“undruggable” target; however clinically viable inhibitors have yet to be identified. Here, we report efforts to exploit a cryptic pocket (H95/Y96/Q99) we identified in KRASG12C to identify inhibitors suitable for clinical development. Structure-based design efforts leading to the identification of a novel quinazolinone scaffold are described, along with optimization efforts that overcame a configurational stability issue arising from restricted rotation about an axially chiral biaryl bond. Biopharmaceutical optimization of the resulting leads culminated in the identification of AMG 510, a highly potent, selective, and well-tolerated KRASG12C inhibitor currently in phase I clinical trials (NCT03600883).&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01180&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01180" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01180&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01180" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01180&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01180" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01180&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01180&amp;href=/doi/10.1021/acs.jmedchem.9b01180" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b01180" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b01180" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (7 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b01180%26sid%3Dliteratum%253Aachs%26pmid%3D31820981%26genre%3Darticle%26aulast%3DLanman%26date%3D2020%26atitle%3DDiscovery%2Bof%2Ba%2BCovalent%2BInhibitor%2Bof%2BKRASG12C%2B%2528AMG%2B510%2529%2Bfor%2Bthe%2BTreatment%2Bof%2BSolid%2BTumors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D1%26spage%3D52%26epage%3D65%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290676" title="Substituents">Substituents</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291155" title="Bioavailability">Bioavailability</a>,</li><li><a href="/action/doSearch?ConceptID=292153" title="Tumors">Tumors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/1" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/jmcmar.2020.63.issue-1/20200109/jmcmar.2020.63.issue-1.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/medium/jm9b01180_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/large/jm9b01180_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01180&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">KRAS<sup>G12C</sup> has emerged as a promising target in the treatment of solid tumors. Covalent inhibitors targeting the mutant cysteine-12 residue have been shown to disrupt signaling by this long-“undruggable” target; however clinically viable inhibitors have yet to be identified. Here, we report efforts to exploit a cryptic pocket (H95/Y96/Q99) we identified in KRAS<sup>G12C</sup> to identify inhibitors suitable for clinical development. Structure-based design efforts leading to the identification of a novel quinazolinone scaffold are described, along with optimization efforts that overcame a configurational stability issue arising from restricted rotation about an axially chiral biaryl bond. Biopharmaceutical optimization of the resulting leads culminated in the identification of AMG 510, a highly potent, selective, and well-tolerated KRAS<sup>G12C</sup> inhibitor currently in phase I clinical trials (NCT03600883).</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35723" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35723" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Mutations in the <i>RAS</i> oncogene are the most common activating mutation in human cancer, occurring in 30% of human tumors.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Although the <i>RAS</i> gene family comprises three isoforms (<i>KRAS</i>, <i>HRAS</i>, and <i>NRAS</i>), 85% of <i>RAS-</i>driven cancers are caused by mutations in the <i>KRAS</i> isoform,<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> with mutations occurring most frequently in solid tumors such as lung adenocarcinoma, pancreatic ductal carcinoma, and colorectal carcinoma.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Among <i>KRAS</i> mutant tumors, 80% of all oncogenic mutations occur within codon 12, with the most common mutations being <i>p.G12D</i> (41%), <i>p.G12V</i> (28%), and <i>p.G12C</i> (14%).<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div><div class="NLM_p">In growth factor signaling pathways, the KRAS protein functions as a molecular switch, regulating proliferation by alternating between a guanosine diphosphate (GDP)-bound inactive form and a guanosine triphosphate (GTP)-bound active form capable of engaging downstream effector proteins to elicit a pro-proliferative response. Codon 12 mutations impair the regulated cycling between these two forms by disrupting the association of GTPase-activating proteins (GAPs), impairing the inactivation of KRAS and leading to the accumulation of the pro-proliferative form.</div><div class="NLM_p">Despite being one of the first oncogenes identified, 3 decades of effort have failed to identify clinically useful inhibitors of the KRAS protein.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Two features of KRAS confound its tractability as a drug target: (1) KRAS binds to GDP and GTP with picomolar affinity, severely hindering efforts to develop nucleotide-competitive inhibitors, and (2) the KRAS protein lacks other deep surface hydrophobic pockets, thwarting efforts to identify high-affinity allosteric inhibitors.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a></div><div class="NLM_p">In 2013, Shokat and co-workers reported a novel strategy aimed at overcoming these challenges that used a covalent inhibitor to target the reactive cysteine-12 of KRAS<sup>G12C</sup>.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> They envisioned that covalent modification of Cys12 would allow for persistent disruption of KRAS<sup>G12C</sup>-driven pro-proliferative signaling by allowing relatively low-affinity, noncovalent interactions to selectively template the formation of a covalent bond between the inhibitor and KRAS, resulting in the permanent inactivation of the adducted protein. In addition to providing a means of overcoming the poor “druggability” of KRAS, it was hoped that this strategy might also allow for the selective growth inhibition of <i>KRAS</i> mutant cells (i.e., tumors) while sparing nonmutant cells (i.e., normal tissue), potentially overcoming the anticipated toxicological challenges posed by nonselective inhibition of <i>KRAS</i>-driven cell growth.</div><div class="NLM_p">After significant optimization efforts, early hits identified by the Shokat group were modified to provide a tool compound suitable for in vivo applications, ARS-1620 (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8,9)</a> A cocrystal structure of ARS-1620 with KRAS<sup>G12C</sup> confirmed that ARS-1620 covalently bound to cysteine-12 of the GDP-bound form of KRAS, with the quinazoline core of the molecule occupying an allosteric pocket (the “switch II pocket” (S-IIP)) located beneath the effector protein-engaging switch II loop region of the protein. While this adduct demonstrated promising antiproliferative activity against <i>KRAS p.G12C</i> mutant tumors both in vitro and in vivo,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> further improvements in cellular potency appeared necessary to deliver a therapeutically useful molecule. Here, we describe efforts at Amgen to discover and develop a targeted covalent inhibitor of KRAS<sup>G12C</sup> suitable for clinical application.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/medium/jm9b01180_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/large/jm9b01180_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Comparison of the GDP-KRAS<sup>G12C</sup> binding modes of ARS-1620 (blue, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5V9U">5V9U</a>)<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> and the internally identified indole lead <b>1</b> (pink, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6P8Z">6P8Z</a>)<sub>.</sub><a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> The tetrahydroisoquinoline portion of indole <b>1</b> engages a “cryptic pocket” (magenta) not exploited by prior inhibitors, which is induced by side chain rotation of H95 and comprises the residues Y96, H95, and Q99. Inhibitor activity on downstream ERK phosphorylation (p-ERK IC<sub>50</sub>, 2 h incubation) is indicated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/large/jm9b01180_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01180&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58014" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58014" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Prior to the Shokat lab’s initial disclosure of their efforts targeting KRAS<sup>G12C</sup>, we had independently initiated our own research program to identify covalent inhibitors of KRAS<sup>G12C</sup>, driven by the same strategic considerations. To support our initial screening efforts and provide access to focused libraries of cysteine-reactive compounds, we entered into a collaboration with Carmot Therapeutics. Using Carmot’s Chemotype Evolution platform,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> we identified a series of selective covalent inhibitors of KRAS<sup>G12C</sup> that were optimized (via structure-based design and additional rounds of targeted library synthesis) to provide advanced lead <b>1</b>, which potently inactivated KRAS<sup>G12C</sup> in biochemical and cellular assays.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div><div class="NLM_p">Cocrystallization of <b>1</b> with GDP-KRAS<sup>G12C</sup> revealed compound <b>1</b> to adopt a novel binding mode relative to ARS-1620, with the tetrahydroisoquinoline ring of <b>1</b> occupying a previously unexploited cryptic pocket on the surface of KRAS unveiled by rotation of the histidine-95 side chain and comprising portions of H95, Y96, and Q99 (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Although engagement of this cryptic pocket led to a multifold enhancement in cellular potency relative to ARS-1620, compound <b>1</b> suffered from very high clearance and low oral bioavailability in rodent model systems, making it unsuitable for in vivo use. We therefore sought alternative means of exploiting the H95/Y96/Q99 cryptic pocket that might deliver leads with improved pharmaceutical properties.</div><div class="NLM_p">Superposition of the binding modes of indole lead <b>1</b> and ARS-1620 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) suggested that substitution of the quinazoline nitrogen (N1) of ARS-1620 might provide an alternative means of accessing the H95 cryptic pocket and thus of generating new, enhanced-potency inhibitors of KRAS<sup>G12C</sup>. Such a strategy was expected to face some challenges: our prior efforts to modify the quinazoline core of ARS-1620 had shown that perturbation of the hydrogen bond between N1 and the H95 side chain of KRAS typically led to significant losses in functional activity. Nevertheless, as this strategy promised to identify new alternatives to the metabolically labile <b>1</b>, we pursued this approach, anticipating that a successful hybrid molecule would not only deliver enhanced potency (via effective engagement of the cryptic pocket)<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> but also improved ADME properties.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/medium/jm9b01180_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/large/jm9b01180_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Overlay of the GDP-KRAS<sup>G12C</sup>-bound conformations of ARS-1620 (blue) and indole lead <b>1</b> (pink), suggesting potential access to the Y96/H95/Q99 cryptic pocket by substitution of the N1 position of the ARS-1620 scaffold. Conceptual hybrid structure is shown at right.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/large/jm9b01180_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01180&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To test this hypothesis, we prepared a series of phthalazine analogues, wherein the C4 position (Y) of the phthalazine core (X = N, Y = C) was substituted with a range of aryl substituents (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). We used a pair of assays to gauge the ability of the resulting analogues to disrupt KRAS-mediated signaling: (1) a cell-free AlphaScreen assay,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> which measured inhibition of SOS1-catalyzed GDP/GTP exchange by monitoring the disruption of the interaction between GTP-KRAS<sup>G12C</sup> and the Ras binding domain (RBD) of c-RAF, and (2) a cell-based phospho-ERK1/2 immunoassay (MSD),<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> which detected decreased ERK phosphorylation resulting from disrupted upstream KRAS signaling. Phenyl substitution of C4 (<b>2</b>) led to an analogue ∼20-fold less potent than ARS-1620 in our exchange assay (IC<sub>50</sub> = 20.1 μM) and 70-fold less potent in our p-ERK cellular assay (IC<sub>50</sub> = 58 μM).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Biochemical and Cellular Activity of Hybrid Scaffolds Designed To Access the Y96/H95/Q99 Cryptic Pocket</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/medium/jm9b01180_0010.gif" alt="" id="gr4" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/medium/jm9b01180_0011.gif" alt="" id="GRAPHIC-d7e838-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">SOS1-catalyzed GDP/GTP exchange (AlphaScreen, KRAS<sup>G12C</sup>/c-RAF Ras binding domain), 5 min incubation.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">p-ERK1/2 immunoassay (MSD), EGF-stimulated MIA PaCa-2 cells, 2 h incubation.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> All data represent <i>n</i> ≥ 2.</p></div></div><div></div></div><div class="NLM_p">Cocrystallization of compound <b>2</b> with GDP-KRAS<sup>G12C</sup> confirmed that compound <b>2</b> adopted a similar binding mode to ARS-1620 but with the newly introduced C4 phenyl substituent occupying the H95/Y96/Q99 cryptic pocket, as designed (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>a). The C4 phenyl group, however, failed to make many noncovalent contacts with the cryptic pocket residues (e.g., Y96), prompting us to examine whether further substitution of the phenyl ring could produce additional contacts with the cryptic pocket residues that would lead to enhanced potency.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/medium/jm9b01180_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/large/jm9b01180_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. X-ray crystallography confirms hybrid scaffolds <b>2</b> (a; tan, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6PGO">6PGO</a>) and <b>9</b> (b; violet, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6PGP">6PGP</a>) access the cryptic pocket. Additional van der Waals contacts between the isopropyl moiety of <b>9</b> and H95, Y96, and Q99 account for the increased biochemical and cellular potency of <b>9</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/large/jm9b01180_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01180&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To test this hypothesis, a series of increasingly large ortho-substituents were added to the phenyl ring of <b>2</b> (see compounds <b>3</b>–<b>8</b>, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) with the aim of enhancing contacts with Y96. Encouragingly, methyl substitution (<b>3</b>) provided a 4-fold increase in biochemical potency and 17-fold increase in cellular activity, and ethyl substitution (<b>5</b>) led to further gains in potency (exchange IC<sub>50</sub> = 0.903 μM, p-ERK IC<sub>50</sub> = 2.6 μM). Isopropyl substitution (<b>8</b>) proved optimal, however, demonstrating biochemical and cellular IC<sub>50</sub> values on a par with ARS-1620.</div><div class="NLM_p">In an effort to further enhance the potency of these initial leads, we also examined the effect of changing the phthalazine core of <b>8</b>. Notably, quinazolinone <b>9</b> (X = CO, Y = N; <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) was found to offer a significant improvement in biochemical and cellular potency relative to <b>8</b>, with the resulting compound proving ∼3–9 times more potent than ARS-1620 in in vitro assays.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><div class="NLM_p">Cocrystallization of compound <b>9</b> with GDP-KRAS<sup>G12C</sup> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>b) confirmed <b>9</b> to adopt a binding mode in which the isopropylphenyl substituent was positioned in close contact with the Y96, H95, and Q99 residues of the cryptic pocket and one in which the isopropylphenyl and phthalazine rings were nearly orthogonally oriented. Although compound <b>9</b> consisted of a mixture of atropisomers about the biaryl C–N bond (due to restricted rotation about the bis-ortho-substituted biaryl linkage), only the <i>R</i>-atropisomer<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> showed significant occupancy of the switch II pocket crystallographically. Separation of the <i>R</i>- and <i>S</i>-atropisomers by chiral chromatography confirmed (<i>R</i>)-<b>9</b> to be significantly more potent than the corresponding <i>S</i>-atropisomer.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Accordingly, subsequent studies were performed with the atropisomer which oriented its larger ortho substituent toward the Y96/H95/Q99 cryptic pocket (typically the <i>R-</i>atropisomer) (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Optimization of the Piperazine Substituent (R<sup>2</sup>) and Lipophilic “Tail” (R<sup>1</sup>) Regions of (<i>R</i>)-<b>9</b> Enhances Potency and Bioavailability</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/medium/jm9b01180_0012.gif" alt="" id="gr7" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/medium/jm9b01180_0013.gif" alt="" id="GRAPHIC-d7e1019-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Unless noted, separable C7 biaryl bond atropisomers were not observed.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">p-ERK1/2 immunoassay (MSD), 2 h incubation.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">Viability assessed at 72 h by CellTiter-Glo luminescence assay (Promega) in MIA PaCa-2 (<i>p.G12C</i>) and A549 (<i>p.G12S</i>) cell lines. All data represent <i>n</i> ≥ 2.</p></div><div class="footnote" id="t2fn4"><sup><sup>d</sup></sup><p class="last">iv/po dosing in BALB/c mice (vehicle: iv, 1 mg/kg, DMSO; po, 10 mg/kg, 1% Tween 80, 2% HPMC, 97% water).</p></div><div class="footnote" id="t2fn5"><sup><sup>e</sup></sup><p class="last">Mixture of four atropisomers (isopropylphenyl and naphthol biaryl bonds).</p></div><div class="footnote" id="t2fn6"><sup><sup>f</sup></sup><p class="last">Single indazole biaryl bond atropisomer.</p></div><div class="footnote" id="t2fn7"><sup><sup>g</sup></sup><p class="last">Mixture of isopropylphenyl atropisomers.</p></div></div><div></div></div><div class="NLM_p">Although (<i>R</i>)-<b>9</b> proved to be an exceptionally potent inhibitor of KRAS<sup>G12C</sup> signaling (p-ERK IC<sub>50</sub> = 0.130 μM), the GDP-KRAS<sup>G12C</sup> cocrystal structure suggested several prospects for further optimization: (1) substitution of the piperazine C2 position appeared to offer an opportunity to enhance activity through additional contacts with C12, E62, and Y96 and (2) replacement of the fluorophenol “tail” of (<i>R</i>)-<b>9</b> appeared to offer an opportunity to form more extensive contacts with lipophilic residues (e.g., V9 and I100) and to modulate polar interactions with R68 or D69. Additionally, despite the promising potency profile of (<i>R</i>)-<b>9</b>, PK studies revealed no measurable oral bioavailability in BALB/c mice. Low membrane permeability (2 μcm/s in a Madin–Darby canine kidney (MDCK) cell trans-well permeability assay) and relatively poor aqueous solubility (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>) were viewed as likely contributing factors. Therefore, C2 and C7 modifications were also viewed as potential opportunities to modulate the biopharmaceutical properties of (<i>R</i>)-<b>9</b> to enhance the bioavailability of future analogues.</div><div class="NLM_p">We began our SAR efforts around (<i>R</i>)-<b>9</b> by replacing its C7 fluorophenol moiety with larger groups designed to make additional contacts with residues in the “tail” subpocket. While we continued to employ an ERK phosphorylation assay as our primary screen for KRAS-based cell activity, we also profiled new compounds in CellTiter-Glo-based proliferation assays<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> using <i>KRAS p.G12C</i> (MIA PaCa-2) and <i>KRAS p.G12S</i> (A549) cells to confirm that growth-inhibitory activity was specific to <i>p.G12C</i> mutant cells and sparing of those in which Gly12 was instead mutated to serine (G12S). Naphthol (<b>10</b>) and indazole (<b>11</b>) substituents did indeed show enhanced activity in ERK phosphorylation and viability assays (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>); however these analogues continued to demonstrate poor aqueous solubility, low MDCK permeability, and in the case of indazole <b>11</b>, no improvement in oral bioavailability.</div><div class="NLM_p">In an effort to enhance MDCK permeability, we examined the effect of removing the phenolic moiety from (<i>R</i>)-<b>9</b> to provide fluorophenyl <b>12</b>. Interestingly, this modification led to no loss in activity in either the p-ERK or viability assays and a more than 3-fold increase in MDCK permeability. Good MDCK permeability was also retained in a related analogue wherein a piperazine C2-methyl substituent was introduced (<b>13</b>). Notably, methylpiperazine <b>13</b> demonstrated not only further improvements in cellular activity (p-ERK IC<sub>50</sub> = 47 nM) but also measurable mouse oral bioavailability (12%). Attempts to replace the fluorophenyl tail of <b>13</b> with larger lipophilic substituents (e.g., <i>o</i>-chlorophenyl (<b>14</b>) or <i>o-</i>trifluorotolyl (<b>15</b>)) proved detrimental, however, and led to reduced cellular activity and MDCK permeability. Likewise, while reintroduction of the phenolic moiety into <b>13</b> (to provide fluorophenol <b>16</b>) again had minimal impact on cellular activity, membrane permeability was dramatically reduced (<i>P</i><sub>AB</sub> = 1 μcm/s).</div><div class="NLM_p">With the phenolic functionality of (<i>R</i>)-<b>9</b> and (<i>R</i>)-<b>16</b> emerging as a key contributor to the reduced MDCK permeability of these analogues, we also decided to examine an alternative strategy to mitigate the adverse effect of this group. As desolvation of the phenol during membrane diffusion was hypothesized to add to the energetic cost of membrane permeation, we investigated whether nitrogen incorporation at the C8 position of the quinazolinone ring could enhance MDCK permeability by providing an internal hydrogen-bond acceptor to satisfy the adjacent phenolic donor during membrane permeation.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Gratifyingly, azaquinazolinones <b>17</b> and <b>18</b> both demonstrated not only significantly enhanced MDCK permeability relative to their nonaza congeners (<b>9</b> and <b>16</b>) but also significantly improved aqueous solubility. While the oral bioavailability of compound <b>17</b> remained disappointing (1.3%), azaquinazolinone <b>18</b> demonstrated significantly enhanced oral bioavailability (33%) and excellent cellular activity (p-ERK IC<sub>50</sub> = 44 nM; MIA PaCa-2 viability IC<sub>50</sub> = 5 nM).</div><div class="NLM_p">While further improvements in MDCK permeability could be achieved by removing the phenolic functionality from compound <b>18</b> (see compounds <b>19</b> and <b>20</b>), the resulting compounds suffered from reduced bioavailability and increased in vivo clearance relative to <b>18</b>. Similarly, although removal of the fluorine substituent from <b>18</b> (to provide phenol <b>21</b>) enhanced both MDCK permeability and aqueous solubility, such benefits came at the cost of reduced potency, metabolic stability, and oral bioavailability. Thus, due to its unique balance of promising pharmacokinetic profile and excellent potency, azaquinazolinone <b>18</b> became our new lead for subsequent optimization.</div><div class="NLM_p">Disappointingly, we soon discovered a new challenge with compound <b>18</b>, originating in the axial chirality of its isopropylphenyl–quinazolinone biaryl bond. Although the sterically congested environment about this bond dramatically restricted rotation, giving rise to separable atropisomers, it unfortunately did not <i>completely</i> restrict rotation about this bond. Slow interconversion of the <i>R</i>- and <i>S</i>-atropisomers occurred at 25 °C with a half-life of 8 days and an interconversion free energy barrier (Δ<i>G</i><sup>⧧</sup>) of 26 kcal/mol,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> behavior that promised to greatly complicate the development of (<i>R</i>)-<b>18</b> as a pure substance (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/medium/jm9b01180_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/large/jm9b01180_0004.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Compound <b>18</b> atropisomers are not configurationally stable at 25 °C.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/large/jm9b01180_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01180&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Strategies for addressing atropisomerism in drug discovery have previously been reviewed,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> however, and drawing upon this guidance, we initiated a trio of strategies to identify a lead molecule with atropisomer configurational properties suitable for drug development needs. These strategies included (1) raising the energetic barrier to atropisomer interconversion (Δ<i>G</i><sup>⧧</sup> > 30 kcal/mol) to allow for the development of a single, pure atropisomer, (2) lowering the interconversion barrier (Δ<i>G</i><sup>⧧</sup> < 20 kcal/mol) to allow for the development of a freely interconverting mixture of atropisomers, or (3) symmetrizing the cryptic pocket substituent to avoid the generation of an axis of chirality.</div><div class="NLM_p">We used two methods to assess the atropisomer interconversion free-energy barriers of our lead molecules: slowly interconverting atropisomers were assessed using time-course <sup>1</sup>H NMR experiments, fitting atropisomer ratio information with the Eyring equation to determine Δ<i>G</i><sup>⧧</sup>; rapidly interconverting atropisomers, in contrast, were assessed using the VT NMR method described in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/medium/jm9b01180_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/large/jm9b01180_0005.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. VT NMR method for determining atropisomer interconversion free energy barriers (Δ<i>G</i><sup>⧧</sup>). Coalescence of the H5 <sup>1</sup>H NMR resonance was monitored at elevated temperature, and the coalescences temperature (<i>T</i><sub>c</sub>) and chemical shift difference (Δν; slow exchange limit) were used for calculation of Δ<i>G</i><sup>⧧</sup>. (Compensation applied for minor temperature dependence in the H5 chemical shift.) <sup>1</sup>H spectra (DMSO-<i>d</i><sub>6</sub>) for compound <b>27</b> are depicted. At 298 K, methylpiperazine conformational exchange causes H5 line broadening, which is averaged out at <i>T</i> > 320 K.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/large/jm9b01180_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01180&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We first explored methods to further restrict rotation about the isopropylphenyl–quinazolinone biaryl bond, probing the effect of <i>ortho</i>-substituent steric demand on the rotational free-energy barrier. While replacement of isopropyl substituent with a cyclopropyl ring (<b>22</b>) did little to alter the atropisomer interconversion barrier (and led to some loss in activity, see <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>), introduction of a <i>tert-</i>butyl group (<b>23</b>) led to significantly increased configurational stability, with minimal loss in activity. Bis-ortho substitution (<b>24</b>) proved optimal, however, both locking of rotation about the biaryl bond (Δ<i>G</i><sup>⧧</sup> > 30 kcal/mol) and leading to enhanced biochemical and cellular activity (p-ERK IC<sub>50</sub> = 28 nM). The isopropyl group in <b>24</b> proved crucial to this effect, as its replacement with a nonbranched ethyl substituent (<b>25</b>) led to a significant reduction in the biaryl rotational barrier (Δ<i>G</i><sup>⧧</sup> = 29.0 kcal/mol), as well as some loss in biochemical potency.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Atropisomer Stability and KRAS<sup>G12C</sup> Activity as a Function of Cryptic Pocket Arene Identity and Substitution Pattern</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/medium/jm9b01180_0014.gif" alt="" id="gr11" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/medium/jm9b01180_0015.gif" alt="" id="GRAPHIC-d7e1417-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Atropisomer configuration assigned by cocrystallization with GDP-KRAS<sup>G12C</sup> except for compound <b>29</b> (configuration assigned by analogy; more potent isomer assigned <i>R</i>-configuration).</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">SOS1-catalyzed GDP/GTP exchange (AlphaScreen, KRAS<sup>G12C</sup>/c-RAF Ras binding domain), 5 min incubation.</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">p-ERK1/2 immunoassay (MSD), 2 h incubation. All data represent <i>n</i> ≥ 2. For separable atropisomers, data are reported for the more potent <i>R</i>-atropisomer, as depicted.</p></div><div class="footnote" id="t3fn4"><sup><sup>d</sup></sup><p class="last">Atropisomer interconversion barrier (Δ<i>G</i><sup>⧧</sup>) as determined by <sup>1</sup>time-course NMR experiment or <sup>2</sup>VT NMR.</p></div></div><div></div></div><div class="NLM_p">We next examined whether replacement of the isopropylphenyl ring of (<i>R</i>)-<b>18</b> with less sterically demanding groups could lower the rotational barrier sufficiently to restore free rotation about the biaryl bond. Replacing the isopropylphenyl group with an analogous isopropylpyridine (cf., compound <b>26</b>) meaningfully reduced the rotational barrier (Δ<i>G</i><sup>⧧</sup> = 23.5 kcal/mol); however the resulting atropisomers remained metastable (<i>t</i><sub>1/2</sub> ∼ 5 h at 25 °C) and unsuitable for further development. Contraction of the pendant six-membered ring to a five-membered ring (cf., pyrazole <b>27</b>) further reduced the rotational barrier (Δ<i>G</i><sup>⧧</sup> = 21.5 kcal/mol) but failed to fully free rotation about the biaryl bond and led to moderate losses in biochemical and cellular potency. Introducing a sulfur atom at the open ortho-position of the five-membered ring (c.f., <b>28</b>), however, restored free rotation about the biaryl bond and restored biochemical and cellular activity. Interestingly, attempts to fully restrict biaryl bond rotation by bis-ortho-substitution of five-membered ring cryptic pocket substituents (cf., <b>29</b>) were unsuccessful, contrasting with this strategy’s success in the context of six-membered rings substituents (cf., (<i>R</i>)-<b>24</b>). These studies hence reveal biaryl bond rotation to be influenced by a complex interplay of factors including substituent size, substitution pattern, and ring size.</div><div class="NLM_p">As a final strategy to avoid configurationally unstable biaryl bond atropisomers, we examined the properties of symmetrically bis-ortho-substituted cryptic pocket substituents. Although bis-methyl substitution (<b>30</b>) failed to afford a potent lead, bis-ethyl (<b>31</b>), cyclopropyl (<b>32</b>), and isopropyl (<b>33</b>) substitution all afforded compounds with good biochemical and cellular activity and no potential to generate rotational atropisomers.</div><div class="NLM_p">Although all three strategies to address the axial chirality/configurational stability issue were ultimately successful in identifying potent KRAS<sup>G12C</sup> inhibitors suitable for subsequent development, the resulting leads demonstrated quite distinct pharmacological profiles when dosed orally (10 mg/kg) in BALB/c mice (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Whereas (<i>R</i>)-<b>24</b> showed moderate oral bioavailability (21%) and good in vivo target coverage (4.5× coverage of the p-ERK IC<sub>50</sub> at <i>C</i><sub>max</sub>),<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> compound <b>28</b> demonstrated much more modest in vivo target coverage, and compounds <b>31</b>–<b>33</b> failed to show appreciable in vivo target coverage, even at <i>C</i><sub>max</sub>, possibly due in part to the reduced oral bioavailability of these analogues. (<i>R</i>)-<b>24</b> thus became our lead candidate for subsequent pharmacodynamic and efficacy testing in xenograft models.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Mouse PK Profiles<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a> of Compounds with Atropisomer Configurational Properties Suitable for Development</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cmpd</th><th class="colsep0 rowsep0" align="center" char=".">CL (L h<sup>–1</sup> kg<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center" char=".">PPB (<i>f</i><sub>u</sub>)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i> (%)</th><th class="colsep0 rowsep0" align="center" char=".">10 mg/kg <i>C</i><sub>max,u</sub><a class="ref internalNav" href="#t4fn3" aria-label="c">c</a>/p-ERK IC<sub>50</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>R</i>)-<b>24</b></td><td class="colsep0 rowsep0" align="char" char=".">2.7</td><td class="colsep0 rowsep0" align="char" char=".">0.03</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">21</td><td class="colsep0 rowsep0" align="char" char=".">4.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="char" char=".">2.2</td><td class="colsep0 rowsep0" align="char" char=".">0.02</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td><td class="colsep0 rowsep0" align="char" char=".">22</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="char" char=".">3.3</td><td class="colsep0 rowsep0" align="char" char=".">0.03</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">0.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="char" char=".">3.3</td><td class="colsep0 rowsep0" align="char" char=".">0.08</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">7</td><td class="colsep0 rowsep0" align="char" char=".">0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="char" char=".">2.3</td><td class="colsep0 rowsep0" align="char" char=".">0.03</td><td class="colsep0 rowsep0" align="char" char=".">0.8</td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="char" char=".">0.8</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">iv/po dosing in BALB/c mice (vehicle: iv, 1 mg/kg, DMSO; po, 10 mg/kg, 1% Tween 80, 2% HPMC, 97% water).</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">PPB by ultracentrifugation.</p></div><div class="footnote" id="t4fn3"><sup><sup>c</sup></sup><p class="last">Maximum unbound plasma concentration (<i>C</i><sub>max</sub>·<i>f</i><sub>u</sub>).</p></div></div></div><div class="NLM_p">To test the effect of (<i>R</i>)-<b>24</b> on KRAS signaling in vivo, (<i>R</i>)-<b>24</b> was dosed orally in athymic nude mice that had been subcutaneously implanted with MIA PaCa-2 T2 human tumor cells (homozygous <i>KRAS p.G12C</i>). Serum and tumor samples were collected 2 h postdosing, revealing dose-proportional exposure of (<i>R</i>)<i>-</i><b>24</b> across administered doses (10–100 mg/kg), with maximal suppression of downstream ERK phosphorylation achieved at doses as low as 30 mg/kg (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>a).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Significantly, at this time point, the 30 mg/kg dose group showed unbound plasma and total tumor exposures (3 and 11 nM, respectively) considerably lower than the in vitro p-ERK IC<sub>50</sub> (28 nM; determined after a 2 h incubation), providing an initial indication that covalent inactivation of KRAS<sup>G12C</sup> could have durable downstream effects, even in the absence of circulating drug.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/medium/jm9b01180_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/large/jm9b01180_0006.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (<i>R</i>)-<b>24</b> inhibits ERK1/2 phosphorylation in <i>KRAS p.G12C</i> tumors (MIA PaCa-2 T2) and causes tumor regression at QD po doses of ≥60 mg/kg. (a) Mice bearing MIA PaCa-2 T2 tumors were given a single oral dose of vehicle (black bar), (<i>R</i>)-<b>24</b> (blue bars), or ARS-1620 (red bar); tumors were harvested 2 h later and assessed for p-ERK levels. Plasma and tumor concentrations of (<i>R</i>)-<b>24</b> are indicated by red triangles and blue open circles, respectively. Data are presented as percent of control versus vehicle ± SEM (<i>n</i> = 3/group): ****<i>p</i> < 0.0001; *<i>p</i> < 0.05 by one-way ANOVA with Dunnett’s post hoc analysis. (b) Effect of (<i>R</i>)-<b>24</b> on MIA PaCa-2 T2 tumor growth in nude mice (QD po dosing). Data represent mean tumor volume ± SEM (<i>n</i> = 10/group): ****<i>p</i> < 0.0001 by RMANOVA followed by Dunnett’s post hoc analysis, <sup>#</sup><i>p</i> < 0.0001 regression by paired <i>t</i> test. (c) Mean unbound plasma concentrations + SEM (<i>n</i> = 3) following 30 mg/kg po dosing in nude mice. p-ERK IC<sub>50,u</sub> = in vitro cellular IC<sub>50</sub>·<i>f</i><sub>u,media</sub> (fraction unbound in cell culture media).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/large/jm9b01180_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01180&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Greatly encouraged by this result, we subsequently profiled (<i>R</i>)-<b>24</b> in a nude mouse xenograft efficacy study using the same MIA PaCa-2 T2 cell line employed in the prior study. Dosed orally once daily (10–100 mg/kg) over 2 weeks following tumor establishment, (<i>R</i>)-<b>24</b> fully suppressed tumor growth at a dose of 30 mg/kg and elicited tumor regression at doses of ≥60 mg/kg (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>b).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> A time-course PK study of (<i>R</i>)-<b>24</b> in nude mice (30 mg/kg, po) again confirmed results from our earlier PK/PD study, showing that in vivo coverage of the in vitro 2 h p-ERK IC<sub>50</sub> for <2–3 h was sufficient to achieve tumor growth stasis (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>c).</div><div class="NLM_p">It came as a great disappointment to us, then, when we subsequently found crystalline polymorphic forms of (<i>R</i>)-<b>24</b> to have significantly reduced oral bioavailability (4–12%) relative to that of the amorphous form used in our earlier studies (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>), impairing our ability to achieve suitable plasma exposures in future studies. As reduced bioavailability coincided with dramatically reduced solubility in biorelevant media (<0.004 mg/mL (crystalline forms) vs >0.108 mg/mL (amorphous form) in FaSSGF, FaSSIF, PBS), we subsequently prioritized efforts to identify (<i>R</i>)-<b>24</b> analogues that demonstrated superior aqueous solubility. Two strategies dominated these efforts: (1) reducing the lipophilicity of (<i>R</i>)-<b>24</b> by changing the quinazolinone C6 halogen substituent and (2) increasing the polar surface area of (<i>R</i>)-<b>24</b> by introducing an additional nitrogen atom into the cryptic pocket ring (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Biopharmaceutical Optimization of (<i>R</i>)-<b>24</b> Significantly Enhances Bioavailability</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/medium/jm9b01180_0016.gif" alt="" id="GRAPHIC-d7e1931-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cmpd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">Y</th><th class="colsep0 rowsep0" align="center">log <i>D</i> (pH 7.4)|PSA (Å<sup>2</sup>)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">p-ERK IC<sub>50</sub> MIA PaCa-2 (μM)<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">viability IC<sub>50</sub> MIA PaCa-2|A549 (μM)<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">Mu|H hep CL<sub>int</sub> ((μL/min)/10<sup>6</sup> cells)</th><th class="colsep0 rowsep0" align="center">MDCK permeability A–B (μcm/s)</th><th class="colsep0 rowsep0" align="center">HT solubility (μM, PBS|FaSSIF|0.01 N HCl)</th><th class="colsep0 rowsep0" align="center">mouse CL (L h<sup>–1</sup> kg<sup>–1</sup>)|<i>V</i><sub>ss</sub> (L/kg)|<i>t</i><sub>1/2</sub> (h)|<i>F</i> (%)<a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>R</i>)-<b>24</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">3.6 | 89</td><td class="colsep0 rowsep0" align="left">0.028</td><td class="colsep0 rowsep0" align="left">0.002 | 11.9</td><td class="colsep0 rowsep0" align="left">102 | 30</td><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left">12|204|9</td><td class="colsep0 rowsep0" align="left">1.4|0.8|0.9|4–12<a class="ref internalNav" href="#t5fn5" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>R</i>)-<b>34</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">2.4 | 102</td><td class="colsep0 rowsep0" align="left">0.011</td><td class="colsep0 rowsep0" align="left">0.001 | 34.1</td><td class="colsep0 rowsep0" align="left">75 | 11</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">46|381|500</td><td class="colsep0 rowsep0" align="left">3.9|1.4|0.4|< 0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>S</i>)-<b>35</b><a class="ref internalNav" href="#t5fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">2.4 | 102</td><td class="colsep0 rowsep0" align="left">0.065</td><td class="colsep0 rowsep0" align="left">0.003 | 32.4</td><td class="colsep0 rowsep0" align="left">96 | 5</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">335|435|534</td><td class="colsep0 rowsep0" align="left">1.4|0.4|0.4|< 0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>R</i>)-<b>36</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">1.7 | 115</td><td class="colsep0 rowsep0" align="left">0.038</td><td class="colsep0 rowsep0" align="left">0.003 | >50</td><td class="colsep0 rowsep0" align="left">139 | 5</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">499|500|421</td><td class="colsep0 rowsep0" align="left">3.5|1.1|0.3|< 0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>R</i>)-<b>37</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">3.0 | 89</td><td class="colsep0 rowsep0" align="left">0.090</td><td class="colsep0 rowsep0" align="left">0.011 | 11.6</td><td class="colsep0 rowsep0" align="left">111 | 37</td><td class="colsep0 rowsep0" align="left">22</td><td class="colsep0 rowsep0" align="left">41|164|24</td><td class="colsep0 rowsep0" align="left">2.0|1.0|0.5|< 0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>R</i>)-<b>38</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">2.0 | 102</td><td class="colsep0 rowsep0" align="left">0.068</td><td class="colsep0 rowsep0" align="left">0.005  |36.5</td><td class="colsep0 rowsep0" align="left">36 | 9</td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">423|492|499</td><td class="colsep0 rowsep0" align="left">1.6|0.7|0.5|22–40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>S</i>)-<b>39</b><a class="ref internalNav" href="#t5fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">2.0 | 102</td><td class="colsep0 rowsep0" align="left">0.142</td><td class="colsep0 rowsep0" align="left">0.016 | 49.1</td><td class="colsep0 rowsep0" align="left">100 | 9</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">426|477|484</td><td class="colsep0 rowsep0" align="left">3.7|1.1|0.3|15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>R</i>)-<b>40</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">1.2 | 115</td><td class="colsep0 rowsep0" align="left">0.128</td><td class="colsep0 rowsep0" align="left">0.009 | >50</td><td class="colsep0 rowsep0" align="left">65 | 5</td><td class="colsep0 rowsep0" align="left"><1</td><td class="colsep0 rowsep0" align="left">495|500|500</td><td class="colsep0 rowsep0" align="left">4.7|1.7|0.3|10</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">log <i>D</i> (pH 7.4) and PSA (polar surface area) calculated using ACD/Percepta (ACD/Labs, Toronto, Canada).</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">p-ERK1/2 immunoassay (MSD), 2 h incubation.</p></div><div class="footnote" id="t5fn3"><sup><sup>c</sup></sup><p class="last">Viability assessed at 72 h by CellTiter-Glo luminescence assay (Promega) in MIA PaCa-2 (<i>p.G12C</i>) and A549 (<i>p.G12S</i>) cell lines. All data represent <i>n</i> ≥ 2.</p></div><div class="footnote" id="t5fn4"><sup><sup>d</sup></sup><p class="last">iv/po dosing in BALB/c mice (vehicle: iv, 1 mg/kg, DMSO; po, 10 mg/kg, 1% Tween 80, 2% HPMC, 97% water).</p></div><div class="footnote" id="t5fn5"><sup><sup>e</sup></sup><p class="last">Crystalline polymorphs.</p></div><div class="footnote" id="t5fn6"><sup><sup>f</sup></sup><p class="last">Presence of the pyridyl nitrogen changes IUPAC substituent priority for naming purposes; the isopropyl substituent remains oriented toward the cryptic pocket, as in other analogues.</p></div></div></div><div class="NLM_p">Initial efforts focused on nitrogen atom incorporation into the cryptic pocket ring. Replacement of the carbon atoms adjacent to the isopropyl or methyl substituents with nitrogen atoms (cf., compounds <b>34</b> and <b>35</b>, respectively) significantly enhanced aqueous solubility without appreciably altering KRAS activity. Such substitution also substantially reduced MDCK permeability, however, affording molecules with no measurable oral bioavailability (BALB/c mice). Although bis-nitrogen substitution (<b>36</b>) likewise further enhanced aqueous solubility, the resulting pyrimidine analogue similarly suffered from low permeability and no measurable oral bioavailability.</div><div class="NLM_p">We next investigated whether reducing the lipophilicity of the quinazolinone C6 substituent could enhance aqueous solubility while preserving cellular activity. While replacing the C6 chloro substituent of (<i>R</i>)-<b>24</b> with a fluoro substituent (compound <b>37</b>) led to a modest loss of activity in cellular assays (e.g., p-ERK IC<sub>50</sub> = 90 nM), the change also resulted in a modest increase in aqueous solubility (∼3-fold) and no adverse impact on membrane permeability (<i>P</i><sub>AB</sub> = 22 μcm/s). Unfortunately, (<i>R</i>)-<b>37</b> failed to show any measurable oral bioavailability (<i>F</i> < 0.5%). Combining C6 fluoro substitution with nitrogen incorporation in the cryptic pocket arene ring (compounds <b>38</b>–<b>40</b>), however, overcame the consistently low bioavailabilities seen with prior analogues. Although nitrogen atom incorporation again led to significantly reduced MDCK permeabilities for all three compounds, this combination of features led to dramatically enhanced aqueous solubilities (>423 μM in all biorelevant media). From these studies, (<i>R</i>)-<b>38</b> emerged as the standout molecule, showing good activity in cellular assays (p-ERK IC<sub>50</sub> = 68 nM), moderate permeability (<i>P</i><sub>AB</sub> = 6 μcm/s), and exceptional oral bioavailability (22–40% as a crystalline form).</div><div class="NLM_p">Gratifyingly, (<i>R</i>)-<b>38</b> demonstrated dose-proportional plasma exposure when dosed orally (0.3–100 mg/kg) in our nude mouse MIA PaCa-2 xenograft model and significantly suppressed ERK phosphorylation at doses of ≥10 mg/kg (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>a).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> To further interrogate the PK/PD relationship for (<i>R</i>)-<b>38</b>, we also conducted a time-course pharmacodynamic study in this xenograft model (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>b). This study supported earlier results with (<i>R</i>)-<b>24</b> and (<i>R</i>)-<b>38</b>, showing that, while maximal suppression of ERK phosphorylation was achieved 60–120 min postdosing, peak (<i>R</i>)-<b>38</b> plasma and tumor exposures were achieved 30 min postdosing, and by the 120 min time point, only low concentrations of (<i>R</i>)-<b>38</b> remained in circulation.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/medium/jm9b01180_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/large/jm9b01180_0007.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Data are initially published in ref <a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a>. p-ERK (a) dose–response and (b) time-course (MSD) data with plasma and tumor exposures for compound (<i>R</i>)-<b>38</b>. Mice bearing MIA PaCa-2 T2 tumors were given a single oral dose of either vehicle (black bars) or (<i>R</i>)-<b>38</b> (blue bars) and harvested at the indicated time. Data represent percent of control versus vehicle ± SEM (<i>n</i> = 3/group). Plasma and tumor concentrations of (<i>R</i>)-<b>24</b> are indicated by red triangles and blue open circles, respectively: ****<i>p</i> < 0.0001; ***<i>p</i> < 0.001; *<i>p</i> < 0.05 by one-way ANOVA with Dunnett’s post hoc analysis. (c) p-ERK POC (MSD) and percent KRAS<sup>G12C</sup> covalent modification (MS) time-course in MIA PaCa-2 T2 mouse xenografts. Markers represent mean p-ERK1/2 levels (percent of basal ERK1/2) ± SEM and mean % covalent modification ± SEM (<i>n</i> = 3/group).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/large/jm9b01180_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01180&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A time-course study of KRAS<sup>G12C</sup> ligand occupancy in the MIA PaCa-2 xenograft model shed further light on this PK/PD relationship (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>c). By use of protein immunocapture, trypsin digestion, and mass spectrometry, KRAS<sup>G12C</sup> covalent modification in tumor cells recovered from treated mice was monitored over time, revealing suppression of ERK phosphorylation to closely mirror the extent of covalent modification of KRAS<sup>G12C</sup>.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Covalent modification of KRAS<sup>G12C</sup> was nearly complete 120 min postdosing, at which point minimal (<i>R</i>)-<b>38</b> remained in circulation.</div><div class="NLM_p">Encouraged by these promising pharmacodynamic effects, (<i>R</i>)-<b>38</b> was profiled in a mouse xenograft efficacy study employing MIA PaCa-2 T2 (<i>p.G12C</i>) tumor cells. Once-daily oral dosing (10–100 mg/kg) achieved 86% tumor growth inhibition (TGI) at 10 mg/kg and produced significant tumor regression at doses of ≥30 mg/kg (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>a). Unbound plasma exposures from this study (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>b) again illustrated that durable growth responses could be achieved in the absence of continuous drug exposure given the covalent inhibitor mechanism of action. At a dose of 10 mg/kg, plasma coverage of the in vitro p-ERK IC<sub>50</sub> was only sustained for ∼1 h, and circulating, unbound concentrations of (<i>R</i>)-<b>38</b> had dropped below 1 nM 8 h postdosing. Nonetheless, 1 h coverage of the in vitro p-ERK IC<sub>50</sub> proved sufficient to achieve near-stasis in tumor growth, and in vitro IC<sub>50</sub> coverage for as little as 2 h (30 mg/kg dose) was sufficient to cause tumor regression.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/medium/jm9b01180_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/large/jm9b01180_0008.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Data are initially published in ref <a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Compound (<i>R</i>)-<b>38</b> dosed orally once daily results in regression of <i>KRAS p.G12C</i> tumor xenografts. (a) Effect of compound (<i>R</i>)-<b>38</b> on MIA PaCa-2 T2 xenograft growth in nude mice (QD PO dosing). Data represent the mean tumor volume ± SEM (<i>n</i> = 10/group): ****<i>p</i> < 0.0001 by Dunnett’s post hoc analysis; <sup>#</sup><i>p</i> < 0.05 regression by paired <i>t</i> test. (b) Mean unbound plasma concentrations ± SEM (<i>n</i> = 2/group). p-ERK IC<sub>50,u</sub> = in vitro cellular IC<sub>50</sub>·<i>f</i><sub>u,media</sub> (fraction unbound in cell culture media).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/large/jm9b01180_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01180&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Delighted by the promising pharmacodynamic effect of (<i>R</i>)-<b>38</b> in our mouse models, we undertook further characterization of (<i>R</i>)-<b>38</b> to assess its potential as a possible development candidate. Cocrystallization with KRAS<sup>G12C</sup> revealed (<i>R</i>)-<b>38</b> to adopt a similar binding mode to prior quinazolinone leads, with the quinazolinone core of (<i>R</i>)-<b>38</b> occupying the KRAS switch II pocket and the acrylamide moiety making a covalent bond with C12 (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>). The (<i>S</i>)-methylpiperazine ring of (<i>R</i>)-<b>38</b> adopted a twist-boat conformation, with the C2 methyl substituent making close contacts with C12 and Y96. Critically, the isopropyl substituent of the pyridyl ring again made close contacts with Y96, H95, and Q99, largely filling the cryptic pocket revealed by side chain rotation of the H95 residue and contributing to the exceptional potency of this molecule. Nitrogen substitution of the cryptic pocket arene ring was not found to adversely impact the configurational stability of the potent <i>R</i>-atropisomer, which was calculated to have a racemization <i>t</i><sub>1/2</sub> of >180 years at 25 °C (Δ<i>G</i><sup>⧧</sup><sub>rotation</sub> > 31 kcal/mol; <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>).</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/medium/jm9b01180_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/large/jm9b01180_0009.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. X-ray crystal structure of compound (<i>R</i>)-<b>38</b> bound to GDP-KRAS<sup>G12C</sup> (cyan, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6OIM">6OIM</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/large/jm9b01180_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01180&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Additional in Vitro and PK Characterization of Compound (<i>R</i>)-<b>38</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">atropisomer interconversion barrier (Δ<i>G</i><sup>⧧</sup>, kcal/mol)<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">>31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat CL (L h<sup>–1</sup> kg<sup>–1</sup>)|<i>V</i><sub>ss</sub> (L/kg)|<i>t</i><sub>1/2</sub> (h)|<i>F</i> (%)<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">3.4|2.0|0.5|28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog CL (L h<sup>–1</sup> kg<sup>–1</sup>)|<i>V</i><sub>ss</sub> (L/kg)|<i>t</i><sub>1/2</sub> (h)|<i>F</i> (%)<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">2.2|0.73|0.4|34</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PPB Mu|R|D|Hu (0.25 μM, UC, <i>f</i><sub>u</sub>)</td><td class="colsep0 rowsep0" align="left">0.06|0.05|0.17|0.09</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">KRAS<sup>G12C</sup><i>k</i><sub>inact</sub>/<i>K</i><sub>I</sub> (M<sup>–1</sup> s<sup>–1</sup>)<a class="ref internalNav" href="#t6fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">9900 ± 1800</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5 mM GSH <i>t</i><sub>1/2</sub> (min)<a class="ref internalNav" href="#t6fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">200</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">Determined by NMR kinetic data.</p></div><div class="footnote" id="t6fn2"><sup><sup>b</sup></sup><p class="last">iv/po dosing in Sprague-Dawley rat (vehicle: iv, 1 mg/kg, DMSO; po, 10 mg/kg, 1% Tween 80, 2% HPMC, 97% water).</p></div><div class="footnote" id="t6fn3"><sup><sup>c</sup></sup><p class="last">iv/po dosing in Beagle dog (vehicle: iv, 1 mg/kg, 10% DMAC, 10% EtOH, 30% propylene glycol, 50% water; po, 10 mg/kg, 1% Tween 80, 2% HPMC, 97% water).</p></div><div class="footnote" id="t6fn4"><sup><sup>d</sup></sup><p class="last"><i>k</i><sub>inact</sub>/<i>K</i><sub>I</sub> was determined from time-course relative % bound data at varied inhibitor concentrations, as assessed by mass spectrometry.<a onclick="showRef(event, 'ref28 ref31'); return false;" href="javascript:void(0);" class="ref ref28 ref31">(28,31)</a></p></div><div class="footnote" id="t6fn5"><sup><sup>e</sup></sup><p class="last"><i>t</i><sub>1/2</sub> determined by parent depletion (MS detection) in 5 mM GSH, 37 °C, pH 7.4 aqueous phosphate buffer.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></p></div></div></div><div class="NLM_p">Rat and dog pharmacokinetic parameters for (<i>R</i>)-<b>38</b> were in line with those observed in mouse, with reasonable oral bioavailability observed in all species. Although terminal half-lives for (<i>R</i>)-<b>38</b> were relatively short in all species, this was not viewed as a liability, given our findings from prior pharmacodynamic studies that durable covalent inhibition of KRAS<sup>G12C</sup> could be achieved without continuous drug exposure. Such persistent PD effects are in line with those expected for covalent inhibitors, where duration of target inhibition is determined not by the duration of target IC<sub>50</sub> coverage but rather by the resynthesis rate of the covalently inactivated target protein.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Given KRAS’s long protein half-life (∼22 h),<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> rapid covalent inactivation allows for durable pharmacodynamic effects even in the face of relatively short inhibitor plasma half-lives.</div><div class="NLM_p">Although mass spectrometric studies<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> established (<i>R</i>)-<b>38</b> to have a second-order rate constant for covalent inactivation of KRAS<sup>G12C</sup> (<i>k</i><sub>inact</sub>/<i>K</i><sub>I</sub>) of 9900 M<sup>–1</sup> s<sup>–1</sup>, rapid inactivation of KRAS was not indicative of promiscuous cysteine reactivity. Incubation of (<i>R</i>)-<b>38</b> under conditions mimicking intracellular glutathione levels (5 mM GSH, 37 °C, pH 7.4)<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> revealed (<i>R</i>)-<b>38</b> to have a GSH conjugation half-life of 200 min. Cysteine-proteome profiling (MS) further revealed (<i>R</i>)-<b>38</b> to be highly selective for covalent modification of KRAS<sup>G12C</sup>: of 6451 cysteine-containing peptides profiled, only the KRAS<sup>G12C</sup> C12 peptide was found to be significantly modified .<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><div class="NLM_p last">On the basis of the compelling pharmacological profile of (<i>R</i>)-<b>38</b> and its marked ability to regress <i>KRAS p.G12C</i> mutant tumors in vivo, its promising biopharmaceutical properties, and its excellent tolerability in preclinical toxicological models,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> we nominated (<i>R</i>)-<b>38</b> for clinical development as AMG 510. AMG 510 entered human clinical trials in August 2018, and a phase I/II trial evaluating its safety, tolerability, pharmacokinetic properties, and efficacy in <i>KRAS p.G12C</i> mutant tumors is currently ongoing (NCT03600883<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a>). Early results from this study have confirmed AMG 510 to demonstrate excellent tolerability and promising antitumor activity when administered as a monotherapy to patients with advanced <i>KRAS p.G12C</i> mutant solid tumors.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Dose-expansion efforts are currently ongoing.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18275" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18275" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">By exploiting a previously unrecognized H95/Y96/Q99 cryptic pocket in GDP-KRAS<sup>G12C</sup>, we were able to create highly potent and selective covalent inhibitors of KRAS<sup>G12C</sup>. A collaboration with Carmot Therapeutics<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> enabled us to rapidly screen cysteine-reactive libraries and investigate the potential of this cryptic pocket. Structure-based design efforts facilitated our discovery of a quinazolinone-based scaffold, which exploited this pocket for enhanced potency and provided ADME properties suitable for further optimization. Optimally leveraging the H95/Y96/Q99 cryptic pocket required us to address axial chirality and configurational stability issues, which were overcome by optimization of the cryptic pocket-engaging arene moiety. Further refinement of the resulting leads to address permeability, solubility, and oral bioavailability challenges then led to our discovery of AMG 510. AMG 510 has shown great promise in the treatment of <i>KRAS p.G12C</i> mutant tumors both preclinically and clinically. Efforts to further demonstrate the clinical potential of AMG 510 are currently underway.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52261" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52261" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> General Synthetic Procedures</h3><div class="NLM_p last">All materials were obtained from commercial suppliers and used without further purification unless otherwise noted. Anhydrous solvents were obtained from Sigma-Aldrich and used directly. Reactions involving air- or moisture-sensitive reagents were performed under a nitrogen or argon atmosphere. Silica gel chromatography was performed using prepacked silica gel cartridges (RediSep Rf, Teledyne ISCO). Reverse-phase HPLC purification was performed using Gilson (Middleton, WI) workstations. NMR spectra were acquired on Bruker Avance 400, 500, and 600 MHz spectrometers equipped with 5 mm BBFO probes. All final compounds were purified to >95% purity as determined by LC–MS using an Agilent 1100 or 1260 multiwavelength detector (215 nm detection) and an Advanced Materials Technology HALO C18 column (50 mm × 3.0 mm, 2.7 μm) at 40 °C with a 2.0 mL/min flow rate using a 5–95% gradient of acetonitrile/water with 0.1% trifluoracetic acid over 1.5 min. Low-resolution MS data were obtained concurrently with UV chromatography using an Agilent G1956B MSD SL, 6120B, 6130B, or 6140A quadrupole MS in positive electrospray ionization mode. Resolved atropisomers were purified to >95% ee (or de) using a Thar 80, 200, or 350 preparative SFC. Enantiomeric and diastereomeric excesses were determined by SFC (Waters Acquity UPC2 or Agilent 1260 Infinity analytical systems).</div></div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Synthesis of AMG 510 [(<i>R</i>)-<b>38</b>]. Step 1. 2,6-Dichloro-5-fluoronicotinamide</h3><div class="NLM_p last">Oxalyl chloride (2 M solution in DCM, 11.9 mL, 23.8 mmol) and DMF (0.05 mL) were sequentially added to 2,6-dichloro-5-fluoronicotinic acid (4.0 g, 19.1 mmol, AstaTech, Inc.) in DCM (48 mL), and the resulting mixture was stirred at ambient temperature for 16 h. The reaction mixture was then concentrated in vacuo, and the residue was dissolved in 1,4-dioxane (48 mL) and cooled to 0 °C. Ammonium hydroxide solution (28–30% NH<sub>3</sub> basis, 3.6 mL, 28.6 mmol) was slowly added, and the resulting mixture was stirred at 0 °C for 30 min. The mixture was then concentrated in vacuo, and the residue was diluted with 1:1 EtOAc/heptane, agitated for 5 min, and filtered. The filtrate was concentrated to half-volume and refiltered. The combined collected solids were washed with heptane and dried overnight in a reduced-pressure oven (45 °C) to provide 2,6-dichloro-5-fluoronicotinamide (2.0 g, 50% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.23 (d, <i>J</i> = 7.9 Hz, 1 H) 8.09 (br s, 1 H) 7.93 (br s, 1 H). <sup>19</sup>F NMR (376 MHz, DMSO-<i>d</i><sub>6</sub>) δ: – 122.39 (s, 1 F). <i>m</i>/<i>z</i> (ESI, +ve ion): 208.9 (M + H)<sup>+</sup>.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Step 2. 2,6-Dichloro-5-fluoro-<i>N</i>-((2-isopropyl-4-methylpyridin-3-yl)carbamoyl)nicotinamide</h3><div class="NLM_p last">To an ice-cooled slurry of 2,6-dichloro-5-fluoronicotinamide (5.0 g, 23.9 mmol) in THF (20 mL) was slowly added oxalyl chloride (2 M solution in DCM, 14.4 mL, 28.8 mmol). The resulting mixture was stirred at 75 °C for 1 h, then allowed to cool and concentrated in vacuo to half volume. The concentrate was cooled to 0 °C and diluted with THF (20 mL). A solution of 2-isopropyl-4-methylpyridin-3-amine (3.59 g, 23.9 mmol) in THF (10 mL) was added dropwise via cannula. The resulting mixture was stirred at 0 °C for 1 h, diluted with a 1:1 mixture of brine and saturated aqueous ammonium chloride, and extracted with EtOAc (3×). The combined organic extracts were dried over anhydrous sodium sulfate and concentrated in vacuo to provide 2,6-dichloro-5-fluoro-<i>N</i>-((2-isopropyl-4-methylpyridin-3-yl)carbamoyl)nicotinamide, which was used without further purification. <i>m</i>/<i>z</i> (ESI, +ve ion): 385.1 (M + H)<sup>+</sup>.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Intermediate, Step 2. 2-Isopropyl-4-methylpyridin-3-amine</h3><div class="NLM_p last">To a slurry of 3-amino-2-bromo-4-picoline (360 mg, 1.9 mmol; Combi-Blocks, Inc.) in THF (4 mL) was added [1,1′-bis(diphenylphosphino)ferrocene]dichloropalladium(II), complex with DCM (79 mg, 0.10 mmol). The resulting slurry was deoxygenated with argon, then 2-propylzinc bromide (0.5 M solution in THF, 5.4 mL, 2.7 mmol) was added. The resulting solution was stirred at 60 °C for 17 h, then the reaction was allowed to cool to ambient temperature. Water (10 mL) and 1 N NaOH solution (20 mL) were sequentially added, and the resulting mixture was extracted with EtOAc (2×). The combined organic extracts were dried over anhydrous sodium sulfate and concentrated in vacuo. Chromatographic purification of the residue (silica gel; 0–15% MeOH/DCM) provided 2-isopropyl-4-methylpyridin-3-amine (284 mg, 98% yield) as a brown solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub><i>6</i></sub>) δ ppm 7.66 (d, <i>J</i> = 4.6 Hz, 1 H), 6.78 (d, <i>J</i> = 4.8 Hz, 1 H), 4.72 (br s, 2 H), 3.14–3.25 (m, 1 H), 2.08 (s, 3 H), 1.14 (d, <i>J</i> = 6.8 Hz, 6 H). <i>m</i>/<i>z</i> (ESI, +ve ion): 151.1 (M + H)<sup>+</sup>.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Step 3. 7-Chloro-6-fluoro-1-(2-isopropyl-4-methylpyridin-3-yl)pyrido[2,3-<i>d</i>]pyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione</h3><div class="NLM_p last">To an ice-cooled solution of 2,6-dichloro-5-fluoro-<i>N</i>-((2-isopropyl-4-methylpyridin-3-yl)carbamoyl)nicotinamide (9.2 g, 24.0 mmol) in THF (40 mL) was slowly added KHMDS (1 M solution in THF, 50.2 mL, 50.2 mmol). The ice bath was removed, and the resulting mixture was stirred for 40 min at ambient temperature. Saturated aqueous ammonium chloride solution was added, and the resulting mixture was extracted with EtOAc (3×). The combined organic extracts were dried over anhydrous sodium sulfate and concentrated in vacuo. Chromatographic purification of the residue (silica gel; 0–50% 3:1 EtOAc–EtOH/heptane) provided 7-chloro-6-fluoro-1-(2-isopropyl-4-methylpyridin-3-yl)pyrido[2,3-<i>d</i>]pyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione (9.24 g, quantitative yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub><i>6</i></sub>) δ 12.27 (br s, 1 H), 8.48–8.55 (m, 2 H), 7.29 (d, <i>J</i> = 4.8 Hz, 1 H), 2.87 (quin, <i>J</i> = 6.6 Hz, 1 H), 1.99–2.06 (m, 3 H), 1.09 (d, <i>J</i> = 6.6 Hz, 3 H), 1.01 (d, <i>J</i> = 6.6 Hz, 3 H). <sup>19</sup>F NMR (376 MHz, DMSO-<i>d</i><sub>6</sub>) δ −126.90 (s, 1 F). <i>m</i>/<i>z</i> (ESI, +ve ion): 349.1 (M + H)<sup>+</sup>.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Step 4. 4,7-Dichloro-6-fluoro-1-(2-isopropyl-4-methylpyridin-3-yl)pyrido[2,3-<i>d</i>]pyrimidin-2(1<i>H</i>)-one</h3><div class="NLM_p last">Phosphorus oxychloride (1.63 mL, 17.5 mmol) was added, dropwise, to a solution of 7-chloro-6-fluoro-1-(2-isopropyl-4-methylpyridin-3-yl)pyrido[2,3-<i>d</i>]pyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione (4.7 g, 13.5 mmol) and DIPEA (3.5 mL, 20 mmol) in acetonitrile (20 mL), and the resulting mixture was stirred at 80 °C for 1 h, then cooled to ambient temperature and concentrated in vacuo to provide 4,7-dichloro-6-fluoro-1-(2-isopropyl-4-methylpyridin-3-yl)pyrido[2,3-<i>d</i>]pyrimidin-2(1<i>H</i>)-one, which was used without further purification. <i>m</i>/<i>z</i> (ESI, +ve ion): 367.1 (M + H)<sup>+</sup>.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Step 5. (<i>S</i>)-<i>tert</i>-Butyl 4-(7-Chloro-6-fluoro-1-(2-isopropyl-4-methylpyridin-3-yl)-2-oxo-1,2-dihydropyrido[2,3-<i>d</i>]pyrimidin-4-yl)-3-methylpiperazine-1-carboxylate</h3><div class="NLM_p last">To an ice-cooled solution of 4,7-dichloro-6-fluoro-1-(2-isopropyl-4-methylpyridin-3-yl)pyrido[2,3-<i>d</i>]pyrimidin-2(1<i>H</i>)-one (13.5 mmol) in acetonitrile (20 mL) was added DIPEA (7.1 mL, 40.3 mmol) followed by (<i>S</i>)-4-Boc-2-methylpiperazine (3.23 g, 16.1 mmol, Combi-Blocks, Inc.). The resulting mixture was warmed to ambient temperature and stirred for 1 h, then diluted with cold saturated aqueous sodium bicarbonate solution (200 mL) and EtOAc (300 mL). The mixture was stirred for an additional 5 min, and the organic layer was collected. The aqueous layer was extracted with additional EtOAc (1×), and the combined organic extracts were dried over anhydrous sodium sulfate and concentrated in vacuo. Chromatographic purification of the residue (silica gel; 0–50% EtOAc/heptane) gave (<i>S</i>)-<i>tert</i>-butyl 4-(7-chloro-6-fluoro-1-(2-isopropyl-4-methylpyridin-3-yl)-2-oxo-1,2-dihydropyrido[2,3-<i>d</i>]pyrimidin-4-yl)-3-methylpiperazine-1-carboxylate (5.71 g, 80% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub><i>6</i></sub>) δ 8.45–8.51 (1 H, m), 8.31–8.41 (1 H, m), 7.23–7.29 (1 H, m), 4.67–5.01 (1 H, m), 4.09–4.25 (1 H, m), 3.88–4.07 (1 H, m), 3.78–3.87 (1 H, m), 3.59–3.74 (1 H, m), 3.04–3.21 (2 H, m), 2.59–2.66 (1 H, m), 1.88–1.98 (3 H, m), 1.43–1.50 (9 H, m), 1.27–1.35 (3 H, m), 1.03–1.10 (3 H, m), 0.94–1.03 (3 H, m). <i>m</i>/<i>z</i> (ESI, +ve ion): 531.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Step 6. (3<i>S</i>)-<i>tert</i>-Butyl 4-(6-Fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(2-isopropyl-4-methylpyridin-3-yl)-2-oxo-1,2-dihydropyrido[2,3-<i>d</i>]pyrimidin-4-yl)-3-methylpiperazine-1-carboxylate</h3><div class="NLM_p last">A mixture of (<i>S</i>)-<i>tert</i>-butyl 4-(7-chloro-6-fluoro-1-(2-isopropyl-4-methylpyridin-3-yl)-2-oxo-1,2-dihydropyrido[2,3-<i>d</i>]pyrimidin-4-yl)-3-methylpiperazine-1-carboxylate (4.3 g, 8.1 mmol), (2-fluoro-6-hydroxyphenyl)potassium trifluoroborate (2.9 g, 10.5 mmol), potassium acetate (3.2 g, 32.4 mmol), and [1,1′-bis(diphenylphosphino)ferrocene]dichloropalladium(II) complex with dichloromethane (661 mg, 0.81 mmol) in 1,4-dioxane (80 mL) was sparged with nitrogen for 1 min. Deoxygenated water (14 mL) was added, and the resulting mixture was heated at 90 °C for 1 h, then cooled to ambient temperature, diluted with half-saturated aqueous sodium bicarbonate, and sequentially extracted with EtOAc (2×) and DCM (1×). The combined organic extracts were dried over anhydrous sodium sulfate and concentrated in vacuo. Chromatographic purification of the residue (silica gel; 0–60% 3:1 EtOAc–EtOH/heptane) furnished (3<i>S</i>)-<i>tert</i>-butyl 4-(6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(2-isopropyl-4-methylpyridin-3-yl)-2-oxo-1,2-dihydropyrido[2,3-<i>d</i>]pyrimidin-4-yl)-3-methylpiperazine-1-carboxylate (4.52 g, 92% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub><i>6</i></sub>) δ 10.19 (br s, 1 H), 8.38 (d, <i>J</i> = 5.0 Hz, 1 H), 8.26 (dd, <i>J</i> = 12.5, 9.2 Hz, 1 H), 7.23–7.28 (m, 1 H), 7.18 (d, <i>J</i> = 5.0 Hz, 1 H), 6.72 (d, <i>J</i> = 8.0 Hz, 1 H), 6.68 (t, <i>J</i> = 8.9 Hz, 1 H), 4.77–4.98 (m, 1 H), 4.24 (br t, <i>J</i> = 14.2 Hz, 1 H), 3.93–4.08 (m, 1 H), 3.84 (br d, <i>J</i> = 12.9 Hz, 1 H), 3.52–3.75 (m, 1 H), 3.07–3.28 (m, 1 H), 2.62–2.74 (m, 1 H), 1.86–1.93 (m, 3 H), 1.43–1.48 (m, 9 H), 1.35 (dd, <i>J</i> = 10.8, 6.8 Hz, 3 H), 1.26–1.32 (m, 1 H), 1.07 (dd, <i>J</i> = 6.6, 1.7 Hz, 3 H), 0.93 (dd, <i>J</i> = 6.6, 2.1 Hz, 3 H). <sup>19</sup>F NMR (376 MHz, DMSO-<i>d</i><sub>6</sub>) δ −115.6 (s, 1 F), −128.6 (s, 1 F). <i>m</i>/<i>z</i> (ESI, +ve ion): 607.3 (M + H)<sup>+</sup>.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Intermediate, Step 6. (2-Fluoro-6-hydroxyphenyl)potassium Trifluoroborate</h3><div class="NLM_p last">A solution of potassium fluoride (44.7 g, 770 mmol) in water (75 mL) was added to a suspension of (2-fluoro-6-hydroxyphenyl)boronic acid (30 g, 192 mmol, Combi-Blocks, Inc.) in acetonitrile (750 mL). After 2 min of stirring, a solution of <span class="smallcaps smallerCapital">l</span>-(+)-tartaric acid (72.2 g, 481 mmol) in THF (375 mL) was added over 10 min. The resulting mixture was mechanically stirred for 1 h. Suspended solids were removed by filtration and washed with a small amount of THF. The combined filtrate was then partially concentrated in vacuo until solids began to precipitate. The filtrate was cooled to −20 °C and stirred for 16 h, then slowly warmed to ambient temperature. 2-Propanol (20 mL) was added, and the precipitated solid was collected by filtration and washed with 2-propanol to provide 27.5 g of solid. The filtrate was again partially concentrated (until precipitation was observed), cooled to −20 °C, and stirred for 20 min. Additional 2-propanol was added, and the precipitated solid was collected by filtration and washed with 2-propanol. The two batches of solid were combined to provide (2-fluoro-6-hydroxyphenyl)potassium trifluoroborate (34.6 g, 82% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub><i>6</i></sub>) δ 8.07 (q, <i>J</i> = 14.7 Hz, 1 H), 6.93 (q, <i>J</i> = 7.5 Hz, 1 H), 6.30–6.38 (m, 2 H).</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> AMG 510 [(<i>R</i>)-<b>38</b>]. (1<i>R</i>)-6-Fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-[4-methyl-2-(1-methylethyl)-3-pyridinyl]-4-[(2<i>S</i>)-2-methyl-4-(1-oxo-2-propen-1-yl)-1-piperazinyl]-pyrido[2,3-<i>d</i>]pyrimidin-2(1<i>H</i>)-one</h3><div class="NLM_p last">Trifluoroacetic acid (25 mL, 320 mmol) was added to a solution of (3<i>S</i>)-<i>tert</i>-butyl 4-(6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(2-isopropyl-4-methylpyridin-3-yl)-2-oxo-1,2-dihydropyrido[2,3-<i>d</i>]pyrimidin-4-yl)-3-methylpiperazine-1-carboxylate (6.3 g, 10 mmol) in DCM (30 mL), and the resulting mixture was stirred at ambient temperature for 1 h. The mixture was then concentrated in vacuo, and the residue was taken up in DCM (30 mL), cooled to 0 °C, and sequentially treated with DIPEA (7.3 mL, 42 mmol) and a solution of acryloyl chloride (0.849 mL, 10.4 mmol) in DCM (3 mL; added dropwise). The resulting mixture was stirred at 0 °C for 10 min, then diluted with half-saturated aqueous sodium bicarbonate and extracted with DCM (2×). The combined extracts were dried over anhydrous sodium sulfate and concentrated in vacuo. Chromatographic purification of the residue (silica gel; 0–100% 3:1 EtOAc–EtOH/heptane) followed by chiral supercritical fluid chromatography (Chiralpak IC, 30 mm × 250 mm, 5 μm, 55% MeOH/CO<sub>2</sub>, 120 mL/min, 102 bar) provided (1<i>R</i>)-6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-[4-methyl-2-(1-methylethyl)-3-pyridinyl]-4-[(2<i>S</i>)-2-methyl-4-(1-oxo-2-propen-1-yl)-1-piperazinyl]pyrido[2,3-<i>d</i>]pyrimidin-2(1<i>H</i>)-one (AMG 510; (<i>R</i>)-<b>38</b>; 2.25 g, 43% yield) as the first-eluting peak. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 10.20 (s, 1H), 8.39 (d, <i>J</i> = 4.9 Hz, 1H), 8.30 (d, <i>J</i> = 8.9 Hz, 0.5H), 8.27 (d, <i>J</i> = 8.7 Hz, 0.5H), 7.27 (q, <i>J</i> = 8.4 Hz, 1H), 7.18 (d, <i>J</i> = 4.9 Hz, 1H), 6.87 (dd, <i>J</i> = 16.2, 10.8 Hz, 0.5H), 6.84 (dd, <i>J</i> = 16.2, 10.7 Hz, 0.5H), 6.74 (d, <i>J</i> = 8.4 Hz, 1H), 6.68 (t, <i>J</i> = 8.4 Hz, 1H), 6.21 (d, <i>J</i> = 16.2 Hz, 0.5H), 6.20 (d, <i>J</i> = 16.2 Hz, 0.5H), 5.76 (d, <i>J</i> = 10.8 Hz, 0.5H), 5.76 (d, <i>J</i> = 10.7 Hz, 0.5H), 4.91 (m, 1H), 4.41 (d, <i>J</i> = 12.2 Hz, 0.5H), 4.33 (d, <i>J</i> = 12.2 Hz, 1H), 4.28 (d, <i>J</i> = 12.2 Hz, 0.5H), 4.14 (d, <i>J</i> = 12.2 Hz, 0.5H), 4.02 (d, <i>J</i> = 13.6 Hz, 0.5H), 3.69 (m, 1H), 3.65 (d, <i>J</i> = 13.6 Hz, 0.5H), 3.52 (t, <i>J</i> = 12.2 Hz, 0.5H), 3.27 (d, <i>J</i> = 12.2 Hz, 0.5H), 3.15 (t, <i>J</i> = 12.2 Hz, 0.5H), 2.72 (m, 1H), 1.90 (s, 3H), 1.35 (d, <i>J</i> = 6.7 Hz, 3H), 1.08 (d, <i>J</i> = 6.7 Hz, 3H), 0.94 (d, <i>J</i> = 6.7 Hz, 3H). <sup>19</sup>F NMR (376 MHz, DMSO-<i>d</i><sub>6</sub>) δ −115.6 (d, <i>J</i> = 5.2 Hz, 1 F), −128.6 (br s, 1 F). <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 165.0 (1C), 163.4 (1C), 162.5 (1C), 160.1 (1C), 156.8 (1C), 153.7 (1C), 151.9 (1C), 149.5 (1C), 148.3 (1C), 145.2 (1C), 144.3 (1C), 131.6 (1C), 130.8 (1C), 127.9 (0.5C), 127.9 (0.5C), 127.8 (0.5C), 127.7 (0.5C), 123.2 (1C), 122.8 (1C), 111.7 (1C), 109.7 (1C), 105.7 (1C), 105.3 (1C), 51.4 (0.5C), 51.0 (0.5C), 48.9 (0.5C), 45.4 (0.5C), 44.6 (0.5C), 43.7 (0.5C), 43.5 (0.5C), 41.6 (0.5C), 29.8 (1C), 21.9 (1C), 21.7 (1C), 17.0 (1C), 15.5 (0.5C), 14.8 (0.5C). FTMS (ESI) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> calcd for C<sub>30</sub>H<sub>30</sub>F<sub>2</sub>N<sub>6</sub>O<sub>3</sub> 561.24202. Found 561.24150.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22"><a href="/doi/suppl/10.1021/acs.jmedchem.9b01180" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27077" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27077" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.9b01180?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01180</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Experimental details for in vitro and in vivo studies, additional crystallographic data for compounds <b>2</b> and <b>9</b>, and synthetic procedures for compounds <b>2</b>–<b>40</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01180/suppl_file/jm9b01180_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01180/suppl_file/jm9b01180_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01180/suppl_file/jm9b01180_si_001.pdf">jm9b01180_si_001.pdf (629.26 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01180/suppl_file/jm9b01180_si_002.csv">jm9b01180_si_002.csv (4.24 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Atomic coordinates for the X-ray structures of compound <b>2</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6PGO">6PGO</a>) and compound <b>9</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6PGP">6PGP</a>) bound to GDP-KRAS<sup>G12C</sup> are available from the RCSB Protein Data Bank (<a href="http://www.rcsb.org" class="extLink">www.rcsb.org</a>).</p><div class="testing" data-doi="10.1021/acs.jmedchem.9b01180" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10100" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10100" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian A. Lanman</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, , , , and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8768-7188" title="Orcid link">http://orcid.org/0000-0002-8768-7188</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#82e0eee3ecefe3ecc2e3efe5e7ecace1edef"><span class="__cf_email__" data-cfemail="147678757a79757a54757973717a3a777b79">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jennifer R. Allen</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, , , , and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John G. Allen</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, , , , and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Albert K. Amegadzie</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, , , , and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kate S. Ashton</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, , , , and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shon K. Booker</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, , , , and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jian Jeffrey Chen</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, , , , and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ning Chen</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, , , , and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael J. Frohn</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, , , , and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guy Goodman</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, , , , and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David J. Kopecky</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, , , , and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Longbin Liu</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, , , , and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patricia Lopez</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, , , , and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jonathan D. Low</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, , , , and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vu Ma</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, , , , and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ana E. Minatti</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, , , , and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas T. Nguyen</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, , , , and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nobuko Nishimura</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, , , , and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alexander J. Pickrell</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, , , , and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anthony B. Reed</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, , , , and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Youngsook Shin</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, , , , and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3866-354X" title="Orcid link">http://orcid.org/0000-0003-3866-354X</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aaron C. Siegmund</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, , , , and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nuria A. Tamayo</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, , , , and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher M. Tegley</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, , , , and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mary C. Walton</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, , , , and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hui-Ling Wang</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, , , , and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2748-5266" title="Orcid link">http://orcid.org/0000-0003-2748-5266</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ryan P. Wurz</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, , , , and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1413-5208" title="Orcid link">http://orcid.org/0000-0003-1413-5208</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">May Xue</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, , , , and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin C. Yang</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, , , , and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pragathi Achanta</span> - <span class="hlFld-Affiliation affiliation">Oncology Research, , , , and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael D. Bartberger</span> - <span class="hlFld-Affiliation affiliation">Molecular Engineering, , , , and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5167-3139" title="Orcid link">http://orcid.org/0000-0002-5167-3139</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jude Canon</span> - <span class="hlFld-Affiliation affiliation">Oncology Research, , , , and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">L. Steven Hollis</span> - <span class="hlFld-Affiliation affiliation">Departments of Discovery Attribute Sciences and , Amgen Research, 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John D. McCarter</span> - <span class="hlFld-Affiliation affiliation">Discovery Technologies, , , , and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher Mohr</span> - <span class="hlFld-Affiliation affiliation">Molecular Engineering, , , , and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karen Rex</span> - <span class="hlFld-Affiliation affiliation">Oncology Research, , , , and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anne Y. Saiki</span> - <span class="hlFld-Affiliation affiliation">Oncology Research, , , , and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tisha San Miguel</span> - <span class="hlFld-Affiliation affiliation">Discovery Technologies, , , , and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laurie P. Volak</span> - <span class="hlFld-Affiliation affiliation">Pharmacokinetics
and Drug Metabolism, , , , and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin H. Wang</span> - <span class="hlFld-Affiliation affiliation">Molecular Engineering and , Amgen Research, 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Douglas A. Whittington</span> - <span class="hlFld-Affiliation affiliation">Molecular Engineering and , Amgen Research, 360 Binney Street, Cambridge, Massachusetts 02142, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5946-8543" title="Orcid link">http://orcid.org/0000-0002-5946-8543</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephan G. Zech</span> - <span class="hlFld-Affiliation affiliation">Departments of Discovery Attribute Sciences and , Amgen Research, 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">J. Russell Lipford</span> - <span class="hlFld-Affiliation affiliation">Oncology Research, , , , and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Victor J. Cee</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, , , , and, Amgen Research, One Amgen Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7714-397X" title="Orcid link">http://orcid.org/0000-0002-7714-397X</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was prepared by B.A.L. with contributions from all authors.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): All authors are employees/former employees of Amgen, Inc. and may hold stock in the same. All studies were funded by Amgen, Inc.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26728" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26728" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">These discovery efforts were critically enabled by the support of a diverse set of talented teams, functional leaders, and highly motivated scientists, without whom this work would not have been possible. Special thanks are extended to Larry Miller, Wes Barnhart, Heather Eastwood, and Shannon Rumfelt for their crucial assistance with the chiral and achiral purification of project leads and intermediates. Thanks are extended to David Bauer, Jim Brown, Rob Rzasa, and Ted Judd for their efforts in the initial synthetic scale-up of AMG 510 and to Rajiv Kapoor and the Syngene Amgen Research Collaboration (SARC) for their support in supplying key intermediates. Our thanks are extended to Roman Shimanovich, Prashant Agarwal, and Melanie Cooke for their pharmaceutics and formulation support. We also thank Crystallographic Consulting, LLC and the Advanced Light Source staff at beamline 5.0.2 for data collection and their support. The Berkeley Center for Structural Biology is supported in part by the National Institutes of Health, National Institute of General Medical Sciences, and the Howard Hughes Medical Institute. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under Contract DE-AC02-05CH11231. We also acknowledge the Southeast Regional Collaborative Access Team (SER-CAT) 22-ID beamline at the Advanced Photon Source, Argonne National Laboratory for data collection and support. SER-CAT is supported by its member institutions and equipment grants (S10_RR25528 and S10_RR028976) from the National Institutes of Health. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract W-31-109-Eng-38. Figures were generated using The PyMOL Molecular Graphics System, version 2.2.0, Schrödinger, LLC.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">KRAS</td><td class="NLM_def"><p class="first last">Kirsten rat sarcoma virus oncogene</p></td></tr><tr><td class="NLM_term">GDP</td><td class="NLM_def"><p class="first last">guanosine diphosphate</p></td></tr><tr><td class="NLM_term">GTP</td><td class="NLM_def"><p class="first last">guanosine triphosphate</p></td></tr><tr><td class="NLM_term">S-IIP</td><td class="NLM_def"><p class="first last">switch II pocket</p></td></tr><tr><td class="NLM_term">SOS1</td><td class="NLM_def"><p class="first last">son of sevenless homolog 1 protein</p></td></tr><tr><td class="NLM_term">c-RAF</td><td class="NLM_def"><p class="first last">rapidly accelerated fibrosarcoma kinase (cellular homolog)</p></td></tr><tr><td class="NLM_term">p-ERK</td><td class="NLM_def"><p class="first last">phosphorylated extracellular signal-regulated kinase</p></td></tr><tr><td class="NLM_term">MSD</td><td class="NLM_def"><p class="first last">Meso Scale Diagnostics</p></td></tr><tr><td class="NLM_term">EGF</td><td class="NLM_def"><p class="first last">epidermal growth factor</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetic</p></td></tr><tr><td class="NLM_term">MDCK</td><td class="NLM_def"><p class="first last">Madin–Darby canine kidney cell</p></td></tr><tr><td class="NLM_term">iv</td><td class="NLM_def"><p class="first last">intravenous</p></td></tr><tr><td class="NLM_term">po</td><td class="NLM_def"><p class="first last">per os (oral)</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">QD</td><td class="NLM_def"><p class="first last">quaque die (once daily)</p></td></tr><tr><td class="NLM_term">TGI</td><td class="NLM_def"><p class="first last">tumor growth inhibition</p></td></tr><tr><td class="NLM_term">FaSSGF</td><td class="NLM_def"><p class="first last">fasted-state simulated gastric fluid</p></td></tr><tr><td class="NLM_term">FaSSIF</td><td class="NLM_def"><p class="first last">fasted-state simulated intestinal fluid</p></td></tr><tr><td class="NLM_term">PBS</td><td class="NLM_def"><p class="first last">phosphate buffered saline</p></td></tr><tr><td class="NLM_term">MS</td><td class="NLM_def"><p class="first last">mass spectrometry</p></td></tr><tr><td class="NLM_term">GSH</td><td class="NLM_def"><p class="first last">glutathione</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23000" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23000" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 35 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cox, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimmelman, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Der, C. J.</span></span> <span> </span><span class="NLM_article-title">Drugging the Undruggable RAS: Mission Possible?</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">828</span>– <span class="NLM_lpage">851</span>, <span class="refDoi"> DOI: 10.1038/nrd4389</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=10.1038%2Fnrd4389" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=25323927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslKmu7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=828-851&author=A.+D.+Coxauthor=S.+W.+Fesikauthor=A.+C.+Kimmelmanauthor=J.+Luoauthor=C.+J.+Der&title=Drugging+the+Undruggable+RAS%3A+Mission+Possible%3F&doi=10.1038%2Fnrd4389"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Drugging the undruggable RAS: Mission Possible?</span></div><div class="casAuthors">Cox, Adrienne D.; Fesik, Stephen W.; Kimmelman, Alec C.; Luo, Ji; Der, Channing J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">828-851</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Despite more than three decades of intensive effort, no effective pharmacol. inhibitors of the RAS oncoproteins have reached the clinic, prompting the widely held perception that RAS proteins are 'undruggable'.  However, recent data from the lab. and the clinic have renewed our hope for the development of RAS-inhibitory mols.  In this Review, we summarize the progress and the promise of five key approaches.  Firstly, we focus on the prospects of using direct inhibitors of RAS.  Secondly, we address the issue of whether blocking RAS membrane assocn. is a viable approach.  Thirdly, we assess the status of targeting RAS downstream effector signalling, which is arguably the most favorable current approach.  Fourthly, we address whether the search for synthetic lethal interactors of mutant RAS still holds promise.  Finally, RAS-mediated changes in cell metab. have recently been described and we discuss whether these changes could be exploited for new therapeutic directions.  We conclude with perspectives on how addnl. complexities, which are not yet fully understood, may affect each of these approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvWzW1JqxN4LVg90H21EOLACvtfcHk0lifRbFsvpcZrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslKmu7zE&md5=6c8645293b079023de7d31011ae1a192</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrd4389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4389%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DA.%2BD.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DKimmelman%26aufirst%3DA.%2BC.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DDer%26aufirst%3DC.%2BJ.%26atitle%3DDrugging%2520the%2520Undruggable%2520RAS%253A%2520Mission%2520Possible%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2014%26volume%3D13%26spage%3D828%26epage%3D851%26doi%3D10.1038%2Fnrd4389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hobbs, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Der, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossman, K. L.</span></span> <span> </span><span class="NLM_article-title">RAS Isoforms and Mutations in Cancer at a Glance</span>. <i>J. Cell Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">1287</span>– <span class="NLM_lpage">1292</span>, <span class="refDoi"> DOI: 10.1242/jcs.182873</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=10.1242%2Fjcs.182873" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=26985062" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVKltr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2016&pages=1287-1292&author=G.+A.+Hobbsauthor=C.+J.+Derauthor=K.+L.+Rossman&title=RAS+Isoforms+and+Mutations+in+Cancer+at+a+Glance&doi=10.1242%2Fjcs.182873"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">RAS isoforms and mutations in cancer at a glance</span></div><div class="casAuthors">Hobbs, G. Aaron; Der, Channing J.; Rossman, Kent L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1287-1292</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">RAS proteins (KRAS4A, KRAS4B, NRAS and HRAS) function as GDP-GTP-regulated binary on-off switches, which regulate cytoplasmic signaling networks that control diverse normal cellular processes.  Gain-of-function missense mutations in RAS genes are found in ∼ 25% of human cancers, prompting interest in identifying anti-RAS therapeutic strategies for cancer treatment.  However, despite more than three decades of intense effort, no anti-RAS therapies have reached clin. application.  Contributing to this failure has been an underestimation of the complexities of RAS.  First, there is now appreciation that the four human RAS proteins are not functionally identical.  Second, with >130 different missense mutations found in cancer, there is an emerging view that there are mutation-specific consequences on RAS structure, biochem. and biol., and mutation-selective therapeutic strategies are needed.  In this Cell Science at a Glance article and accompanying poster, we provide a snapshot of the differences between RAS isoforms and mutations, as well as the current status of anti-RAS drug-discovery efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNufX89IRJk7Vg90H21EOLACvtfcHk0liKqfHhQMbHVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVKltr7I&md5=bf50d212b900fb437cad2b650a9dc07a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1242%2Fjcs.182873&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.182873%26sid%3Dliteratum%253Aachs%26aulast%3DHobbs%26aufirst%3DG.%2BA.%26aulast%3DDer%26aufirst%3DC.%2BJ.%26aulast%3DRossman%26aufirst%3DK.%2BL.%26atitle%3DRAS%2520Isoforms%2520and%2520Mutations%2520in%2520Cancer%2520at%2520a%2520Glance%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2016%26volume%3D129%26spage%3D1287%26epage%3D1292%26doi%3D10.1242%2Fjcs.182873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prior, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattos, C.</span></span> <span> </span><span class="NLM_article-title">A Comprehensive Survey of Ras Mutations in Cancer</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">2457</span>– <span class="NLM_lpage">2467</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-11-2612</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=10.1158%2F0008-5472.CAN-11-2612" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=22589270" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=1%3ACAS%3A528%3ADC%252BC38XmvF2ntL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=2457-2467&author=I.+A.+Priorauthor=P.+D.+Lewisauthor=C.+Mattos&title=A+Comprehensive+Survey+of+Ras+Mutations+in+Cancer&doi=10.1158%2F0008-5472.CAN-11-2612"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">A Comprehensive Survey of Ras Mutations in Cancer</span></div><div class="casAuthors">Prior, Ian A.; Lewis, Paul D.; Mattos, Carla</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2457-2467</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  All mammalian cells express 3 closely related Ras proteins, termed H-Ras, K-Ras, and N-Ras, that promote oncogenesis when they are mutationally activated at codon 12, 13, or 61.  Although there is a high degree of similarity among the isoforms, K-Ras mutations are far more frequently obsd. in cancer, and each isoform displays preferential coupling to particular cancer types.  We examd. the mutational spectra of Ras isoforms curated from large-scale tumor profiling and found that each isoform exhibits surprisingly distinctive codon mutation and amino-acid substitution biases.  These findings were unexpected given that these mutations occur in regions that share 100% amino-acid sequence identity among the 3 isoforms.  Of importance, many of these mutational biases were not due to differences in exposure to mutagens, because the patterns were still evident when compared within specific cancer types.  We discuss potential genetic and epigenetic mechanisms, as well as isoform-specific differences in protein structure and signaling, that may promote these distinct mutation patterns and differential coupling to specific cancers.  Cancer Res; 72(10); 2457-67.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqg2lqiicosOLVg90H21EOLACvtfcHk0liKqfHhQMbHVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmvF2ntL4%253D&md5=6d1894847015468f77c8b08b57c6d62a</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-11-2612&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-11-2612%26sid%3Dliteratum%253Aachs%26aulast%3DPrior%26aufirst%3DI.%2BA.%26aulast%3DLewis%26aufirst%3DP.%2BD.%26aulast%3DMattos%26aufirst%3DC.%26atitle%3DA%2520Comprehensive%2520Survey%2520of%2520Ras%2520Mutations%2520in%2520Cancer%26jtitle%3DCancer%2520Res.%26date%3D2012%26volume%3D72%26spage%3D2457%26epage%3D2467%26doi%3D10.1158%2F0008-5472.CAN-11-2612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holderfield, M.</span></span> <span> </span><span class="NLM_article-title">Efforts to Develop KRAS Inhibitors</span>. <i>Cold Spring Harbor Perspect. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">a031864</span>, <span class="refDoi"> DOI: 10.1101/cshperspect.a031864</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=10.1101%2Fcshperspect.a031864" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=29101115" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhs1Ogu7bP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=a031864&author=M.+Holderfield&title=Efforts+to+Develop+KRAS+Inhibitors&doi=10.1101%2Fcshperspect.a031864"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Efforts to develop KRAS inhibitors</span></div><div class="casAuthors">Holderfield, Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Cold Spring Harbor Perspectives in Medicine</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">a031864/1-a031864/9</span>CODEN:
                <span class="NLM_cas:coden">CSHPFV</span>;
        ISSN:<span class="NLM_cas:issn">2157-1422</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">The high prevalence of KRAS mutations in human cancers and the lack of effective treatments for patients ranks KRAS among the most highly sought-after targets for preclin. oncologists.  Pharmaceutical companies and academic labs. have tried for decades to identify small mol. inhibitors of oncogenic KRAS proteins, but little progress has been made and many have labeled KRAS undruggable.  However, recent progress in in silico screening, fragmentbased drug design, disulfide tethered screening, and some emerging themes in RAS biol. have caused the field to reconsider previously held notions about targeting KRAS.  This review will cover some of the historical efforts to identify RAS inhibitors, and some of the most promising efforts currently being pursued.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo79VAhwaV0c7Vg90H21EOLACvtfcHk0lgwvRnfmxYisQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhs1Ogu7bP&md5=7b55a0a4a9a8a18253ed804967be1b13</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1101%2Fcshperspect.a031864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fcshperspect.a031864%26sid%3Dliteratum%253Aachs%26aulast%3DHolderfield%26aufirst%3DM.%26atitle%3DEfforts%2520to%2520Develop%2520KRAS%2520Inhibitors%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Med.%26date%3D2018%26volume%3D8%26spage%3Da031864%26doi%3D10.1101%2Fcshperspect.a031864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ostrem, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sos, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shokat, K. M.</span></span> <span> </span><span class="NLM_article-title">K-Ras(G12C) Inhibitors Allosterically Control GTP Affinity and Effector Interactions</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>503</i></span>,  <span class="NLM_fpage">548</span>– <span class="NLM_lpage">551</span>, <span class="refDoi"> DOI: 10.1038/nature12796</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=10.1038%2Fnature12796" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=24256730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVGqs7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=503&publication_year=2013&pages=548-551&author=J.+M.+Ostremauthor=U.+Petersauthor=M.+L.+Sosauthor=J.+A.+Wellsauthor=K.+M.+Shokat&title=K-Ras%28G12C%29+Inhibitors+Allosterically+Control+GTP+Affinity+and+Effector+Interactions&doi=10.1038%2Fnature12796"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions</span></div><div class="casAuthors">Ostrem, Jonathan M.; Peters, Ulf; Sos, Martin L.; Wells, James A.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">503</span>
        (<span class="NLM_cas:issue">7477</span>),
    <span class="NLM_cas:pages">548-551</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Somatic mutations in the small GTPase K-Ras are the most common activating lesions found in human cancer, and are generally assocd. with poor response to std. therapies.  Efforts to target this oncogene directly have faced difficulties owing to its picomolar affinity for GTP/GDP and the absence of known allosteric regulatory sites.  Oncogenic mutations result in functional activation of Ras family proteins by impairing GTP hydrolysis.  With diminished regulation by GTPase activity, the nucleotide state of Ras becomes more dependent on relative nucleotide affinity and concn.  This gives GTP an advantage over GDP and increases the proportion of active GTP-bound Ras.  Here we report the development of small mols. that irreversibly bind to a common oncogenic mutant, K-Ras(G12C).  These compds. rely on the mutant cysteine for binding and therefore do not affect the wild-type protein.  Crystallog. studies reveal the formation of a new pocket that is not apparent in previous structures of Ras, beneath the effector binding switch-II region.  Binding of these inhibitors to K-Ras(G12C) disrupts both switch-I and switch-II, subverting the native nucleotide preference to favor GDP over GTP and impairing binding to Raf.  Our data provide structure-based validation of a new allosteric regulatory site on Ras that is targetable in a mutant-specific manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokkgcVXuBn_rVg90H21EOLACvtfcHk0lgwvRnfmxYisQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVGqs7jO&md5=27c1e7d8ef6b7e4b2919e9f00a073923</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnature12796&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12796%26sid%3Dliteratum%253Aachs%26aulast%3DOstrem%26aufirst%3DJ.%2BM.%26aulast%3DPeters%26aufirst%3DU.%26aulast%3DSos%26aufirst%3DM.%2BL.%26aulast%3DWells%26aufirst%3DJ.%2BA.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DK-Ras%2528G12C%2529%2520Inhibitors%2520Allosterically%2520Control%2520GTP%2520Affinity%2520and%2520Effector%2520Interactions%26jtitle%3DNature%26date%3D2013%26volume%3D503%26spage%3D548%26epage%3D551%26doi%3D10.1038%2Fnature12796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Janes, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babbar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firdaus, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darjania, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, Y. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thach, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarieh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ely, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kucharski, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessler, L. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarrinkar, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brehmer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhanak, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorenzi, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu-Lowe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patricelli, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span> <span> </span><span class="NLM_article-title">Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>172</i></span>,  <span class="NLM_fpage">578</span>– <span class="NLM_lpage">589</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2018.01.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=10.1016%2Fj.cell.2018.01.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=29373830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=1%3ACAS%3A528%3ADC%252BC1cXislyisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2018&pages=578-589&author=M.+R.+Janesauthor=J.+Zhangauthor=L.-S.+Liauthor=R.+Hansenauthor=U.+Petersauthor=X.+Guoauthor=Y.+Chenauthor=A.+Babbarauthor=S.+J.+Firdausauthor=L.+Darjaniaauthor=J.+Fengauthor=J.+H.+Chenauthor=S.+Liauthor=S.+Liauthor=Y.+O.+Longauthor=C.+Thachauthor=Y.+Liuauthor=A.+Zariehauthor=T.+Elyauthor=J.+M.+Kucharskiauthor=L.+V.+Kesslerauthor=T.+Wuauthor=K.+Yuauthor=Y.+Wangauthor=Y.+Yaoauthor=X.+Dengauthor=P.+P.+Zarrinkarauthor=D.+Brehmerauthor=D.+Dhanakauthor=M.+V.+Lorenziauthor=D.+Hu-Loweauthor=M.+P.+Patricelliauthor=P.+Renauthor=Y.+Liu&title=Targeting+KRAS+Mutant+Cancers+with+a+Covalent+G12C-Specific+Inhibitor&doi=10.1016%2Fj.cell.2018.01.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor</span></div><div class="casAuthors">Janes, Matthew R.; Zhang, Jingchuan; Li, Lian-Sheng; Hansen, Rasmus; Peters, Ulf; Guo, Xin; Chen, Yuching; Babbar, Anjali; Firdaus, Sarah J.; Darjania, Levan; Feng, Jun; Chen, Jeffrey H.; Li, Shuangwei; Li, Shisheng; Long, Yun O.; Thach, Carol; Liu, Yuan; Zarieh, Ata; Ely, Tess; Kucharski, Jeff M.; Kessler, Linda V.; Wu, Tao; Yu, Ke; Wang, Yi; Yao, Yvonne; Deng, Xiaohu; Zarrinkar, Patrick P.; Brehmer, Dirk; Dhanak, Dashyant; Lorenzi, Matthew V.; Hu-Lowe, Dana; Patricelli, Matthew P.; Ren, Pingda; Liu, Yi</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">578-589.e17</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">KRASG12C was recently identified to be potentially druggable by allele-specific covalent targeting of Cys 12 in vicinity to an inducible allosteric switch II pocket (S-IIP).  Success of this approach requires active cycling of KRASG12C between its active-GTP and inactive-GDP conformations as accessibility of the S-IIP is restricted only to the GDP-bound state.  This strategy proved feasible for inhibiting mutant KRAS in vitro; however, it is uncertain whether this approach would translate to in vivo.  Here, the authors describe structure-based design and identification of ARS-1620, a covalent compd. with high potency and selectivity for KRASG12C.  ARS-1620 achieves rapid and sustained in vivo target occupancy to induce tumor regression.  The authors use ARS-1620 to dissect oncogenic KRAS dependency and demonstrate that monolayer culture formats significantly underestimate KRAS dependency in vivo.  This study provides in vivo evidence that mutant KRAS can be selectively targeted and reveals ARS-1620 as representing a new generation of KRASG12C-specific inhibitors with promising therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVmv4KAl4_dLVg90H21EOLACvtfcHk0lgwvRnfmxYisQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXislyisb8%253D&md5=d0883bde981b51e41a794179ffae87be</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2018.01.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2018.01.006%26sid%3Dliteratum%253Aachs%26aulast%3DJanes%26aufirst%3DM.%2BR.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DL.-S.%26aulast%3DHansen%26aufirst%3DR.%26aulast%3DPeters%26aufirst%3DU.%26aulast%3DGuo%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DBabbar%26aufirst%3DA.%26aulast%3DFirdaus%26aufirst%3DS.%2BJ.%26aulast%3DDarjania%26aufirst%3DL.%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DJ.%2BH.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DLong%26aufirst%3DY.%2BO.%26aulast%3DThach%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZarieh%26aufirst%3DA.%26aulast%3DEly%26aufirst%3DT.%26aulast%3DKucharski%26aufirst%3DJ.%2BM.%26aulast%3DKessler%26aufirst%3DL.%2BV.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DYu%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26aulast%3DBrehmer%26aufirst%3DD.%26aulast%3DDhanak%26aufirst%3DD.%26aulast%3DLorenzi%26aufirst%3DM.%2BV.%26aulast%3DHu-Lowe%26aufirst%3DD.%26aulast%3DPatricelli%26aufirst%3DM.%2BP.%26aulast%3DRen%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DY.%26atitle%3DTargeting%2520KRAS%2520Mutant%2520Cancers%2520with%2520a%2520Covalent%2520G12C-Specific%2520Inhibitor%26jtitle%3DCell%26date%3D2018%26volume%3D172%26spage%3D578%26epage%3D589%26doi%3D10.1016%2Fj.cell.2018.01.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wurz, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Achanta, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arvedson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartberger, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campuzano, I. D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fucini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingersoll, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwig, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipford, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopecky, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">San Miguel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohr, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saiki, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawayama, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sethofer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tegley, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volak, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanman, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erlanson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cee, V. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of <i>N</i>-(1-Acryloylazetidin-3-yl)-2-(1<i>H</i>-indol-1-yl)acetamides as a Covalent Inhibitor of KRAS<sup>G12C</sup></span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1302</span>– <span class="NLM_lpage">1308</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.9b00258</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.9b00258" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsF2qs73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=1302-1308&author=Y.+Shinauthor=J.+W.+Jeongauthor=R.+P.+Wurzauthor=P.+Achantaauthor=T.+Arvedsonauthor=M.+D.+Bartbergerauthor=I.+D.+G.+Campuzanoauthor=R.+Fuciniauthor=S.+K.+Hansenauthor=J.+Ingersollauthor=J.+Iwigauthor=J.+R.+Lipfordauthor=V.+Maauthor=D.+J.+Kopeckyauthor=J.+McCarterauthor=T.+San+Miguelauthor=C.+Mohrauthor=S.+Sabetauthor=A.+Y.+Saikiauthor=A.+Sawayamaauthor=S.+Sethoferauthor=C.+M.+Tegleyauthor=L.+P.+Volakauthor=K.+Yangauthor=B.+A.+Lanmanauthor=D.+A.+Erlansonauthor=V.+J.+Cee&title=Discovery+of+N-%281-Acryloylazetidin-3-yl%29-2-%281H-indol-1-yl%29acetamides+as+a+Covalent+Inhibitor+of+KRASG12C&doi=10.1021%2Facsmedchemlett.9b00258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of N-(1-Acryloylazetidin-3-yl)-2-(1H-indol-1-yl)acetamides as Covalent Inhibitors of KRASG12C</span></div><div class="casAuthors">Shin, Youngsook; Jeong, Joon Won; Wurz, Ryan P.; Achanta, Pragathi; Arvedson, Tara; Bartberger, Michael D.; Campuzano, Iain D. G.; Fucini, Ray; Hansen, Stig K.; Ingersoll, John; Iwig, Jeffrey S.; Lipford, J. Russell; Ma, Vu; Kopecky, David J.; McCarter, John; San Miguel, Tisha; Mohr, Christopher; Sabet, Sudi; Saiki, Anne Y.; Sawayama, Andrew; Sethofer, Steven; Tegley, Christopher M.; Volak, Laurie P.; Yang, Kevin; Lanman, Brian A.; Erlanson, Daniel A.; Cee, Victor J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1302-1308</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Discovery of N-(1-Acryloylazetidin-3-yl)-2-(1H-indol-1-yl)acetamides as Covalent Inhibitors of KRASG12C.  KRAS regulates many cellular processes including proliferation, survival, and differentiation.  Point mutants of KRAS have long been known to be mol. drivers of cancer.  KRAS p.G12C, which occurs in approx. 14% of lung adenocarcinomas, 3-5% of colorectal cancers, and low levels in other solid tumors, represents an attractive therapeutic target for covalent inhibitors.  Herein, we disclose the discovery of a class of novel, potent, and selective covalent inhibitors of KRASG12C identified through a custom library synthesis and screening platform called Chemotype Evolution and structure-based design.  Identification of a hidden surface groove bordered by H95/Y96/Q99 side chains was key to the optimization of this class of mols.  Best-in-series exemplars exhibit a rapid covalent reaction with cysteine 12 of GDP-KRASG12C with submicromolar inhibition of downstream signaling in a KRASG12C-specific manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSOlO88sogkLVg90H21EOLACvtfcHk0ljrpRuDr0Ty3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsF2qs73P&md5=ec097c0fb0e018a2d86f024117f8008f</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.9b00258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.9b00258%26sid%3Dliteratum%253Aachs%26aulast%3DShin%26aufirst%3DY.%26aulast%3DJeong%26aufirst%3DJ.%2BW.%26aulast%3DWurz%26aufirst%3DR.%2BP.%26aulast%3DAchanta%26aufirst%3DP.%26aulast%3DArvedson%26aufirst%3DT.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DCampuzano%26aufirst%3DI.%2BD.%2BG.%26aulast%3DFucini%26aufirst%3DR.%26aulast%3DHansen%26aufirst%3DS.%2BK.%26aulast%3DIngersoll%26aufirst%3DJ.%26aulast%3DIwig%26aufirst%3DJ.%26aulast%3DLipford%26aufirst%3DJ.%2BR.%26aulast%3DMa%26aufirst%3DV.%26aulast%3DKopecky%26aufirst%3DD.%2BJ.%26aulast%3DMcCarter%26aufirst%3DJ.%26aulast%3DSan%2BMiguel%26aufirst%3DT.%26aulast%3DMohr%26aufirst%3DC.%26aulast%3DSabet%26aufirst%3DS.%26aulast%3DSaiki%26aufirst%3DA.%2BY.%26aulast%3DSawayama%26aufirst%3DA.%26aulast%3DSethofer%26aufirst%3DS.%26aulast%3DTegley%26aufirst%3DC.%2BM.%26aulast%3DVolak%26aufirst%3DL.%2BP.%26aulast%3DYang%26aufirst%3DK.%26aulast%3DLanman%26aufirst%3DB.%2BA.%26aulast%3DErlanson%26aufirst%3DD.%2BA.%26aulast%3DCee%26aufirst%3DV.%2BJ.%26atitle%3DDiscovery%2520of%2520N-%25281-Acryloylazetidin-3-yl%2529-2-%25281H-indol-1-yl%2529acetamides%2520as%2520a%2520Covalent%2520Inhibitor%2520of%2520KRASG12C%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D10%26spage%3D1302%26epage%3D1308%26doi%3D10.1021%2Facsmedchemlett.9b00258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patricelli, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janes, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessler, L. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kucharski, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ely, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firdaus, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babbar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span> <span> </span><span class="NLM_article-title">Selective Inhibition of Oncogenic KRAS Output with Small Molecules Targeting the Inactive State</span>. <i>Cancer Discovery</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">316</span>– <span class="NLM_lpage">329</span>, <span class="refDoi"> DOI: 10.1158/2159-8290.CD-15-1105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=10.1158%2F2159-8290.CD-15-1105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=26739882" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=1%3ACAS%3A528%3ADC%252BC28XktVyru7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=316-329&author=M.+P.+Patricelliauthor=M.+R.+Janesauthor=L.-S.+Liauthor=R.+Hansenauthor=U.+Petersauthor=L.+V.+Kesslerauthor=Y.+Chenauthor=J.+M.+Kucharskiauthor=J.+Fengauthor=T.+Elyauthor=J.+H.+Chenauthor=S.+J.+Firdausauthor=A.+Babbarauthor=P.+Renauthor=Y.+Liu&title=Selective+Inhibition+of+Oncogenic+KRAS+Output+with+Small+Molecules+Targeting+the+Inactive+State&doi=10.1158%2F2159-8290.CD-15-1105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Inhibition of Oncogenic KRAS Output with Small Molecules Targeting the Inactive State</span></div><div class="casAuthors">Patricelli, Matthew P.; Janes, Matthew R.; Li, Lian-Sheng; Hansen, Rasmus; Peters, Ulf; Kessler, Linda V.; Chen, Yuching; Kucharski, Jeff M.; Feng, Jun; Ely, Tess; Chen, Jeffrey H.; Firdaus, Sarah J.; Babbar, Anjali; Ren, Pingda; Liu, Yi</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Discovery</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">316-329</span>CODEN:
                <span class="NLM_cas:coden">CDAIB2</span>;
        ISSN:<span class="NLM_cas:issn">2159-8274</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">KRAS gain-of-function mutations occur in approx. 30% of all human cancers.  Despite more than 30 years of KRAS-focused research and development efforts, no targeted therapy has been discovered for cancers with KRAS mutations.  Here, we describe ARS-853, a selective, covalent inhibitor of KRASG12C that inhibits mutant KRAS-driven signaling by binding to the GDP-bound oncoprotein and preventing activation.  Based on the rates of engagement and inhibition obsd. for ARS-853, along with a mutant-specific mass spectrometry-based assay for assessing KRAS activation status, we show that the nucleotide state of KRASG12C is in a state of dynamic flux that can be modulated by upstream signaling factors.  These studies provide convincing evidence that the KRASG12C mutation generates a "hyperexcitable" rather than a "statically active" state and that targeting the inactive, GDP-bound form is a promising approach for generating novel anti-RAS therapeutics.  Significance: A cell-active, mutant-specific, covalent inhibitor of KRASG12C is described that targets the GDP-bound, inactive state and prevents subsequent activation.  Using this novel compd., we demonstrate that KRASG12C oncoprotein rapidly cycles bound nucleotide and responds to upstream signaling inputs to maintain a highly active state.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJJA-9IIHeN7Vg90H21EOLACvtfcHk0ljDp6DaNKNdeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktVyru7s%253D&md5=41db2f02006e8f0be7a9bb47354addcd</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-15-1105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-15-1105%26sid%3Dliteratum%253Aachs%26aulast%3DPatricelli%26aufirst%3DM.%2BP.%26aulast%3DJanes%26aufirst%3DM.%2BR.%26aulast%3DLi%26aufirst%3DL.-S.%26aulast%3DHansen%26aufirst%3DR.%26aulast%3DPeters%26aufirst%3DU.%26aulast%3DKessler%26aufirst%3DL.%2BV.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DKucharski%26aufirst%3DJ.%2BM.%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DEly%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DJ.%2BH.%26aulast%3DFirdaus%26aufirst%3DS.%2BJ.%26aulast%3DBabbar%26aufirst%3DA.%26aulast%3DRen%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DY.%26atitle%3DSelective%2520Inhibition%2520of%2520Oncogenic%2520KRAS%2520Output%2520with%2520Small%2520Molecules%2520Targeting%2520the%2520Inactive%2520State%26jtitle%3DCancer%2520Discovery%26date%3D2016%26volume%3D6%26spage%3D316%26epage%3D329%26doi%3D10.1158%2F2159-8290.CD-15-1105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Janes, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babbar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firdaus, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darjania, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, Y. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thach, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarieh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ely, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kucharski, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessler, L. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarrinkar, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brehmer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhanak, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorenzi, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu-Lowe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patricelli, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span> <span> </span><span class="NLM_article-title">Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>172</i></span>,  <span class="NLM_fpage">578</span>– <span class="NLM_lpage">589</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2018.01.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=10.1016%2Fj.cell.2018.01.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=29373830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=1%3ACAS%3A528%3ADC%252BC1cXislyisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2018&pages=578-589&author=M.+R.+Janesauthor=J.+Zhangauthor=L.-S.+Liauthor=R.+Hansenauthor=U.+Petersauthor=X.+Guoauthor=Y.+Chenauthor=A.+Babbarauthor=S.+J.+Firdausauthor=L.+Darjaniaauthor=J.+Fengauthor=J.+H.+Chenauthor=S.+Liauthor=S.+Liauthor=Y.+O.+Longauthor=C.+Thachauthor=Y.+Liuauthor=A.+Zariehauthor=T.+Elyauthor=J.+M.+Kucharskiauthor=L.+V.+Kesslerauthor=T.+Wuauthor=K.+Yuauthor=Y.+Wangauthor=Y.+Yaoauthor=X.+Dengauthor=P.+P.+Zarrinkarauthor=D.+Brehmerauthor=D.+Dhanakauthor=M.+V.+Lorenziauthor=D.+Hu-Loweauthor=M.+P.+Patricelliauthor=P.+Renauthor=Y.+Liu&title=Targeting+KRAS+Mutant+Cancers+with+a+Covalent+G12C-Specific+Inhibitor&doi=10.1016%2Fj.cell.2018.01.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor</span></div><div class="casAuthors">Janes, Matthew R.; Zhang, Jingchuan; Li, Lian-Sheng; Hansen, Rasmus; Peters, Ulf; Guo, Xin; Chen, Yuching; Babbar, Anjali; Firdaus, Sarah J.; Darjania, Levan; Feng, Jun; Chen, Jeffrey H.; Li, Shuangwei; Li, Shisheng; Long, Yun O.; Thach, Carol; Liu, Yuan; Zarieh, Ata; Ely, Tess; Kucharski, Jeff M.; Kessler, Linda V.; Wu, Tao; Yu, Ke; Wang, Yi; Yao, Yvonne; Deng, Xiaohu; Zarrinkar, Patrick P.; Brehmer, Dirk; Dhanak, Dashyant; Lorenzi, Matthew V.; Hu-Lowe, Dana; Patricelli, Matthew P.; Ren, Pingda; Liu, Yi</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">578-589.e17</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">KRASG12C was recently identified to be potentially druggable by allele-specific covalent targeting of Cys 12 in vicinity to an inducible allosteric switch II pocket (S-IIP).  Success of this approach requires active cycling of KRASG12C between its active-GTP and inactive-GDP conformations as accessibility of the S-IIP is restricted only to the GDP-bound state.  This strategy proved feasible for inhibiting mutant KRAS in vitro; however, it is uncertain whether this approach would translate to in vivo.  Here, the authors describe structure-based design and identification of ARS-1620, a covalent compd. with high potency and selectivity for KRASG12C.  ARS-1620 achieves rapid and sustained in vivo target occupancy to induce tumor regression.  The authors use ARS-1620 to dissect oncogenic KRAS dependency and demonstrate that monolayer culture formats significantly underestimate KRAS dependency in vivo.  This study provides in vivo evidence that mutant KRAS can be selectively targeted and reveals ARS-1620 as representing a new generation of KRASG12C-specific inhibitors with promising therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVmv4KAl4_dLVg90H21EOLACvtfcHk0ljDp6DaNKNdeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXislyisb8%253D&md5=d0883bde981b51e41a794179ffae87be</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2018.01.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2018.01.006%26sid%3Dliteratum%253Aachs%26aulast%3DJanes%26aufirst%3DM.%2BR.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DL.-S.%26aulast%3DHansen%26aufirst%3DR.%26aulast%3DPeters%26aufirst%3DU.%26aulast%3DGuo%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DBabbar%26aufirst%3DA.%26aulast%3DFirdaus%26aufirst%3DS.%2BJ.%26aulast%3DDarjania%26aufirst%3DL.%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DJ.%2BH.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DLong%26aufirst%3DY.%2BO.%26aulast%3DThach%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZarieh%26aufirst%3DA.%26aulast%3DEly%26aufirst%3DT.%26aulast%3DKucharski%26aufirst%3DJ.%2BM.%26aulast%3DKessler%26aufirst%3DL.%2BV.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DYu%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26aulast%3DBrehmer%26aufirst%3DD.%26aulast%3DDhanak%26aufirst%3DD.%26aulast%3DLorenzi%26aufirst%3DM.%2BV.%26aulast%3DHu-Lowe%26aufirst%3DD.%26aulast%3DPatricelli%26aufirst%3DM.%2BP.%26aulast%3DRen%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DY.%26atitle%3DTargeting%2520KRAS%2520Mutant%2520Cancers%2520with%2520a%2520Covalent%2520G12C-Specific%2520Inhibitor%26jtitle%3DCell%26date%3D2018%26volume%3D172%26spage%3D578%26epage%3D589%26doi%3D10.1016%2Fj.cell.2018.01.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, S.</span>; <span class="NLM_string-name">Erlanson, D.</span>; <span class="NLM_string-name">Cancilla, M.</span></span> <span> </span><span class="NLM_article-title">Methods of Chemotype Evolution</span>. U.S. Patent <span class="NLM_patent">10,107,798</span>, October 23, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=S.+Hansen&author=D.+Erlanson&author=M.+Cancilla&title=Methods+of+Chemotype+Evolution"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHansen%26aufirst%3DS.%26atitle%3DMethods%2520of%2520Chemotype%2520Evolution%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span> For independent identification
of the H95/Y96/Q99 groove from a KRAS M72C screen, see<span class="NLM_contrib-group"><span class="NLM_string-name">Gentile, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rathinaswamy, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moss, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siempelkamp, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renslo, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shokat, K. M.</span></span> <span> </span><span class="NLM_article-title">Ras Binder Induces a Modified Switch-II Pocket in GTP and GDP States</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1455</span>– <span class="NLM_lpage">1466</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2017.08.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=10.1016%2Fj.chembiol.2017.08.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=29033317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Gjs7zK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2017&pages=1455-1466&author=D.+R.+Gentileauthor=M.+K.+Rathinaswamyauthor=M.+L.+Jenkinsauthor=S.+M.+Mossauthor=B.+D.+Siempelkampauthor=A.+R.+Rensloauthor=J.+E.+Burkeauthor=K.+M.+Shokat&title=Ras+Binder+Induces+a+Modified+Switch-II+Pocket+in+GTP+and+GDP+States&doi=10.1016%2Fj.chembiol.2017.08.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Ras Binder Induces a Modified Switch-II Pocket in GTP and GDP States</span></div><div class="casAuthors">Gentile, Daniel R.; Rathinaswamy, Manoj K.; Jenkins, Meredith L.; Moss, Steven M.; Siempelkamp, Braden D.; Renslo, Adam R.; Burke, John E.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1455-1466.e14</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Covalent inhibitors of K-Ras(G12C) have been reported that exclusively recognize the GDP state.  Here, we utilize disulfide tethering of a non-natural cysteine (K-Ras(M72C)) to identify a new switch-II pocket (S-IIP) binding ligand (2C07) that engages the active GTP state.  Co-crystal structures of 2C07 bound to H-Ras(M72C) reveal binding in a cryptic groove we term S-IIG.  In the GppNHp state, 2C07 binding to a modified S-IIP pushes switch I away from the nucleotide, breaking the network of polar contacts essential for adopting the canonical GTP state.  Biochem. studies show that 2C07 alters nucleotide preference and inhibits SOS binding and catalyzed nucleotide exchange. 2C07 was converted to irreversible covalent analogs, which target both nucleotide states, inhibit PI3K activation in vitro, and function as occupancy probes to detect reversible engagement in competition assays.  Targeting both nucleotide states opens the possibility of inhibiting oncogenic mutants of Ras, which exist predominantly in the GTP state in cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqfzb5EFJWK7Vg90H21EOLACvtfcHk0lj3S2k43-iYEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Gjs7zK&md5=082a1311777fc813b312d5a60430433e</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2017.08.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2017.08.025%26sid%3Dliteratum%253Aachs%26aulast%3DGentile%26aufirst%3DD.%2BR.%26aulast%3DRathinaswamy%26aufirst%3DM.%2BK.%26aulast%3DJenkins%26aufirst%3DM.%2BL.%26aulast%3DMoss%26aufirst%3DS.%2BM.%26aulast%3DSiempelkamp%26aufirst%3DB.%2BD.%26aulast%3DRenslo%26aufirst%3DA.%2BR.%26aulast%3DBurke%26aufirst%3DJ.%2BE.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DRas%2520Binder%2520Induces%2520a%2520Modified%2520Switch-II%2520Pocket%2520in%2520GTP%2520and%2520GDP%2520States%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2017%26volume%3D24%26spage%3D1455%26epage%3D1466%26doi%3D10.1016%2Fj.chembiol.2017.08.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="note"><p class="first last">It should be noted that covalent inhibitors derive their potency not only from noncovalent protein binding affinity (which facilitates protein–ligand preassociation) but also from features of the protein–ligand complex that accelerate covalent bond formation. Improved ligand “potencies” as described in this manuscript should be understood as arising from varying contributions of these two factors.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span>For details,
see <a href="https://www.perkinelmer.com/Content/RelatedMaterials/Brochures/BRO_AlphaScreen2004.pdf" class="extLink">https://www.perkinelmer.com/Content/RelatedMaterials/Brochures/BRO_AlphaScreen2004.pdf</a> (accessed Sep 7, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=For+details%2C%0Asee+https%3A%2F%2Fwww.perkinelmer.com%2FContent%2FRelatedMaterials%2FBrochures%2FBRO_AlphaScreen2004.pdf+%28accessed+Sep+7%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span>For details,
see <a href="https://www.mesoscale.com/en/products/phospho-total-erk1-2-whole-cell-lysate-kit-k15107d/" class="extLink">https://www.mesoscale.com/en/products/phospho-total-erk1-2-whole-cell-lysate-kit-k15107d/</a> (accessed Sep 7, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=For+details%2C%0Asee+https%3A%2F%2Fwww.mesoscale.com%2Fen%2Fproducts%2Fphospho-total-erk1-2-whole-cell-lysate-kit-k15107d%2F+%28accessed+Sep+7%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="note"><p class="first last">A 5 min incubation represented the shortest incubation time that could be practically executed.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="note"><p class="first last">A 2 h incubation was estimated to be the minimum time required to achieve “complete” (∼95%) covalent modification of KRAS<sup>G12C</sup> based on the GTP hydrolysis rate reported in ref <a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="note"><p class="first last">Possible reasons for the increased activity of compound <b>9</b> include more optimal orientation of the isopropylphenyl substituent in the cryptic pocket (a B3LYP/6-31G* quantum mechanical model predicts compound <b>8</b> to adopt a ground-state biaryl torsion angle of 65°, whereas the quinazolinone and phenyl rings are nearly perpendicular in compound <b>9</b>, enhancing contacts with the cryptic pocket residues) and enhanced contacts between the quinazolinone carbonyl group and proximal protein residues and water molecules.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span> For IUPAC naming
conventions,
see<span class="NLM_contrib-group"><span class="NLM_string-name">Moss, G. P.</span></span> <span> </span><span class="NLM_article-title">Basic Terminology of Stereochemistry (IUPAC Recommendations 1996)</span>. <i>Pure Appl. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">2193</span>– <span class="NLM_lpage">2222</span>, <span class="refDoi"> DOI: 10.1351/pac199668122193</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=10.1351%2Fpac199668122193" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=1%3ACAS%3A528%3ADyaK2sXot1Wruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=1996&pages=2193-2222&author=G.+P.+Moss&title=Basic+Terminology+of+Stereochemistry+%28IUPAC+Recommendations+1996%29&doi=10.1351%2Fpac199668122193"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Basic terminology of stereochemistry</span></div><div class="casAuthors">Moss, G. P.</div><div class="citationInfo"><span class="NLM_cas:title">Pure and Applied Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2193-2222</span>CODEN:
                <span class="NLM_cas:coden">PACHAS</span>;
        ISSN:<span class="NLM_cas:issn">0033-4545</span>.
    
            (<span class="NLM_cas:orgname">Blackwell</span>)
        </div><div class="casAbstract">This is a glossary of the more important, and most widely-used stereochem. terms.  It extends the list of those defined in the IUPAC Nomenclature of Org. Chem., Section E: Stereochem. (Recommendations 1974) and includes some terms from the Glossary of Terms used in Phys. Org. Chem. (Recommendations 1994).  Addnl. terms have been added from inorg. and macromol. chem.  Some misleading terms are included together with guidance on correct usage or acceptable alternatives.  Many of the symbols used in stereochem. nomenclature are mentioned but details of their assignment or their incorporation into chem. names are left to the appropriate recommendations.  Terminol. related to techniques used in the detn. of stereochem. are largely excluded as well as terms used to describe reaction mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplnwq600kNP7Vg90H21EOLACvtfcHk0lj3S2k43-iYEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXot1Wruw%253D%253D&md5=81b14a1d5cf6be717cd467808d644af0</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1351%2Fpac199668122193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1351%252Fpac199668122193%26sid%3Dliteratum%253Aachs%26aulast%3DMoss%26aufirst%3DG.%2BP.%26atitle%3DBasic%2520Terminology%2520of%2520Stereochemistry%2520%2528IUPAC%2520Recommendations%25201996%2529%26jtitle%3DPure%2520Appl.%2520Chem.%26date%3D1996%26volume%3D68%26spage%3D2193%26epage%3D2222%26doi%3D10.1351%2Fpac199668122193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="note"><p class="first last">(<i>R</i>)<i>-</i><b>9</b> was ∼20-fold more potent than (<i>S</i>)-<b>9</b> in the ERK phosphorylation assay (MSD, 4 h incubation).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span>For details,
see <a href="https://www.promega.com/products/cell-health-assays/cell-viability-and-cytotoxicity-assays/celltiter_glo-luminescent-cell-viability-assay/?catNum=G7570" class="extLink">https://www.promega.com/products/cell-health-assays/cell-viability-and-cytotoxicity-assays/celltiter_glo-luminescent-cell-viability-assay/?catNum=G7570</a> (accessed Sep 7, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=For+details%2C%0Asee+https%3A%2F%2Fwww.promega.com%2Fproducts%2Fcell-health-assays%2Fcell-viability-and-cytotoxicity-assays%2Fcelltiter_glo-luminescent-cell-viability-assay%2F%3FcatNum%3DG7570+%28accessed+Sep+7%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span> Intramolecular hydrogen
bonding has previously been demonstrated to enhance passive membrane
permeability:<span class="NLM_contrib-group"><span class="NLM_string-name">Rezai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bock, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalyanaraman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lokey, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, M. P.</span></span> <span> </span><span class="NLM_article-title">Conformational Flexibility, Internal Hydrogen Bonding, and Passive Membrane Permeability: Successful In Silico Prediction of the Relative Permeabilities of Cyclic Peptides</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">14073</span>– <span class="NLM_lpage">14080</span>, <span class="refDoi"> DOI: 10.1021/ja063076p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja063076p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVCmur3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2006&pages=14073-14080&author=T.+Rezaiauthor=J.+E.+Bockauthor=M.+V.+Zhouauthor=C.+Kalyanaramanauthor=R.+S.+Lokeyauthor=M.+P.+Jacobson&title=Conformational+Flexibility%2C+Internal+Hydrogen+Bonding%2C+and+Passive+Membrane+Permeability%3A+Successful+In+Silico+Prediction+of+the+Relative+Permeabilities+of+Cyclic+Peptides&doi=10.1021%2Fja063076p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Conformational Flexibility, Internal Hydrogen Bonding, and Passive Membrane Permeability: Successful in Silico Prediction of the Relative Permeabilities of Cyclic Peptides</span></div><div class="casAuthors">Rezai, Taha; Bock, Jonathan E.; Zhou, Mai V.; Kalyanaraman, Chakrapani; Lokey, R. Scott; Jacobson, Matthew P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">14073-14080</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report an atomistic phys. model for the passive membrane permeability of cyclic peptides.  The computational modeling was performed in advance of the expts. and did not involve the use of "training data".  The model explicitly treats the conformational flexibility of the peptides by extensive conformational sampling in low (membrane) and high (water) dielec. environments.  The passive membrane permeabilities of 11 cyclic peptides were obtained exptl. using a parallel artificial membrane permeability assay (PAMPA) and showed a linear correlation with the computational results with R2 = 0.96.  In general, the results support the hypothesis, already well established in the literature, that the ability to form internal hydrogen bonds is crit. for passive membrane permeability and can be the distinguishing factor among closely related compds., such as those studied here.  However, we have found that the no. of internal hydrogen bonds that can form in the membrane and the solvent-exposed polar surface area correlate more poorly with PAMPA permeability than our model, which quant. ests. the solvation free energy losses upon moving from high-dielec. water to the low-dielec. interior of a membrane.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofxfL018o86rVg90H21EOLACvtfcHk0lj3S2k43-iYEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVCmur3I&md5=78d4b4082e6a72b288d4b6dac933ca35</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fja063076p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja063076p%26sid%3Dliteratum%253Aachs%26aulast%3DRezai%26aufirst%3DT.%26aulast%3DBock%26aufirst%3DJ.%2BE.%26aulast%3DZhou%26aufirst%3DM.%2BV.%26aulast%3DKalyanaraman%26aufirst%3DC.%26aulast%3DLokey%26aufirst%3DR.%2BS.%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26atitle%3DConformational%2520Flexibility%252C%2520Internal%2520Hydrogen%2520Bonding%252C%2520and%2520Passive%2520Membrane%2520Permeability%253A%2520Successful%2520In%2520Silico%2520Prediction%2520of%2520the%2520Relative%2520Permeabilities%2520of%2520Cyclic%2520Peptides%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2006%26volume%3D128%26spage%3D14073%26epage%3D14080%26doi%3D10.1021%2Fja063076p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span>Atropisomer
interconversion was monitored by <sup>1</sup>H NMR. Exchange
rates were calculated from line-shape analysis, coalescence temperatures,
or half-lives. Free energy barriers (Δ<i>G</i><sup>⧧</sup>) were calculated from exchange rates using Eyring’s
equation. For details, see <span class="NLM_contrib-group"><span class="NLM_string-name">Claridge, T. D. W.</span></span> <i>High-Resolution NMR Techniques in Organic Chemistry</i>, <span class="NLM_edition">3</span>rd ed.; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">Amsterdam, The Netherlands</span>, <span class="NLM_year">2016</span>; p  <span class="NLM_fpage">50</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&pages=50&author=T.+D.+W.+Claridge&title=High-Resolution+NMR+Techniques+in+Organic+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DClaridge%26aufirst%3DT.%2BD.%2BW.%26btitle%3DHigh-Resolution%2520NMR%2520Techniques%2520in%2520Organic%2520Chemistry%26pub%3DElsevier%26date%3D2016%26spage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laplante, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fader, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fandrick, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fandrick, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hucke, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemper, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, P. J.</span></span> <span> </span><span class="NLM_article-title">Assessing Atropisomer Axial Chirality in Drug Discovery and Development</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">7005</span>– <span class="NLM_lpage">7022</span>, <span class="refDoi"> DOI: 10.1021/jm200584g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200584g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFygu7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7005-7022&author=S.+R.+Laplanteauthor=L.+D.+Faderauthor=K.+R.+Fandrickauthor=D.+R.+Fandrickauthor=O.+Huckeauthor=R.+Kemperauthor=S.+P.+Millerauthor=P.+J.+Edwards&title=Assessing+Atropisomer+Axial+Chirality+in+Drug+Discovery+and+Development&doi=10.1021%2Fjm200584g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Assessing Atropisomer Axial Chirality in Drug Discovery and Development</span></div><div class="casAuthors">LaPlante, Steven R.; Fader, Lee D.; Fandrick, Keith R.; Fandrick, Daniel R.; Hucke, Oliver; Kemper, Ray; Miller, Stephen P. F.; Edwards, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7005-7022</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQ8uS-SDx68bVg90H21EOLACvtfcHk0lhorPDGPmxxGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFygu7zN&md5=6b44135b3871d2460fba4b3246b899e3</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm200584g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200584g%26sid%3Dliteratum%253Aachs%26aulast%3DLaplante%26aufirst%3DS.%2BR.%26aulast%3DFader%26aufirst%3DL.%2BD.%26aulast%3DFandrick%26aufirst%3DK.%2BR.%26aulast%3DFandrick%26aufirst%3DD.%2BR.%26aulast%3DHucke%26aufirst%3DO.%26aulast%3DKemper%26aufirst%3DR.%26aulast%3DMiller%26aufirst%3DS.%2BP.%26aulast%3DEdwards%26aufirst%3DP.%2BJ.%26atitle%3DAssessing%2520Atropisomer%2520Axial%2520Chirality%2520in%2520Drug%2520Discovery%2520and%2520Development%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7005%26epage%3D7022%26doi%3D10.1021%2Fjm200584g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rotzler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gsellinger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bihlmeier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gantenbein, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vonlanthen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Häussinger, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klopper, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayor, M.</span></span> <span> </span><span class="NLM_article-title">Atropisomerization of di-<i>para</i>-Substituted Propyl-Bridged Biphenyl Cyclophanes</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">110</span>– <span class="NLM_lpage">118</span>, <span class="refDoi"> DOI: 10.1039/C2OB26243F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=10.1039%2FC2OB26243F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=23059962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslOjsbnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2013&pages=110-118&author=J.+Rotzlerauthor=H.+Gsellingerauthor=A.+Bihlmeierauthor=M.+Gantenbeinauthor=D.+Vonlanthenauthor=D.+H%C3%A4ussingerauthor=W.+Klopperauthor=M.+Mayor&title=Atropisomerization+of+di-para-Substituted+Propyl-Bridged+Biphenyl+Cyclophanes&doi=10.1039%2FC2OB26243F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Atropisomerization of di-para-substituted propyl-bridged biphenyl cyclophanes</span></div><div class="casAuthors">Rotzler, Juergen; Gsellinger, Heiko; Bihlmeier, Angela; Gantenbein, Markus; Vonlanthen, David; Haeussinger, Daniel; Klopper, Wim; Mayor, Marcel</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">110-118</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The influence of electron donors and electron acceptors of variable strength in the 4 and 4' position of 2 and 2' propyl-bridged axial chiral biphenyl cyclophanes on their atropisomerization process was studied.  Estd. free energies ΔG±(T) of the rotation around the central biphenyl bond which were obtained from 1H-NMR coalescence measurements were correlated to the Hammett parameters σp as a measure for electron donor and acceptor strength.  It is demonstrated that the resulting nice linear correlation is mainly based on the influence of the different substituents on the π-system of the biphenyl cyclophanes.  By lineshape anal. the rate consts. were calcd. and by the use of the Eyring equation the enthalpic and entropic contributions were evaluated.  D. functional theory calcns. show a planar transition state of the isomerization process and the calcd. energy barriers based on this reaction mechanism are in good agreement with the exptl. obtained free energies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWTv2XXtp9XbVg90H21EOLACvtfcHk0lhorPDGPmxxGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslOjsbnJ&md5=f06d7f8220a05450327283e425c94c04</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1039%2FC2OB26243F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC2OB26243F%26sid%3Dliteratum%253Aachs%26aulast%3DRotzler%26aufirst%3DJ.%26aulast%3DGsellinger%26aufirst%3DH.%26aulast%3DBihlmeier%26aufirst%3DA.%26aulast%3DGantenbein%26aufirst%3DM.%26aulast%3DVonlanthen%26aufirst%3DD.%26aulast%3DH%25C3%25A4ussinger%26aufirst%3DD.%26aulast%3DKlopper%26aufirst%3DW.%26aulast%3DMayor%26aufirst%3DM.%26atitle%3DAtropisomerization%2520of%2520di-para-Substituted%2520Propyl-Bridged%2520Biphenyl%2520Cyclophanes%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2013%26volume%3D11%26spage%3D110%26epage%3D118%26doi%3D10.1039%2FC2OB26243F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="note"><p class="first last">In vitro p-ERK IC<sub>50</sub> values were derived from EGF-stimulated MIA PaCa-2 cells.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="note"><p class="first last">Residual ERK phosphorylation (∼30%) is attributable to nonmutant KRAS activity resulting from stromal contamination of the clonal <i>KRAS p.G12C</i> tumors (confirmed by RNA-seq) and is observed both at later time points and at higher doses.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="note"><p class="first last">No significant body weight loss was observed at any dose level in this study.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span> Data initially published
in<span class="NLM_contrib-group"><span class="NLM_string-name">Canon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rex, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saiki, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohr, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooke, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bagal, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaida, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knutson, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koppada, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanman, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rapaport, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">San Miguel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortiz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osgood, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarter, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volak, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houk, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fakih, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neil, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falchook, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Govindan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouyang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henary, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arvedson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cee, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipford, J. R.</span></span> <span> </span><span class="NLM_article-title">The Clinical KRAS<sup>G12C</sup> Inhibitor AMG 510 Drives Anti-Tumor Immunity</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>575</i></span>,  <span class="NLM_fpage">217</span>– <span class="NLM_lpage">223</span>, <span class="refDoi"> DOI: 10.1038/s41586-019-1694-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=10.1038%2Fs41586-019-1694-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=31666701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitV2hsb7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=575&publication_year=2019&pages=217-223&author=J.+Canonauthor=K.+Rexauthor=A.+Y.+Saikiauthor=C.+Mohrauthor=K.+Cookeauthor=D.+Bagalauthor=K.+Gaidaauthor=T.+Holtauthor=C.+G.+Knutsonauthor=N.+Koppadaauthor=B.+A.+Lanmanauthor=J.+Wernerauthor=A.+S.+Rapaportauthor=T.+San+Miguelauthor=R.+Ortizauthor=T.+Osgoodauthor=J.-R.+Sunauthor=X.+Zhuauthor=J.+D.+McCarterauthor=L.+P.+Volakauthor=B.+E.+Houkauthor=M.+G.+Fakihauthor=B.+H.+O%E2%80%99Neilauthor=T.+J.+Priceauthor=G.+S.+Falchookauthor=J.+Desaiauthor=J.+Kuoauthor=R.+Govindanauthor=D.+S.+Hongauthor=W.+Ouyangauthor=H.+Henaryauthor=T.+Arvedsonauthor=V.+J.+Ceeauthor=J.+R.+Lipford&title=The+Clinical+KRASG12C+Inhibitor+AMG+510+Drives+Anti-Tumor+Immunity&doi=10.1038%2Fs41586-019-1694-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity</span></div><div class="casAuthors">Canon, Jude; Rex, Karen; Saiki, Anne Y.; Mohr, Christopher; Cooke, Keegan; Bagal, Dhanashri; Gaida, Kevin; Holt, Tyler; Knutson, Charles G.; Koppada, Neelima; Lanman, Brian A.; Werner, Jonathan; Rapaport, Aaron S.; San Miguel, Tisha; Ortiz, Roberto; Osgood, Tao; Sun, Ji-Rong; Zhu, Xiaochun; McCarter, John D.; Volak, Laurie P.; Houk, Brett E.; Fakih, Marwan G.; O'Neil, Bert H.; Price, Timothy J.; Falchook, Gerald S.; Desai, Jayesh; Kuo, James; Govindan, Ramaswamy; Hong, David S.; Ouyang, Wenjun; Henary, Haby; Arvedson, Tara; Cee, Victor J.; Lipford, J. Russell</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">575</span>
        (<span class="NLM_cas:issue">7781</span>),
    <span class="NLM_cas:pages">217-223</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">KRAS is the most frequently mutated oncogene in cancer and encodes a key signalling protein in tumors1,2.  The KRAS(G12C) mutant has a cysteine residue that has been exploited to design covalent inhibitors that have promising preclin. activity3-5.  Here we optimized a series of inhibitors, using novel binding interactions to markedly enhance their potency and selectivity.  Our efforts have led to the discovery of AMG 510, which is, to our knowledge, the first KRAS(G12C) inhibitor in clin. development.  In preclin. analyses, treatment with AMG 510 led to the regression of KRASG12C tumors and improved the anti-tumor efficacy of chemotherapy and targeted agents.  In immune-competent mice, treatment with AMG 510 resulted in a pro-inflammatory tumor microenvironment and produced durable cures alone as well as in combination with immune-checkpoint inhibitors.  Cured mice rejected the growth of isogenic KRASG12D tumors, which suggests adaptive immunity against shared antigens.  Furthermore, in clin. trials, AMG 510 demonstrated anti-tumor activity in the first dosing cohorts and represents a potentially transformative therapy for patients for whom effective treatments are lacking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTHdBftQfnhbVg90H21EOLACvtfcHk0ljzzYf0UR9NwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitV2hsb7F&md5=3819175980905976ba87ff545b9506e1</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fs41586-019-1694-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-019-1694-1%26sid%3Dliteratum%253Aachs%26aulast%3DCanon%26aufirst%3DJ.%26aulast%3DRex%26aufirst%3DK.%26aulast%3DSaiki%26aufirst%3DA.%2BY.%26aulast%3DMohr%26aufirst%3DC.%26aulast%3DCooke%26aufirst%3DK.%26aulast%3DBagal%26aufirst%3DD.%26aulast%3DGaida%26aufirst%3DK.%26aulast%3DHolt%26aufirst%3DT.%26aulast%3DKnutson%26aufirst%3DC.%2BG.%26aulast%3DKoppada%26aufirst%3DN.%26aulast%3DLanman%26aufirst%3DB.%2BA.%26aulast%3DWerner%26aufirst%3DJ.%26aulast%3DRapaport%26aufirst%3DA.%2BS.%26aulast%3DSan%2BMiguel%26aufirst%3DT.%26aulast%3DOrtiz%26aufirst%3DR.%26aulast%3DOsgood%26aufirst%3DT.%26aulast%3DSun%26aufirst%3DJ.-R.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DMcCarter%26aufirst%3DJ.%2BD.%26aulast%3DVolak%26aufirst%3DL.%2BP.%26aulast%3DHouk%26aufirst%3DB.%2BE.%26aulast%3DFakih%26aufirst%3DM.%2BG.%26aulast%3DO%25E2%2580%2599Neil%26aufirst%3DB.%2BH.%26aulast%3DPrice%26aufirst%3DT.%2BJ.%26aulast%3DFalchook%26aufirst%3DG.%2BS.%26aulast%3DDesai%26aufirst%3DJ.%26aulast%3DKuo%26aufirst%3DJ.%26aulast%3DGovindan%26aufirst%3DR.%26aulast%3DHong%26aufirst%3DD.%2BS.%26aulast%3DOuyang%26aufirst%3DW.%26aulast%3DHenary%26aufirst%3DH.%26aulast%3DArvedson%26aufirst%3DT.%26aulast%3DCee%26aufirst%3DV.%2BJ.%26aulast%3DLipford%26aufirst%3DJ.%2BR.%26atitle%3DThe%2520Clinical%2520KRASG12C%2520Inhibitor%2520AMG%2520510%2520Drives%2520Anti-Tumor%2520Immunity%26jtitle%3DNature%26date%3D2019%26volume%3D575%26spage%3D217%26epage%3D223%26doi%3D10.1038%2Fs41586-019-1694-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalvie, D. K.</span></span> <span> </span><span class="NLM_article-title">Drug Discovery for a New Generation of Covalent Drugs</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">561</span>– <span class="NLM_lpage">581</span>, <span class="refDoi"> DOI: 10.1517/17460441.2012.688744</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=10.1517%2F17460441.2012.688744" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=22607458" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=1%3ACAS%3A528%3ADC%252BC38XptFWmt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=561-581&author=A.+S.+Kalgutkarauthor=D.+K.+Dalvie&title=Drug+Discovery+for+a+New+Generation+of+Covalent+Drugs&doi=10.1517%2F17460441.2012.688744"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Drug discovery for a new generation of covalent drugs</span></div><div class="casAuthors">Kalgutkar, Amit S.; Dalvie, Deepak K.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">561-581</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: The design of target-specific covalent inhibitors is conceptually attractive because of increased biochem. efficiency through covalency and increased duration of action that outlasts the pharmacokinetics of the agent.  Although many covalent inhibitors have been approved or are in advanced clin. trials to treat indications such as cancer and hepatitis C, there is a general tendency to avoid them as drug candidates because of concerns regarding immune-mediated toxicity that can arise from indiscriminate reactivity with off-target proteins.Areas covered: The review examines potential reason(s) for the excellent safety record of marketed covalent agents and advanced clin. candidates for emerging therapeutic targets.  A significant emphasis is placed on proteomic techniques and chem./biochem. reactivity assays that aim to provide a systematic rank ordering of pharmacol. selectivity relative to off-target protein reactivity of covalent inhibitors.Expert opinion: While tactics to examine selective covalent modification of the pharmacol. target are broadly applicable in drug discovery, it is unclear whether the output from such studies can prospectively predict idiosyncratic immune-mediated drug toxicity.  Opinions regarding an acceptable threshold of protein reactivity/body burden for a toxic electrophile and a non-toxic electrophilic covalent drug have not been defined.  Increasing confidence in proteomic and chem./biochem. reactivity screens will require a retrospective side-by-side profiling of marketed covalent drugs and electrophiles known to cause deleterious toxic effects via non-selective covalent binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowmXy20mDTPbVg90H21EOLACvtfcHk0liUxpk-bRrf_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XptFWmt7k%253D&md5=b7fc8e60b263dda5765dd8380f52df17</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1517%2F17460441.2012.688744&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2012.688744%26sid%3Dliteratum%253Aachs%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DDalvie%26aufirst%3DD.%2BK.%26atitle%3DDrug%2520Discovery%2520for%2520a%2520New%2520Generation%2520of%2520Covalent%2520Drugs%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2012%26volume%3D7%26spage%3D561%26epage%3D581%26doi%3D10.1517%2F17460441.2012.688744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="note"><p class="first last">As determined by stable-isotope labelling (SILAC) experiments; see ref <a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Campuzano, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">San Miguel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onea, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cee, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arvedson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarter, J. D.</span></span> <span> </span><span class="NLM_article-title">High-Throughput Mass Spectrometric Analysis of Covalent Protein-Inhibitor Adducts for the Discovery of Irreversible Inhibitors: A Complete Workflow</span>. <i>J. Biomol. Screening</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">136</span>– <span class="NLM_lpage">144</span>, <span class="refDoi"> DOI: 10.1177/1087057115621288</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=10.1177%2F1087057115621288" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=26676098" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=1%3ACAS%3A528%3ADC%252BC28XmvVSrtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=136-144&author=I.+D.+Campuzanoauthor=T.+San+Miguelauthor=T.+Roweauthor=D.+Oneaauthor=V.+J.+Ceeauthor=T.+Arvedsonauthor=J.+D.+McCarter&title=High-Throughput+Mass+Spectrometric+Analysis+of+Covalent+Protein-Inhibitor+Adducts+for+the+Discovery+of+Irreversible+Inhibitors%3A+A+Complete+Workflow&doi=10.1177%2F1087057115621288"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">High-throughput mass spectrometric analysis of covalent protein-inhibitor adducts for the discovery of irreversible inhibitors: a complete workflow</span></div><div class="casAuthors">Campuzano, Iain D. G.; San Miguel, Tisha; Rowe, Todd; Onea, Daniel; Cee, Victor J.; Arvedson, Tara; McCarter, John D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">136-144</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">We have implemented a solid-phase extn. based time-of-flight mass spectrometer system in combination with novel informatics to rapidly screen and characterize the covalent binding of different irreversible inhibitors to intact proteins.  This high-throughput screening platform can be used to accurately detect and quantitate the extent of formation of different covalent protein-inhibitor adducts between electrophilic inhibitors and nucleophilic residues such as cysteine or lysine.  For a representative 19.5 kDa protein, the anal. time is approx. 20 s per sample, including an efficient sample loading and desalting step.  Accurate protein masses are measured (±0.5 amu of the theor. mol. wt.; measured precision of ±0.02 amu).  The fraction of protein reacted with an electrophilic compd. is detd. relative to an unmodified protein control.  A key element of the workflow is the automated identification and quantitation of the expected masses of covalent protein-inhibitor adducts using a custom routine that obviates the need to manually inspect each individual spectrum.  Parallel screens were performed on a library of approx. 1000 acrylamide contg. compds. (different structures and reactivities) using the solid-phase extn. mass spectrometry based assay and a fluorescence based thiol-reactive probe assay enabling comparison of false positives and false negatives between these orthogonal screening approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5_Meysg0t4LVg90H21EOLACvtfcHk0liUxpk-bRrf_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmvVSrtb4%253D&md5=060f56816034d61615584239b8bc14ab</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1177%2F1087057115621288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057115621288%26sid%3Dliteratum%253Aachs%26aulast%3DCampuzano%26aufirst%3DI.%2BD.%26aulast%3DSan%2BMiguel%26aufirst%3DT.%26aulast%3DRowe%26aufirst%3DT.%26aulast%3DOnea%26aufirst%3DD.%26aulast%3DCee%26aufirst%3DV.%2BJ.%26aulast%3DArvedson%26aufirst%3DT.%26aulast%3DMcCarter%26aufirst%3DJ.%2BD.%26atitle%3DHigh-Throughput%2520Mass%2520Spectrometric%2520Analysis%2520of%2520Covalent%2520Protein-Inhibitor%2520Adducts%2520for%2520the%2520Discovery%2520of%2520Irreversible%2520Inhibitors%253A%2520A%2520Complete%2520Workflow%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2016%26volume%3D21%26spage%3D136%26epage%3D144%26doi%3D10.1177%2F1087057115621288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cee, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volak, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartberger, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tegley, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arvedson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tasker, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fotsch, C.</span></span> <span> </span><span class="NLM_article-title">Systematic Study of the Glutathione (GSH) Reactivity of <i>N</i>-Arylacrylamides: 1. Effects of Aryl Substitution</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">9171</span>– <span class="NLM_lpage">9178</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01018</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01018" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFGrsLfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=9171-9178&author=V.+J.+Ceeauthor=L.+P.+Volakauthor=Y.+Chenauthor=M.+D.+Bartbergerauthor=C.+Tegleyauthor=T.+Arvedsonauthor=J.+McCarterauthor=A.+S.+Taskerauthor=C.+Fotsch&title=Systematic+Study+of+the+Glutathione+%28GSH%29+Reactivity+of+N-Arylacrylamides%3A+1.+Effects+of+Aryl+Substitution&doi=10.1021%2Facs.jmedchem.5b01018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Systematic Study of the Glutathione (GSH) Reactivity of N-Arylacrylamides: 1. Effects of Aryl Substitution</span></div><div class="casAuthors">Cee, Victor J.; Volak, Laurie P.; Chen, Yuping; Bartberger, Michael D.; Tegley, Chris; Arvedson, Tara; McCarter, John; Tasker, Andrew S.; Fotsch, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9171-9178</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Success in the design of targeted covalent inhibitors depends in part on a knowledge of the factors influencing electrophile reactivity.  In an effort to further develop an understanding of structure-reactivity relations among N-arylacrylamides, the authors detd. glutathione (GSH) reaction rates for a family of N-arylacrylamides independently substituted at ortho-, meta-, and para-positions with 11 different groups common to inhibitor design.  Substituent effects on reaction rates show a linear Hammett correlation for ortho-, meta-, and para-substitution.  The authors note a correlation between 1H and 13C NMR chem. shifts of the acrylamide with GSH reaction rates, suggesting that NMR chem. shifts may be a convenient surrogate measure of relative acrylamide reactivity.  D. functional theory calcns. reveal a correlation between computed activation parameters and exptl. detd. reaction rates, validating the use of such methodol. for the screening of synthetic candidates in a prospective fashion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAoYRfo0lRj7Vg90H21EOLACvtfcHk0liUxpk-bRrf_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFGrsLfN&md5=2f3a816446dd73d5be061ad8d2195e2d</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01018%26sid%3Dliteratum%253Aachs%26aulast%3DCee%26aufirst%3DV.%2BJ.%26aulast%3DVolak%26aufirst%3DL.%2BP.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DTegley%26aufirst%3DC.%26aulast%3DArvedson%26aufirst%3DT.%26aulast%3DMcCarter%26aufirst%3DJ.%26aulast%3DTasker%26aufirst%3DA.%2BS.%26aulast%3DFotsch%26aufirst%3DC.%26atitle%3DSystematic%2520Study%2520of%2520the%2520Glutathione%2520%2528GSH%2529%2520Reactivity%2520of%2520N-Arylacrylamides%253A%25201.%2520Effects%2520of%2520Aryl%2520Substitution%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D9171%26epage%3D9178%26doi%3D10.1021%2Facs.jmedchem.5b01018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="note"><p class="first last">Data to be reported separately.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span>Details
of this trial can be found at <a href="https://clinicaltrials.gov/" class="extLink">https://clinicaltrials.gov/</a> (accessed Sep 7, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Details%0Aof+this+trial+can+be+found+at+https%3A%2F%2Fclinicaltrials.gov%2F+%28accessed+Sep+7%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fakih, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neil, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falchook, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Govindan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rasmussen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrow, P. K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henary, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, D. S.</span></span> <span> </span><span class="NLM_article-title">Phase 1 Study Evaluating the Safety, Tolerability, Pharmacokinetics (PK), and Efficacy of AMG 510, a Novel Small Molecule KRASG12C Inhibitor, in Advanced Solid Tumors</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">3003</span>, <span class="refDoi"> DOI: 10.1200/JCO.2019.37.15_suppl.3003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=10.1200%2FJCO.2019.37.15_suppl.3003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2019&pages=3003&author=M.+Fakihauthor=B.+O%E2%80%99Neilauthor=T.+J.+Priceauthor=G.+S.+Falchookauthor=J.+Desaiauthor=J.+Kuoauthor=R.+Govindanauthor=E.+Rasmussenauthor=P.+K.+H.+Morrowauthor=J.+Ngangauthor=H.+A.+Henaryauthor=D.+S.+Hong&title=Phase+1+Study+Evaluating+the+Safety%2C+Tolerability%2C+Pharmacokinetics+%28PK%29%2C+and+Efficacy+of+AMG+510%2C+a+Novel+Small+Molecule+KRASG12C+Inhibitor%2C+in+Advanced+Solid+Tumors&doi=10.1200%2FJCO.2019.37.15_suppl.3003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1200%2FJCO.2019.37.15_suppl.3003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2019.37.15_suppl.3003%26sid%3Dliteratum%253Aachs%26aulast%3DFakih%26aufirst%3DM.%26aulast%3DO%25E2%2580%2599Neil%26aufirst%3DB.%26aulast%3DPrice%26aufirst%3DT.%2BJ.%26aulast%3DFalchook%26aufirst%3DG.%2BS.%26aulast%3DDesai%26aufirst%3DJ.%26aulast%3DKuo%26aufirst%3DJ.%26aulast%3DGovindan%26aufirst%3DR.%26aulast%3DRasmussen%26aufirst%3DE.%26aulast%3DMorrow%26aufirst%3DP.%2BK.%2BH.%26aulast%3DNgang%26aufirst%3DJ.%26aulast%3DHenary%26aufirst%3DH.%2BA.%26aulast%3DHong%26aufirst%3DD.%2BS.%26atitle%3DPhase%25201%2520Study%2520Evaluating%2520the%2520Safety%252C%2520Tolerability%252C%2520Pharmacokinetics%2520%2528PK%2529%252C%2520and%2520Efficacy%2520of%2520AMG%2520510%252C%2520a%2520Novel%2520Small%2520Molecule%2520KRASG12C%2520Inhibitor%252C%2520in%2520Advanced%2520Solid%2520Tumors%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2019%26volume%3D37%26spage%3D3003%26doi%3D10.1200%2FJCO.2019.37.15_suppl.3003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':[],'ref13':['cit13'],'ref14':['cit14'],'ref15':[],'ref16':[],'ref17':[],'ref18':['cit18'],'ref19':[],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':[],'ref26':[],'ref27':[],'ref28':['cit28'],'ref29':['cit29'],'ref30':[],'ref31':['cit31'],'ref32':['cit32'],'ref33':[],'ref34':['cit34'],'ref35':['cit35']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 69 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Zhijie Wang, Jiongheng Cai, Jie Cheng, Wenqianzi Yang, Yifan Zhu, Hongmei Li, Tao Lu, Yadong Chen, <span class="NLM_string-name hlFld-ContribAuthor">Shuai Lu</span>. </span><span class="cited-content_cbyCitation_article-title">FLT3 Inhibitors in Acute Myeloid Leukemia: Challenges and Recent Developments in Overcoming Resistance. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (6)
                                     , 2878-2900. <a href="https://doi.org/10.1021/acs.jmedchem.0c01851" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01851</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01851&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01851%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFLT3%252BInhibitors%252Bin%252BAcute%252BMyeloid%252BLeukemia%25253A%252BChallenges%252Band%252BRecent%252BDevelopments%252Bin%252BOvercoming%252BResistance%26aulast%3DWang%26aufirst%3DZhijie%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D23102020%26date%3D10032021%26volume%3D64%26issue%3D6%26spage%3D2878%26epage%3D2900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Wolfgang Jahnke, Daniel A. Erlanson, Iwan J. P. de Esch, Christopher N. Johnson, Paul N. Mortenson, Yuji Ochi, <span class="NLM_string-name hlFld-ContribAuthor">Tatsuya Urushima</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-to-Lead Medicinal Chemistry Publications in 2019. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (24)
                                     , 15494-15507. <a href="https://doi.org/10.1021/acs.jmedchem.0c01608" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01608</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01608&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01608%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFragment-to-Lead%252BMedicinal%252BChemistry%252BPublications%252Bin%252B2019%26aulast%3DJahnke%26aufirst%3DWolfgang%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D14092020%26date%3D23112020%26volume%3D63%26issue%3D24%26spage%3D15494%26epage%3D15507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hao Chen, Jeff B. Smaill, Tongzheng Liu, Ke Ding, <span class="NLM_string-name hlFld-ContribAuthor">Xiaoyun Lu</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Inhibitors Directly Targeting KRAS as Anticancer Therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (23)
                                     , 14404-14424. <a href="https://doi.org/10.1021/acs.jmedchem.0c01312" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01312</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01312%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall-Molecule%252BInhibitors%252BDirectly%252BTargeting%252BKRAS%252Bas%252BAnticancer%252BTherapeutics%26aulast%3DChen%26aufirst%3DHao%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D28072020%26date%3D23112020%26volume%3D63%26issue%3D23%26spage%3D14404%26epage%3D14424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dibyendu Mondal, <span class="NLM_string-name hlFld-ContribAuthor">Arieh Warshel</span>. </span><span class="cited-content_cbyCitation_article-title">Exploring the Mechanism of Covalent Inhibition: Simulating the Binding Free Energy of α-Ketoamide Inhibitors of the Main Protease of SARS-CoV-2. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry</span><span> <strong>2020,</strong> <em>59 </em>
                                    (48)
                                     , 4601-4608. <a href="https://doi.org/10.1021/acs.biochem.0c00782" title="DOI URL">https://doi.org/10.1021/acs.biochem.0c00782</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.biochem.0c00782&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.biochem.0c00782%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%26atitle%3DExploring%252Bthe%252BMechanism%252Bof%252BCovalent%252BInhibition%25253A%252BSimulating%252Bthe%252BBinding%252BFree%252BEnergy%252Bof%252B%2525CE%2525B1-Ketoamide%252BInhibitors%252Bof%252Bthe%252BMain%252BProtease%252Bof%252BSARS-CoV-2%26aulast%3DMondal%26aufirst%3DDibyendu%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D22092020%26date%3D20102020%26date%3D18112020%26volume%3D59%26issue%3D48%26spage%3D4601%26epage%3D4608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Keisuke Tokunaga, Mami Sato, Keiko Kuwata, Chizuru Miura, Hirokazu Fuchida, Naoya Matsunaga, Satoru Koyanagi, Shigehiro Ohdo, Naoya Shindo, <span class="NLM_string-name hlFld-ContribAuthor">Akio Ojida</span>. </span><span class="cited-content_cbyCitation_article-title">Bicyclobutane Carboxylic Amide as a Cysteine-Directed Strained Electrophile for Selective Targeting of Proteins. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2020,</strong> <em>142 </em>
                                    (43)
                                     , 18522-18531. <a href="https://doi.org/10.1021/jacs.0c07490" title="DOI URL">https://doi.org/10.1021/jacs.0c07490</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.0c07490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.0c07490%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DBicyclobutane%252BCarboxylic%252BAmide%252Bas%252Ba%252BCysteine-Directed%252BStrained%252BElectrophile%252Bfor%252BSelective%252BTargeting%252Bof%252BProteins%26aulast%3DTokunaga%26aufirst%3DKeisuke%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D12072020%26date%3D13102020%26volume%3D142%26issue%3D43%26spage%3D18522%26epage%3D18531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Adrien Dumas, Jean-Baptiste Garsi, Guillaume Poissonnet, <span class="NLM_string-name hlFld-ContribAuthor">Stephen Hanessian</span>. </span><span class="cited-content_cbyCitation_article-title">Ni-Catalyzed Reductive and Merged Photocatalytic Cross-Coupling Reactions toward sp3/sp2-Functionalized Isoquinolones: Creating Diversity at C-6 and C-7 to Address Bioactive Analogues. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2020,</strong> <em>5 </em>
                                    (42)
                                     , 27591-27606. <a href="https://doi.org/10.1021/acsomega.0c04181" title="DOI URL">https://doi.org/10.1021/acsomega.0c04181</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.0c04181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.0c04181%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DNi-Catalyzed%252BReductive%252Band%252BMerged%252BPhotocatalytic%252BCross-Coupling%252BReactions%252Btoward%252Bsp3%25252Fsp2-Functionalized%252BIsoquinolones%25253A%252BCreating%252BDiversity%252Bat%252BC-6%252Band%252BC-7%252Bto%252BAddress%252BBioactive%252BAnalogues%26aulast%3DDumas%26aufirst%3DAdrien%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D28082020%26date%3D22092020%26date%3D16102020%26volume%3D5%26issue%3D42%26spage%3D27591%26epage%3D27606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jenny Y. Kim, Bailey A. Plaman, <span class="NLM_string-name hlFld-ContribAuthor">Anthony C. Bishop</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting a Pathogenic Cysteine Mutation: Discovery of a Specific Inhibitor of Y279C SHP2. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry</span><span> <strong>2020,</strong> <em>59 </em>
                                    (37)
                                     , 3498-3507. <a href="https://doi.org/10.1021/acs.biochem.0c00471" title="DOI URL">https://doi.org/10.1021/acs.biochem.0c00471</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.biochem.0c00471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.biochem.0c00471%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%26atitle%3DTargeting%252Ba%252BPathogenic%252BCysteine%252BMutation%25253A%252BDiscovery%252Bof%252Ba%252BSpecific%252BInhibitor%252Bof%252BY279C%252BSHP2%26aulast%3DKim%26aufirst%3DJenny%2BY.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D03062020%26date%3D31082020%26date%3D08092020%26date%3D01092020%26volume%3D59%26issue%3D37%26spage%3D3498%26epage%3D3507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Peter Ertl, Eva Altmann, <span class="NLM_string-name hlFld-ContribAuthor">Jeffrey M. McKenna</span>. </span><span class="cited-content_cbyCitation_article-title">The Most Common Functional Groups in Bioactive Molecules and How Their Popularity Has Evolved over Time. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (15)
                                     , 8408-8418. <a href="https://doi.org/10.1021/acs.jmedchem.0c00754" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00754</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00754&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00754%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BMost%252BCommon%252BFunctional%252BGroups%252Bin%252BBioactive%252BMolecules%252Band%252BHow%252BTheir%252BPopularity%252BHas%252BEvolved%252Bover%252BTime%26aulast%3DErtl%26aufirst%3DPeter%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D05052020%26date%3D29072020%26date%3D14072020%26volume%3D63%26issue%3D15%26spage%3D8408%26epage%3D8418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yunyuan Huang, Yixiang Xu, Rongrong Song, Shuaishuai Ni, Jiaqi Liu, Yanhong Xu, Yanliang Ren, Li Rao, Yingjie Wang, Lin Wei, Lingling Feng, Chen Su, Chao Peng, Jian Li, <span class="NLM_string-name hlFld-ContribAuthor">Jian Wan</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of the New Covalent Allosteric Binding Site of Fructose-1,6-bisphosphatase with Disulfiram Derivatives toward Glucose Reduction. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (11)
                                     , 6238-6247. <a href="https://doi.org/10.1021/acs.jmedchem.0c00699" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00699</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00699&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00699%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252Bthe%252BNew%252BCovalent%252BAllosteric%252BBinding%252BSite%252Bof%252BFructose-1%25252C6-bisphosphatase%252Bwith%252BDisulfiram%252BDerivatives%252Btoward%252BGlucose%252BReduction%26aulast%3DHuang%26aufirst%3DYunyuan%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D27042020%26date%3D19052020%26date%3D07052020%26volume%3D63%26issue%3D11%26spage%3D6238%26epage%3D6247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jason G. Kettle, Sharan K. Bagal, Sue Bickerton, Michael S. Bodnarchuk, Jason Breed, Rodrigo J. Carbajo, Doyle J. Cassar, Atanu Chakraborty, Sabina Cosulich, Iain Cumming, Michael Davies, Andrew Eatherton, Laura Evans, Lyman Feron, Shaun Fillery, Emma S. Gleave, Frederick W. Goldberg, Stephanie Harlfinger, Lyndsey Hanson, Martin Howard, Rachel Howells, Anne Jackson, Paul Kemmitt, Jennifer K. Kingston, Scott Lamont, Hilary J. Lewis, Songlei Li, Libin Liu, Derek Ogg, Christopher Phillips, Radek Polanski, Graeme Robb, David Robinson, Sarah Ross, James M. Smith, Michael Tonge, Rebecca Whiteley, Junsheng Yang, Longfei Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Xiliang Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design and Pharmacokinetic Optimization of Covalent Allosteric Inhibitors of the Mutant GTPase KRASG12C. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (9)
                                     , 4468-4483. <a href="https://doi.org/10.1021/acs.jmedchem.9b01720" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01720</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01720&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01720%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDesign%252Band%252BPharmacokinetic%252BOptimization%252Bof%252BCovalent%252BAllosteric%252BInhibitors%252Bof%252Bthe%252BMutant%252BGTPase%252BKRASG12C%26aulast%3DKettle%26aufirst%3DJason%2BG.%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D18102019%26date%3D13022020%26date%3D05022020%26volume%3D63%26issue%3D9%26spage%3D4468%26epage%3D4483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kun  Chen</span>, <span class="hlFld-ContribAuthor ">Yalei  Zhang</span>, <span class="hlFld-ContribAuthor ">Ling  Qian</span>, <span class="hlFld-ContribAuthor ">Peng  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging strategies to target RAS signaling in human cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Hematology & Oncology</span><span> <strong>2021,</strong> <em>14 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13045-021-01127-w" title="DOI URL">https://doi.org/10.1186/s13045-021-01127-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13045-021-01127-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13045-021-01127-w%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Hematology%2520%2526%2520Oncology%26atitle%3DEmerging%252Bstrategies%252Bto%252Btarget%252BRAS%252Bsignaling%252Bin%252Bhuman%252Bcancer%252Btherapy%26aulast%3DChen%26aufirst%3DKun%26date%3D2021%26date%3D2021%26volume%3D14%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Takamasa  Koga</span>, <span class="hlFld-ContribAuthor ">Kenichi  Suda</span>, <span class="hlFld-ContribAuthor ">Toshio  Fujino</span>, <span class="hlFld-ContribAuthor ">Shuta  Ohara</span>, <span class="hlFld-ContribAuthor ">Akira  Hamada</span>, <span class="hlFld-ContribAuthor ">Masaya  Nishino</span>, <span class="hlFld-ContribAuthor ">Masato  Chiba</span>, <span class="hlFld-ContribAuthor ">Masaki  Shimoji</span>, <span class="hlFld-ContribAuthor ">Toshiki  Takemoto</span>, <span class="hlFld-ContribAuthor ">Takeo  Arita</span>, <span class="hlFld-ContribAuthor ">Michael  Gmachl</span>, <span class="hlFld-ContribAuthor ">Marco H.  Hofmann</span>, <span class="hlFld-ContribAuthor ">Junichi  Soh</span>, <span class="hlFld-ContribAuthor ">Tetsuya  Mitsudomi</span>. </span><span class="cited-content_cbyCitation_article-title">KRAS Secondary Mutations That Confer Acquired Resistance to KRAS G12C Inhibitors, Sotorasib and Adagrasib, and Overcoming Strategies: Insights From In Vitro Experiments. </span><span class="cited-content_cbyCitation_journal-name">Journal of Thoracic Oncology</span><span> <strong>2021,</strong> <em>16 </em>
                                    (8)
                                     , 1321-1332. <a href="https://doi.org/10.1016/j.jtho.2021.04.015" title="DOI URL">https://doi.org/10.1016/j.jtho.2021.04.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jtho.2021.04.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jtho.2021.04.015%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Thoracic%2520Oncology%26atitle%3DKRAS%252BSecondary%252BMutations%252BThat%252BConfer%252BAcquired%252BResistance%252Bto%252BKRAS%252BG12C%252BInhibitors%25252C%252BSotorasib%252Band%252BAdagrasib%25252C%252Band%252BOvercoming%252BStrategies%25253A%252BInsights%252BFrom%252BIn%2525C2%2525A0Vitro%252BExperiments%26aulast%3DKoga%26aufirst%3DTakamasa%26date%3D2021%26volume%3D16%26issue%3D8%26spage%3D1321%26epage%3D1332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Severin  Thompson</span>, <span class="hlFld-ContribAuthor ">Andreas  Buckl</span>, <span class="hlFld-ContribAuthor ">Alexander G.  Dossetter</span>, <span class="hlFld-ContribAuthor ">Ed  Griffen</span>, <span class="hlFld-ContribAuthor ">Adrian  Gill</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecule Son of Sevenless 1 (SOS1) inhibitors: a review of the patent literature. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2021,</strong> <em> </em><a href="https://doi.org/10.1080/13543776.2021.1952984" title="DOI URL">https://doi.org/10.1080/13543776.2021.1952984</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2021.1952984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2021.1952984%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DSmall%252Bmolecule%252BSon%252Bof%252BSevenless%252B1%252B%252528SOS1%252529%252Binhibitors%25253A%252Ba%252Breview%252Bof%252Bthe%252Bpatent%252Bliterature%26aulast%3DThompson%26aufirst%3DSeverin%26date%3D2021%26date%3D2021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jonathan A.  Werner</span>, <span class="hlFld-ContribAuthor ">Rhian  Davies</span>, <span class="hlFld-ContribAuthor ">Jan  Wahlstrom</span>, <span class="hlFld-ContribAuthor ">Upendra P.  Dahal</span>, <span class="hlFld-ContribAuthor ">Min  Jiang</span>, <span class="hlFld-ContribAuthor ">Jonathan  Stauber</span>, <span class="hlFld-ContribAuthor ">Benjamin  David</span>, <span class="hlFld-ContribAuthor ">William  Siska</span>, <span class="hlFld-ContribAuthor ">Barbara  Thomas</span>, <span class="hlFld-ContribAuthor ">Katsu  Ishida</span>, <span class="hlFld-ContribAuthor ">W. Griffith  Humphreys</span>, <span class="hlFld-ContribAuthor ">J. Russell  Lipford</span>, <span class="hlFld-ContribAuthor ">Thomas M.  Monticello</span>. </span><span class="cited-content_cbyCitation_article-title">Mercapturate pathway metabolites of sotorasib, a covalent inhibitor of KRASG12C, are associated with renal toxicity in the Sprague Dawley rat. </span><span class="cited-content_cbyCitation_journal-name">Toxicology and Applied Pharmacology</span><span> <strong>2021,</strong> <em>423 </em>, 115578. <a href="https://doi.org/10.1016/j.taap.2021.115578" title="DOI URL">https://doi.org/10.1016/j.taap.2021.115578</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.taap.2021.115578&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.taap.2021.115578%26sid%3Dliteratum%253Aachs%26jtitle%3DToxicology%2520and%2520Applied%2520Pharmacology%26atitle%3DMercapturate%252Bpathway%252Bmetabolites%252Bof%252Bsotorasib%25252C%252Ba%252Bcovalent%252Binhibitor%252Bof%252BKRASG12C%25252C%252Bare%252Bassociated%252Bwith%252Brenal%252Btoxicity%252Bin%252Bthe%252BSprague%252BDawley%252Brat%26aulast%3DWerner%26aufirst%3DJonathan%2BA.%26date%3D2021%26volume%3D423%26spage%3D115578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Colin R.  Lindsay</span>, <span class="hlFld-ContribAuthor ">Marina C.  Garassino</span>, <span class="hlFld-ContribAuthor ">Ernest  Nadal</span>, <span class="hlFld-ContribAuthor ">Katarina  Öhrling</span>, <span class="hlFld-ContribAuthor ">Matthias  Scheffler</span>, <span class="hlFld-ContribAuthor ">Julien  Mazières</span>. </span><span class="cited-content_cbyCitation_article-title">On target: Rational approaches to KRAS inhibition for treatment of non-small cell lung carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Lung Cancer</span><span> <strong>2021,</strong> <em>893 </em><a href="https://doi.org/10.1016/j.lungcan.2021.07.005" title="DOI URL">https://doi.org/10.1016/j.lungcan.2021.07.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.lungcan.2021.07.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.lungcan.2021.07.005%26sid%3Dliteratum%253Aachs%26jtitle%3DLung%2520Cancer%26atitle%3DOn%252Btarget%25253A%252BRational%252Bapproaches%252Bto%252BKRAS%252Binhibition%252Bfor%252Btreatment%252Bof%252Bnon-small%252Bcell%252Blung%252Bcarcinoma%26aulast%3DLindsay%26aufirst%3DColin%2BR.%26date%3D2021%26volume%3D893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ana  Portelinha</span>, <span class="hlFld-ContribAuthor ">Scott  Thompson</span>, <span class="hlFld-ContribAuthor ">Roger A.  Smith</span>, <span class="hlFld-ContribAuthor ">Mariana  Da Silva Ferreira</span>, <span class="hlFld-ContribAuthor ">Zahra  Asgari</span>, <span class="hlFld-ContribAuthor ">Andrea  Knezevic</span>, <span class="hlFld-ContribAuthor ">Venkatraman  Seshan</span>, <span class="hlFld-ContribAuthor ">Elisa  de Stanchina</span>, <span class="hlFld-ContribAuthor ">Sandeep  Gupta</span>, <span class="hlFld-ContribAuthor ">Louis  Denis</span>, <span class="hlFld-ContribAuthor ">Anas  Younes</span>, <span class="hlFld-ContribAuthor ">Sanjeeva  Reddy</span>. </span><span class="cited-content_cbyCitation_article-title">ASN007 is a selective ERK1/2 inhibitor with preferential activity against RAS-and RAF-mutant tumors. </span><span class="cited-content_cbyCitation_journal-name">Cell Reports Medicine</span><span> <strong>2021,</strong> <em>2 </em>
                                    (7)
                                     , 100350. <a href="https://doi.org/10.1016/j.xcrm.2021.100350" title="DOI URL">https://doi.org/10.1016/j.xcrm.2021.100350</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.xcrm.2021.100350&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.xcrm.2021.100350%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Reports%2520Medicine%26atitle%3DASN007%252Bis%252Ba%252Bselective%252BERK1%25252F2%252Binhibitor%252Bwith%252Bpreferential%252Bactivity%252Bagainst%252BRAS-and%252BRAF-mutant%252Btumors%26aulast%3DPortelinha%26aufirst%3DAna%26date%3D2021%26volume%3D2%26issue%3D7%26spage%3D100350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexios  Chatzigoulas</span>, <span class="hlFld-ContribAuthor ">Zoe  Cournia</span>. </span><span class="cited-content_cbyCitation_article-title">Rational design of allosteric modulators: Challenges and successes. </span><span class="cited-content_cbyCitation_journal-name">WIREs Computational Molecular Science</span><span> <strong>2021,</strong> <em>17 </em><a href="https://doi.org/10.1002/wcms.1529" title="DOI URL">https://doi.org/10.1002/wcms.1529</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/wcms.1529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fwcms.1529%26sid%3Dliteratum%253Aachs%26jtitle%3DWIREs%2520Computational%2520Molecular%2520Science%26atitle%3DRational%252Bdesign%252Bof%252Ballosteric%252Bmodulators%25253A%252BChallenges%252Band%252Bsuccesses%26aulast%3DChatzigoulas%26aufirst%3DAlexios%26date%3D2021%26date%3D2021%26volume%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Baoyuan  Zhang</span>, <span class="hlFld-ContribAuthor ">Yan  Zhang</span>, <span class="hlFld-ContribAuthor ">Jiangwei  Zhang</span>, <span class="hlFld-ContribAuthor ">Ping  Liu</span>, <span class="hlFld-ContribAuthor ">Bo  Jiao</span>, <span class="hlFld-ContribAuthor ">Zaiqi  Wang</span>, <span class="hlFld-ContribAuthor ">Ruibao  Ren</span>. </span><span class="cited-content_cbyCitation_article-title">Focal Adhesion Kinase (FAK) Inhibition Synergizes with KRAS G12C Inhibitors in Treating Cancer through the Regulation of the FAK–YAP Signaling. </span><span class="cited-content_cbyCitation_journal-name">Advanced Science</span><span> <strong>2021,</strong> <em> </em>, 2100250. <a href="https://doi.org/10.1002/advs.202100250" title="DOI URL">https://doi.org/10.1002/advs.202100250</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/advs.202100250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadvs.202100250%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Science%26atitle%3DFocal%252BAdhesion%252BKinase%252B%252528FAK%252529%252BInhibition%252BSynergizes%252Bwith%252BKRAS%252BG12C%252BInhibitors%252Bin%252BTreating%252BCancer%252Bthrough%252Bthe%252BRegulation%252Bof%252Bthe%252BFAK%2525E2%252580%252593YAP%252BSignaling%26aulast%3DZhang%26aufirst%3DBaoyuan%26date%3D2021%26date%3D2021%26spage%3D2100250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katsu  Ishida</span>, <span class="hlFld-ContribAuthor ">Jonathan A.  Werner</span>, <span class="hlFld-ContribAuthor ">Rhian  Davies</span>, <span class="hlFld-ContribAuthor ">Fan  Fan</span>, <span class="hlFld-ContribAuthor ">Barbara  Thomas</span>, <span class="hlFld-ContribAuthor ">Jan  Wahlstrom</span>, <span class="hlFld-ContribAuthor ">James Russell  Lipford</span>, <span class="hlFld-ContribAuthor ">Thomas  Monticello</span>. </span><span class="cited-content_cbyCitation_article-title">Nonclinical Safety Profile of Sotorasib, a KRAS
              G12C
              -Specific Covalent Inhibitor for the Treatment of
              KRAS p.G12C
              -Mutated Cancer. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Toxicology</span><span> <strong>2021,</strong> <em>187 </em>, 109158182110229. <a href="https://doi.org/10.1177/10915818211022965" title="DOI URL">https://doi.org/10.1177/10915818211022965</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/10915818211022965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F10915818211022965%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Toxicology%26atitle%3DNonclinical%252BSafety%252BProfile%252Bof%252BSotorasib%25252C%252Ba%252BKRAS%252BG12C%252B-Specific%252BCovalent%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BKRAS%252Bp.G12C%252B-Mutated%252BCancer%26aulast%3DIshida%26aufirst%3DKatsu%26date%3D2021%26date%3D2021%26volume%3D187%26spage%3D109158182110229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Irene A.  Retmana</span>, <span class="hlFld-ContribAuthor ">Nancy H.C.  Loos</span>, <span class="hlFld-ContribAuthor ">Alfred H.  Schinkel</span>, <span class="hlFld-ContribAuthor ">Jos H.  Beijnen</span>, <span class="hlFld-ContribAuthor ">Rolf W.  Sparidans</span>. </span><span class="cited-content_cbyCitation_article-title">Quantification of KRAS inhibitor sotorasib in mouse plasma and tissue homogenates using liquid chromatography-tandem mass spectrometry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chromatography B</span><span> <strong>2021,</strong> <em>1174 </em>, 122718. <a href="https://doi.org/10.1016/j.jchromb.2021.122718" title="DOI URL">https://doi.org/10.1016/j.jchromb.2021.122718</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jchromb.2021.122718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jchromb.2021.122718%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chromatography%2520B%26atitle%3DQuantification%252Bof%252BKRAS%252Binhibitor%252Bsotorasib%252Bin%252Bmouse%252Bplasma%252Band%252Btissue%252Bhomogenates%252Busing%252Bliquid%252Bchromatography-tandem%252Bmass%252Bspectrometry%26aulast%3DRetmana%26aufirst%3DIrene%2BA.%26date%3D2021%26volume%3D1174%26spage%3D122718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul  Hofman</span>. </span><span class="cited-content_cbyCitation_article-title">What Is New in Biomarker Testing at Diagnosis of Advanced Non-Squamous Non-Small Cell Lung Carcinoma? Implications for Cytology and Liquid Biopsy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Pathology</span><span> <strong>2021,</strong> <em>2 </em>
                                    (2)
                                     , 147-172. <a href="https://doi.org/10.3390/jmp2020015" title="DOI URL">https://doi.org/10.3390/jmp2020015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/jmp2020015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fjmp2020015%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Pathology%26atitle%3DWhat%252BIs%252BNew%252Bin%252BBiomarker%252BTesting%252Bat%252BDiagnosis%252Bof%252BAdvanced%252BNon-Squamous%252BNon-Small%252BCell%252BLung%252BCarcinoma%25253F%252BImplications%252Bfor%252BCytology%252Band%252BLiquid%252BBiopsy%26aulast%3DHofman%26aufirst%3DPaul%26date%3D2021%26date%3D2021%26volume%3D2%26issue%3D2%26spage%3D147%26epage%3D172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">K.  Sreedurgalakshmi</span>, <span class="hlFld-ContribAuthor ">R.  Srikar</span>, <span class="hlFld-ContribAuthor ">Reena  Rajkumari</span>. </span><span class="cited-content_cbyCitation_article-title">CRISPR-Cas deployment in non-small cell lung cancer for target screening, validations, and discoveries. </span><span class="cited-content_cbyCitation_journal-name">Cancer Gene Therapy</span><span> <strong>2021,</strong> <em>28 </em>
                                    (6)
                                     , 566-580. <a href="https://doi.org/10.1038/s41417-020-00256-7" title="DOI URL">https://doi.org/10.1038/s41417-020-00256-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41417-020-00256-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41417-020-00256-7%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Gene%2520Therapy%26atitle%3DCRISPR-Cas%252Bdeployment%252Bin%252Bnon-small%252Bcell%252Blung%252Bcancer%252Bfor%252Btarget%252Bscreening%25252C%252Bvalidations%25252C%252Band%252Bdiscoveries%26aulast%3DSreedurgalakshmi%26aufirst%3DK.%26date%3D2021%26date%3D2020%26volume%3D28%26issue%3D6%26spage%3D566%26epage%3D580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ronen  Gabizon</span>, <span class="hlFld-ContribAuthor ">Nir  London</span>. </span><span class="cited-content_cbyCitation_article-title">The rise of covalent proteolysis targeting chimeras. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Chemical Biology</span><span> <strong>2021,</strong> <em>62 </em>, 24-33. <a href="https://doi.org/10.1016/j.cbpa.2020.12.003" title="DOI URL">https://doi.org/10.1016/j.cbpa.2020.12.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cbpa.2020.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cbpa.2020.12.003%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Chemical%2520Biology%26atitle%3DThe%252Brise%252Bof%252Bcovalent%252Bproteolysis%252Btargeting%252Bchimeras%26aulast%3DGabizon%26aufirst%3DRonen%26date%3D2021%26volume%3D62%26spage%3D24%26epage%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel A.  Erlanson</span>, <span class="hlFld-ContribAuthor ">Kevin R.  Webster</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting mutant KRAS. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Chemical Biology</span><span> <strong>2021,</strong> <em>62 </em>, 101-108. <a href="https://doi.org/10.1016/j.cbpa.2021.02.010" title="DOI URL">https://doi.org/10.1016/j.cbpa.2021.02.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cbpa.2021.02.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cbpa.2021.02.010%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Chemical%2520Biology%26atitle%3DTargeting%252Bmutant%252BKRAS%26aulast%3DErlanson%26aufirst%3DDaniel%2BA.%26date%3D2021%26volume%3D62%26spage%3D101%26epage%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shumei  Kato</span>, <span class="hlFld-ContribAuthor ">Jacob J.  Adashek</span>, <span class="hlFld-ContribAuthor ">Justin  Shaya</span>, <span class="hlFld-ContribAuthor ">Ryosuke  Okamura</span>, <span class="hlFld-ContribAuthor ">Rebecca E.  Jimenez</span>, <span class="hlFld-ContribAuthor ">Suzanna  Lee</span>, <span class="hlFld-ContribAuthor ">Jason K.  Sicklick</span>, <span class="hlFld-ContribAuthor ">Razelle  Kurzrock</span>. </span><span class="cited-content_cbyCitation_article-title">Concomitant MEK and Cyclin Gene Alterations: Implications for Response to Targeted Therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Clinical Cancer Research</span><span> <strong>2021,</strong> <em>27 </em>
                                    (10)
                                     , 2792-2797. <a href="https://doi.org/10.1158/1078-0432.CCR-20-3761" title="DOI URL">https://doi.org/10.1158/1078-0432.CCR-20-3761</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1078-0432.CCR-20-3761&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1078-0432.CCR-20-3761%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Cancer%2520Research%26atitle%3DConcomitant%252BMEK%252Band%252BCyclin%252BGene%252BAlterations%25253A%252BImplications%252Bfor%252BResponse%252Bto%252BTargeted%252BTherapeutics%26aulast%3DKato%26aufirst%3DShumei%26date%3D2021%26date%3D2021%26volume%3D27%26issue%3D10%26spage%3D2792%26epage%3D2797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Seong Ho  Hong</span>, <span class="hlFld-ContribAuthor ">Daniel Y.  Yoo</span>, <span class="hlFld-ContribAuthor ">Louis  Conway</span>, <span class="hlFld-ContribAuthor ">Khyle C.  Richards-Corke</span>, <span class="hlFld-ContribAuthor ">Christopher G.  Parker</span>, <span class="hlFld-ContribAuthor ">Paramjit S.  Arora</span>. </span><span class="cited-content_cbyCitation_article-title">A Sos proteomimetic as a pan-Ras inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2021,</strong> <em>118 </em>
                                    (18)
                                     , e2101027118. <a href="https://doi.org/10.1073/pnas.2101027118" title="DOI URL">https://doi.org/10.1073/pnas.2101027118</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.2101027118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.2101027118%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DA%252BSos%252Bproteomimetic%252Bas%252Ba%252Bpan-Ras%252Binhibitor%26aulast%3DHong%26aufirst%3DSeong%2BHo%26date%3D2021%26date%3D2021%26volume%3D118%26issue%3D18%26spage%3De2101027118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ming  Huang</span>, <span class="hlFld-ContribAuthor ">Yinsheng  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">GLOBAL AND TARGETED PROFILING OF GTP‐BINDING PROTEINS IN BIOLOGICAL SAMPLES BY MASS SPECTROMETRY. </span><span class="cited-content_cbyCitation_journal-name">Mass Spectrometry Reviews</span><span> <strong>2021,</strong> <em>40 </em>
                                    (3)
                                     , 215-235. <a href="https://doi.org/10.1002/mas.21637" title="DOI URL">https://doi.org/10.1002/mas.21637</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/mas.21637&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmas.21637%26sid%3Dliteratum%253Aachs%26jtitle%3DMass%2520Spectrometry%2520Reviews%26atitle%3DGLOBAL%252BAND%252BTARGETED%252BPROFILING%252BOF%252BGTP%2525E2%252580%252590BINDING%252BPROTEINS%252BIN%252BBIOLOGICAL%252BSAMPLES%252BBY%252BMASS%252BSPECTROMETRY%26aulast%3DHuang%26aufirst%3DMing%26date%3D2021%26date%3D2020%26volume%3D40%26issue%3D3%26spage%3D215%26epage%3D235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter D.  Koch</span>, <span class="hlFld-ContribAuthor ">Jeremy  Quintana</span>, <span class="hlFld-ContribAuthor ">Maaz S.  Ahmed</span>, <span class="hlFld-ContribAuthor ">Rainer H.  Kohler</span>, <span class="hlFld-ContribAuthor ">Ralph  Weissleder</span>. </span><span class="cited-content_cbyCitation_article-title">Small Molecule Imaging Agent for Mutant KRAS G12C. </span><span class="cited-content_cbyCitation_journal-name">Advanced Therapeutics</span><span> <strong>2021,</strong> <em>4 </em>
                                    (5)
                                     , 2000290. <a href="https://doi.org/10.1002/adtp.202000290" title="DOI URL">https://doi.org/10.1002/adtp.202000290</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adtp.202000290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadtp.202000290%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Therapeutics%26atitle%3DSmall%252BMolecule%252BImaging%252BAgent%252Bfor%252BMutant%252BKRAS%252BG12C%26aulast%3DKoch%26aufirst%3DPeter%2BD.%26date%3D2021%26date%3D2021%26volume%3D4%26issue%3D5%26spage%3D2000290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark J.  Ratain</span>. </span><span class="cited-content_cbyCitation_article-title">Designing Dose-Finding Phase I Clinical Trials: Top Questions That Should Be Discussed With Your Clinical Pharmacologist. </span><span class="cited-content_cbyCitation_journal-name">JCO Precision Oncology</span><span> <strong>2021,</strong> <em> </em>
                                    (5)
                                     , 935-936. <a href="https://doi.org/10.1200/PO.21.00065" title="DOI URL">https://doi.org/10.1200/PO.21.00065</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1200/PO.21.00065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1200%2FPO.21.00065%26sid%3Dliteratum%253Aachs%26jtitle%3DJCO%2520Precision%2520Oncology%26atitle%3DDesigning%252BDose-Finding%252BPhase%252BI%252BClinical%252BTrials%25253A%252BTop%252BQuestions%252BThat%252BShould%252BBe%252BDiscussed%252BWith%252BYour%252BClinical%252BPharmacologist%26aulast%3DRatain%26aufirst%3DMark%2BJ.%26date%3D2021%26issue%3D5%26spage%3D935%26epage%3D936" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael S.  Bodnarchuk</span>, <span class="hlFld-ContribAuthor ">Doyle J.  Cassar</span>, <span class="hlFld-ContribAuthor ">Jason G.  Kettle</span>, <span class="hlFld-ContribAuthor ">Graeme  Robb</span>, <span class="hlFld-ContribAuthor ">Richard A.  Ward</span>. </span><span class="cited-content_cbyCitation_article-title">Drugging the undruggable: a computational chemist's view of KRAS
              G12C. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2021,</strong> <em>12 </em>
                                    (4)
                                     , 609-614. <a href="https://doi.org/10.1039/D1MD00055A" title="DOI URL">https://doi.org/10.1039/D1MD00055A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1MD00055A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1MD00055A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DDrugging%252Bthe%252Bundruggable%25253A%252Ba%252Bcomputational%252Bchemist%252527s%252Bview%252Bof%252BKRAS%252BG12C%26aulast%3DBodnarchuk%26aufirst%3DMichael%2BS.%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D4%26spage%3D609%26epage%3D614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ai  Yang</span>, <span class="hlFld-ContribAuthor ">Min  Li</span>, <span class="hlFld-ContribAuthor ">Mingzhi  Fang</span>. </span><span class="cited-content_cbyCitation_article-title">The Research Progress of Direct KRAS G12C Mutation Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Pathology and Oncology Research</span><span> <strong>2021,</strong> <em>27 </em><a href="https://doi.org/10.3389/pore.2021.631095" title="DOI URL">https://doi.org/10.3389/pore.2021.631095</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/pore.2021.631095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Fpore.2021.631095%26sid%3Dliteratum%253Aachs%26jtitle%3DPathology%2520and%2520Oncology%2520Research%26atitle%3DThe%252BResearch%252BProgress%252Bof%252BDirect%252BKRAS%252BG12C%252BMutation%252BInhibitors%26aulast%3DYang%26aufirst%3DAi%26date%3D2021%26date%3D2021%26volume%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wang  Wan</span>, <span class="hlFld-ContribAuthor ">Yanan  Huang</span>, <span class="hlFld-ContribAuthor ">Qiuxuan  Xia</span>, <span class="hlFld-ContribAuthor ">Yulong  Bai</span>, <span class="hlFld-ContribAuthor ">Yuwen  Chen</span>, <span class="hlFld-ContribAuthor ">Wenhan  Jin</span>, <span class="hlFld-ContribAuthor ">Mengdie  Wang</span>, <span class="hlFld-ContribAuthor ">Di  Shen</span>, <span class="hlFld-ContribAuthor ">Haochen  Lyu</span>, <span class="hlFld-ContribAuthor ">Yuqi  Tang</span>, <span class="hlFld-ContribAuthor ">Xuepeng  Dong</span>, <span class="hlFld-ContribAuthor ">Zhenming  Gao</span>, <span class="hlFld-ContribAuthor ">Qun  Zhao</span>, <span class="hlFld-ContribAuthor ">Lihua  Zhang</span>, <span class="hlFld-ContribAuthor ">Yu  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Covalent Probes for Aggregated Protein Imaging via Michael Addition. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2021,</strong> <em>181 </em><a href="https://doi.org/10.1002/ange.202015988" title="DOI URL">https://doi.org/10.1002/ange.202015988</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.202015988&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.202015988%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DCovalent%252BProbes%252Bfor%252BAggregated%252BProtein%252BImaging%252Bvia%252BMichael%252BAddition%26aulast%3DWan%26aufirst%3DWang%26date%3D2021%26date%3D2021%26volume%3D181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wang  Wan</span>, <span class="hlFld-ContribAuthor ">Yanan  Huang</span>, <span class="hlFld-ContribAuthor ">Qiuxuan  Xia</span>, <span class="hlFld-ContribAuthor ">Yulong  Bai</span>, <span class="hlFld-ContribAuthor ">Yuwen  Chen</span>, <span class="hlFld-ContribAuthor ">Wenhan  Jin</span>, <span class="hlFld-ContribAuthor ">Mengdie  Wang</span>, <span class="hlFld-ContribAuthor ">Di  Shen</span>, <span class="hlFld-ContribAuthor ">Haochen  Lyu</span>, <span class="hlFld-ContribAuthor ">Yuqi  Tang</span>, <span class="hlFld-ContribAuthor ">Xuepeng  Dong</span>, <span class="hlFld-ContribAuthor ">Zhenming  Gao</span>, <span class="hlFld-ContribAuthor ">Qun  Zhao</span>, <span class="hlFld-ContribAuthor ">Lihua  Zhang</span>, <span class="hlFld-ContribAuthor ">Yu  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Covalent Probes for Aggregated Protein Imaging via Michael Addition. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2021,</strong> <em>181 </em><a href="https://doi.org/10.1002/anie.202015988" title="DOI URL">https://doi.org/10.1002/anie.202015988</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.202015988&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.202015988%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DCovalent%252BProbes%252Bfor%252BAggregated%252BProtein%252BImaging%252Bvia%252BMichael%252BAddition%26aulast%3DWan%26aufirst%3DWang%26date%3D2021%26date%3D2021%26volume%3D181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Naveena  Madhyastha</span>, <span class="hlFld-ContribAuthor ">Swapan Kumar  Samantha</span>, <span class="hlFld-ContribAuthor ">Sreekanth  Dittakavi</span>, <span class="hlFld-ContribAuthor ">Meenu  Markose</span>, <span class="hlFld-ContribAuthor ">Sadanand Rangnathrao  Mallurwar</span>, <span class="hlFld-ContribAuthor ">Mohd  Zainuddin</span>, <span class="hlFld-ContribAuthor ">Ramesh  Mullangi</span>. </span><span class="cited-content_cbyCitation_article-title">Validated HPLC‐MS/MS method for quantitation of AMG 510, a KRAS G12C inhibitor, in mouse plasma and its application to a pharmacokinetic study in mice. </span><span class="cited-content_cbyCitation_journal-name">Biomedical Chromatography</span><span> <strong>2021,</strong> <em>35 </em>
                                    (4)
                                     <a href="https://doi.org/10.1002/bmc.5043" title="DOI URL">https://doi.org/10.1002/bmc.5043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/bmc.5043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fbmc.5043%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedical%2520Chromatography%26atitle%3DValidated%252BHPLC%2525E2%252580%252590MS%25252FMS%252Bmethod%252Bfor%252Bquantitation%252Bof%252BAMG%252B510%25252C%252Ba%252BKRAS%252BG12C%252Binhibitor%25252C%252Bin%252Bmouse%252Bplasma%252Band%252Bits%252Bapplication%252Bto%252Ba%252Bpharmacokinetic%252Bstudy%252Bin%252Bmice%26aulast%3DMadhyastha%26aufirst%3DNaveena%26date%3D2021%26date%3D2021%26volume%3D35%26issue%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elena  De Falco</span>, <span class="hlFld-ContribAuthor ">Luca  Pacini</span>, <span class="hlFld-ContribAuthor ">Daniela  Bastianelli</span>, <span class="hlFld-ContribAuthor ">Gian Paolo  Spinelli</span>, <span class="hlFld-ContribAuthor ">Chiara  Spoto</span>, <span class="hlFld-ContribAuthor ">Enzo  Veltri</span>, <span class="hlFld-ContribAuthor ">Antonella  Calogero</span>. </span><span class="cited-content_cbyCitation_article-title">Concomitant Mutations G12D and G13D on the Exon 2 of the KRAS Gene: Two Cases of Women with Colon Adenocarcinoma. </span><span class="cited-content_cbyCitation_journal-name">Diagnostics</span><span> <strong>2021,</strong> <em>11 </em>
                                    (4)
                                     , 659. <a href="https://doi.org/10.3390/diagnostics11040659" title="DOI URL">https://doi.org/10.3390/diagnostics11040659</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/diagnostics11040659&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fdiagnostics11040659%26sid%3Dliteratum%253Aachs%26jtitle%3DDiagnostics%26atitle%3DConcomitant%252BMutations%252BG12D%252Band%252BG13D%252Bon%252Bthe%252BExon%252B2%252Bof%252Bthe%252BKRAS%252BGene%25253A%252BTwo%252BCases%252Bof%252BWomen%252Bwith%252BColon%252BAdenocarcinoma%26aulast%3DDe%2BFalco%26aufirst%3DElena%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D4%26spage%3D659" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jens  Köhler</span>, <span class="hlFld-ContribAuthor ">Pasi A.  Jänne</span>. </span><span class="cited-content_cbyCitation_article-title">If Virchow and Ehrlich Had Dreamt Together: What the Future Holds for KRAS-Mutant Lung Cancer. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (6)
                                     , 3025. <a href="https://doi.org/10.3390/ijms22063025" title="DOI URL">https://doi.org/10.3390/ijms22063025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22063025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22063025%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DIf%252BVirchow%252Band%252BEhrlich%252BHad%252BDreamt%252BTogether%25253A%252BWhat%252Bthe%252BFuture%252BHolds%252Bfor%252BKRAS-Mutant%252BLung%252BCancer%26aulast%3DK%25C3%25B6hler%26aufirst%3DJens%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D6%26spage%3D3025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sean T  Toenjes</span>, <span class="hlFld-ContribAuthor ">Mariam  Basilaia</span>, <span class="hlFld-ContribAuthor ">Jeffrey L  Gustafson</span>. </span><span class="cited-content_cbyCitation_article-title">Leveraging conformational control about a potential atropisomeric axis as a strategy in medical chemistry. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2021,</strong> <em>13 </em>
                                    (5)
                                     , 443-446. <a href="https://doi.org/10.4155/fmc-2020-0348" title="DOI URL">https://doi.org/10.4155/fmc-2020-0348</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2020-0348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2020-0348%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DLeveraging%252Bconformational%252Bcontrol%252Babout%252Ba%252Bpotential%252Batropisomeric%252Baxis%252Bas%252Ba%252Bstrategy%252Bin%252Bmedical%252Bchemistry%26aulast%3DToenjes%26aufirst%3DSean%2BT%26date%3D2021%26volume%3D13%26issue%3D5%26spage%3D443%26epage%3D446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuanzheng  Xiao</span>, <span class="hlFld-ContribAuthor ">Mengzhen  Lai</span>, <span class="hlFld-ContribAuthor ">Zilan  Song</span>, <span class="hlFld-ContribAuthor ">Meiyu  Geng</span>, <span class="hlFld-ContribAuthor ">Jian  Ding</span>, <span class="hlFld-ContribAuthor ">Hua  Xie</span>, <span class="hlFld-ContribAuthor ">Ao  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and pharmacological evaluation of bicyclic and tetracyclic pyridopyrimidinone analogues as new KRASG12C inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>213 </em>, 113082. <a href="https://doi.org/10.1016/j.ejmech.2020.113082" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113082</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113082%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bpharmacological%252Bevaluation%252Bof%252Bbicyclic%252Band%252Btetracyclic%252Bpyridopyrimidinone%252Banalogues%252Bas%252Bnew%252BKRASG12C%252Binhibitors%26aulast%3DXiao%26aufirst%3DXuanzheng%26date%3D2021%26volume%3D213%26spage%3D113082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuran  Qiu</span>, <span class="hlFld-ContribAuthor ">Yuanhao  Wang</span>, <span class="hlFld-ContribAuthor ">Zongtao  Chai</span>, <span class="hlFld-ContribAuthor ">Duan  Ni</span>, <span class="hlFld-ContribAuthor ">Xinyi  Li</span>, <span class="hlFld-ContribAuthor ">Jun  Pu</span>, <span class="hlFld-ContribAuthor ">Jie  Chen</span>, <span class="hlFld-ContribAuthor ">Jian  Zhang</span>, <span class="hlFld-ContribAuthor ">Shaoyong  Lu</span>, <span class="hlFld-ContribAuthor ">Chuan  Lv</span>, <span class="hlFld-ContribAuthor ">Mingfei  Ji</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting RAS phosphorylation in cancer therapy: Mechanisms and modulators. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2021,</strong> <em>116 </em><a href="https://doi.org/10.1016/j.apsb.2021.02.014" title="DOI URL">https://doi.org/10.1016/j.apsb.2021.02.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2021.02.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2021.02.014%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DTargeting%252BRAS%252Bphosphorylation%252Bin%252Bcancer%252Btherapy%25253A%252BMechanisms%252Band%252Bmodulators%26aulast%3DQiu%26aufirst%3DYuran%26date%3D2021%26volume%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhuo-Huan  Li</span>, <span class="hlFld-ContribAuthor ">Yi-Chun  Wang</span>, <span class="hlFld-ContribAuthor ">Tuan-Jie  Li</span>, <span class="hlFld-ContribAuthor ">Jian-Quan  Liu</span>, <span class="hlFld-ContribAuthor ">Xiang-Shan  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">An efficient synthesis of diimidazo[1,2-a:1′,2′-c]quinazolines via a copper-catalyzed double Ullmann cross-coupling reaction. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2021,</strong> <em>81 </em>, 131918. <a href="https://doi.org/10.1016/j.tet.2020.131918" title="DOI URL">https://doi.org/10.1016/j.tet.2020.131918</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2020.131918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2020.131918%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DAn%252Befficient%252Bsynthesis%252Bof%252Bdiimidazo%25255B1%25252C2-a%25253A1%2525E2%252580%2525B2%25252C2%2525E2%252580%2525B2-c%25255Dquinazolines%252Bvia%252Ba%252Bcopper-catalyzed%252Bdouble%252BUllmann%252Bcross-coupling%252Breaction%26aulast%3DLi%26aufirst%3DZhuo-Huan%26date%3D2021%26volume%3D81%26spage%3D131918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christina  Kiel</span>, <span class="hlFld-ContribAuthor ">David  Matallanas</span>, <span class="hlFld-ContribAuthor ">Walter  Kolch</span>. </span><span class="cited-content_cbyCitation_article-title">The Ins and Outs of RAS Effector Complexes. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2021,</strong> <em>11 </em>
                                    (2)
                                     , 236. <a href="https://doi.org/10.3390/biom11020236" title="DOI URL">https://doi.org/10.3390/biom11020236</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom11020236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom11020236%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DThe%252BIns%252Band%252BOuts%252Bof%252BRAS%252BEffector%252BComplexes%26aulast%3DKiel%26aufirst%3DChristina%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D2%26spage%3D236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ajinkya  Buradkar</span>, <span class="hlFld-ContribAuthor ">Evandro  Bezerra</span>, <span class="hlFld-ContribAuthor ">Giacomo  Coltro</span>, <span class="hlFld-ContribAuthor ">Terra L.  Lasho</span>, <span class="hlFld-ContribAuthor ">Christy M.  Finke</span>, <span class="hlFld-ContribAuthor ">Naseema  Gangat</span>, <span class="hlFld-ContribAuthor ">Ryan M.  Carr</span>, <span class="hlFld-ContribAuthor ">Moritz  Binder</span>, <span class="hlFld-ContribAuthor ">Abhishek A.  Mangaonkar</span>, <span class="hlFld-ContribAuthor ">Rhett  Ketterling</span>, <span class="hlFld-ContribAuthor ">Shakila  Khan</span>, <span class="hlFld-ContribAuthor ">Vilmarie  Rodriguez</span>, <span class="hlFld-ContribAuthor ">Ayalew  Tefferi</span>, <span class="hlFld-ContribAuthor ">Mrinal M.  Patnaik</span>. </span><span class="cited-content_cbyCitation_article-title">Landscape of RAS pathway mutations in patients with myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: a study of 461 molecularly annotated patients. </span><span class="cited-content_cbyCitation_journal-name">Leukemia</span><span> <strong>2021,</strong> <em>35 </em>
                                    (2)
                                     , 644-649. <a href="https://doi.org/10.1038/s41375-020-0889-7" title="DOI URL">https://doi.org/10.1038/s41375-020-0889-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41375-020-0889-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41375-020-0889-7%26sid%3Dliteratum%253Aachs%26jtitle%3DLeukemia%26atitle%3DLandscape%252Bof%252BRAS%252Bpathway%252Bmutations%252Bin%252Bpatients%252Bwith%252Bmyelodysplastic%252Bsyndrome%25252Fmyeloproliferative%252Bneoplasm%252Boverlap%252Bsyndromes%25253A%252Ba%252Bstudy%252Bof%252B461%252Bmolecularly%252Bannotated%252Bpatients%26aulast%3DBuradkar%26aufirst%3DAjinkya%26date%3D2021%26date%3D2020%26volume%3D35%26issue%3D2%26spage%3D644%26epage%3D649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aitziber  Buqué</span>, <span class="hlFld-ContribAuthor ">Lorenzo  Galluzzi</span>. </span><span class="cited-content_cbyCitation_article-title">Preface: Chemical carcinogenesis in mice as a model of human cancer: Pros and cons. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, xvii-xxv. <a href="https://doi.org/10.1016/S0091-679X(21)00040-6" title="DOI URL">https://doi.org/10.1016/S0091-679X(21)00040-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/S0091-679X(21)00040-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FS0091-679X%2821%2900040-6%26sid%3Dliteratum%253Aachs%26atitle%3DPreface%25253A%252BChemical%252Bcarcinogenesis%252Bin%252Bmice%252Bas%252Ba%252Bmodel%252Bof%252Bhuman%252Bcancer%25253A%252BPros%252Band%252Bcons%26aulast%3DBuqu%25C3%25A9%26aufirst%3DAitziber%26date%3D2021%26spage%3Dxvii%26epage%3Dxxv%26pub%3DElsevier%26atitle%3DCarcinogen-driven%252Bmouse%252Bmodels%252Bof%252Boncogenesis%26date%3D2021%26volume%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shenxin  Zeng</span>, <span class="hlFld-ContribAuthor ">Wenhai  Huang</span>, <span class="hlFld-ContribAuthor ">Xiaoliang  Zheng</span>, <span class="hlFld-ContribAuthor ">Liyan cheng</span>, <span class="hlFld-ContribAuthor ">Zhimin  Zhang</span>, <span class="hlFld-ContribAuthor ">Jian  Wang</span>, <span class="hlFld-ContribAuthor ">Zhengrong  Shen</span>. </span><span class="cited-content_cbyCitation_article-title">Proteolysis targeting chimera (PROTAC) in drug discovery paradigm: Recent progress and future challenges. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>210 </em>, 112981. <a href="https://doi.org/10.1016/j.ejmech.2020.112981" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112981</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112981&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112981%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DProteolysis%252Btargeting%252Bchimera%252B%252528PROTAC%252529%252Bin%252Bdrug%252Bdiscovery%252Bparadigm%25253A%252BRecent%252Bprogress%252Band%252Bfuture%252Bchallenges%26aulast%3DZeng%26aufirst%3DShenxin%26date%3D2021%26volume%3D210%26spage%3D112981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  Liu</span>, <span class="hlFld-ContribAuthor ">Hui  Li</span>, <span class="hlFld-ContribAuthor ">Jing  Zhu</span>, <span class="hlFld-ContribAuthor ">Yang  Zhang</span>, <span class="hlFld-ContribAuthor ">Xianhong  Liu</span>, <span class="hlFld-ContribAuthor ">Rixin  Li</span>, <span class="hlFld-ContribAuthor ">Qiang  Zhang</span>, <span class="hlFld-ContribAuthor ">Ying  Cheng</span>. </span><span class="cited-content_cbyCitation_article-title">The Prevalence and Concurrent Pathogenic Mutations of KRASG12C in Northeast Chinese Non-small-cell Lung Cancer Patients. </span><span class="cited-content_cbyCitation_journal-name">Cancer Management and Research</span><span> <strong>2021,</strong> <em>Volume 13 </em>, 2447-2454. <a href="https://doi.org/10.2147/CMAR.S282617" title="DOI URL">https://doi.org/10.2147/CMAR.S282617</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2147/CMAR.S282617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2147%2FCMAR.S282617%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Management%2520and%2520Research%26atitle%3DThe%252BPrevalence%252Band%252BConcurrent%252BPathogenic%252BMutations%252Bof%252BKRASG12C%252Bin%252BNortheast%252BChinese%252BNon-small-cell%252BLung%252BCancer%252BPatients%26aulast%3DLiu%26aufirst%3DYan%26date%3D2021%26date%3D2021%26volume%3DVolume%252013%26spage%3D2447%26epage%3D2454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elena De  Vita</span>. </span><span class="cited-content_cbyCitation_article-title">10 years into the resurgence of covalent drugs. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2021,</strong> <em>13 </em>
                                    (2)
                                     , 193-210. <a href="https://doi.org/10.4155/fmc-2020-0236" title="DOI URL">https://doi.org/10.4155/fmc-2020-0236</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2020-0236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2020-0236%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3D10%252Byears%252Binto%252Bthe%252Bresurgence%252Bof%252Bcovalent%252Bdrugs%26aulast%3DVita%26aufirst%3DElena%2BDe%26date%3D2021%26volume%3D13%26issue%3D2%26spage%3D193%26epage%3D210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">György M.  Keserű</span>, <span class="hlFld-ContribAuthor ">Daniel A.  Erlanson</span>. </span><span class="cited-content_cbyCitation_article-title">The future of covalent inhibition. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 267-284. <a href="https://doi.org/10.1016/bs.armc.2020.10.003" title="DOI URL">https://doi.org/10.1016/bs.armc.2020.10.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.armc.2020.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.armc.2020.10.003%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252Bfuture%252Bof%252Bcovalent%252Binhibition%26aulast%3DKeser%25C5%25B1%26aufirst%3DGy%25C3%25B6rgy%2BM.%26date%3D2021%26spage%3D267%26epage%3D284%26pub%3DElsevier%26atitle%3DThe%252BDesign%252Bof%252BCovalent-Based%252BInhibitors%26date%3D2021%26volume%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lyn H.  Jones</span>. </span><span class="cited-content_cbyCitation_article-title">Design of next-generation covalent inhibitors: Targeting residues beyond cysteine. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 95-134. <a href="https://doi.org/10.1016/bs.armc.2020.10.001" title="DOI URL">https://doi.org/10.1016/bs.armc.2020.10.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.armc.2020.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.armc.2020.10.001%26sid%3Dliteratum%253Aachs%26atitle%3DDesign%252Bof%252Bnext-generation%252Bcovalent%252Binhibitors%25253A%252BTargeting%252Bresidues%252Bbeyond%252Bcysteine%26aulast%3DJones%26aufirst%3DLyn%2BH.%26date%3D2021%26spage%3D95%26epage%3D134%26pub%3DElsevier%26atitle%3DThe%252BDesign%252Bof%252BCovalent-Based%252BInhibitors%26date%3D2021%26volume%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Neil P.  Grimster</span>. </span><span class="cited-content_cbyCitation_article-title">Covalent PROTACs: the best of both worlds?. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2021,</strong> <em>10 </em><a href="https://doi.org/10.1039/D1MD00191D" title="DOI URL">https://doi.org/10.1039/D1MD00191D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1MD00191D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1MD00191D%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DCovalent%252BPROTACs%25253A%252Bthe%252Bbest%252Bof%252Bboth%252Bworlds%25253F%26aulast%3DGrimster%26aufirst%3DNeil%2BP.%26date%3D2021%26date%3D2021%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Catherine A.  Hurd</span>, <span class="hlFld-ContribAuthor ">Paul  Brear</span>, <span class="hlFld-ContribAuthor ">Jefferson  Revell</span>, <span class="hlFld-ContribAuthor ">Sarah  Ross</span>, <span class="hlFld-ContribAuthor ">Helen R.  Mott</span>, <span class="hlFld-ContribAuthor ">Darerca  Owen</span>. </span><span class="cited-content_cbyCitation_article-title">Affinity maturation of the RLIP76 Ral binding domain to inform the design of stapled peptides targeting the Ral GTPases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2021,</strong> <em>296 </em>, 100101. <a href="https://doi.org/10.1074/jbc.RA120.015735" title="DOI URL">https://doi.org/10.1074/jbc.RA120.015735</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.RA120.015735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.RA120.015735%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DAffinity%252Bmaturation%252Bof%252Bthe%252BRLIP76%252BRal%252Bbinding%252Bdomain%252Bto%252Binform%252Bthe%252Bdesign%252Bof%252Bstapled%252Bpeptides%252Btargeting%252Bthe%252BRal%252BGTPases%26aulast%3DHurd%26aufirst%3DCatherine%2BA.%26date%3D2021%26volume%3D296%26spage%3D100101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Timothy F.  Burns</span>, <span class="hlFld-ContribAuthor ">Hossein  Borghaei</span>, <span class="hlFld-ContribAuthor ">Suresh S.  Ramalingam</span>, <span class="hlFld-ContribAuthor ">Tony S.  Mok</span>, <span class="hlFld-ContribAuthor ">Solange  Peters</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting
              KRAS
              -Mutant Non–Small-Cell Lung Cancer: One Mutation at a Time, With a Focus on
              KRAS G12C
              Mutations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Clinical Oncology</span><span> <strong>2020,</strong> <em>38 </em>
                                    (35)
                                     , 4208-4218. <a href="https://doi.org/10.1200/JCO.20.00744" title="DOI URL">https://doi.org/10.1200/JCO.20.00744</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1200/JCO.20.00744&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1200%2FJCO.20.00744%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Clinical%2520Oncology%26atitle%3DTargeting%252BKRAS%252B-Mutant%252BNon%2525E2%252580%252593Small-Cell%252BLung%252BCancer%25253A%252BOne%252BMutation%252Bat%252Ba%252BTime%25252C%252BWith%252Ba%252BFocus%252Bon%252BKRAS%252BG12C%252BMutations%26aulast%3DBurns%26aufirst%3DTimothy%2BF.%26date%3D2020%26volume%3D38%26issue%3D35%26spage%3D4208%26epage%3D4218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zoltán  Orgován</span>, <span class="hlFld-ContribAuthor ">György M.  Keserű</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecule inhibitors of RAS proteins with oncogenic mutations. </span><span class="cited-content_cbyCitation_journal-name">Cancer and Metastasis Reviews</span><span> <strong>2020,</strong> <em>39 </em>
                                    (4)
                                     , 1107-1126. <a href="https://doi.org/10.1007/s10555-020-09911-9" title="DOI URL">https://doi.org/10.1007/s10555-020-09911-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10555-020-09911-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10555-020-09911-9%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520and%2520Metastasis%2520Reviews%26atitle%3DSmall%252Bmolecule%252Binhibitors%252Bof%252BRAS%252Bproteins%252Bwith%252Boncogenic%252Bmutations%26aulast%3DOrgov%25C3%25A1n%26aufirst%3DZolt%25C3%25A1n%26date%3D2020%26date%3D2020%26volume%3D39%26issue%3D4%26spage%3D1107%26epage%3D1126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicolas  Bery</span>, <span class="hlFld-ContribAuthor ">Ami  Miller</span>, <span class="hlFld-ContribAuthor ">Terry  Rabbitts</span>. </span><span class="cited-content_cbyCitation_article-title">A potent KRAS macromolecule degrader specifically targeting tumours with mutant KRAS. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2020,</strong> <em>11 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-020-17022-w" title="DOI URL">https://doi.org/10.1038/s41467-020-17022-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-020-17022-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-020-17022-w%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DA%252Bpotent%252BKRAS%252Bmacromolecule%252Bdegrader%252Bspecifically%252Btargeting%252Btumours%252Bwith%252Bmutant%252BKRAS%26aulast%3DBery%26aufirst%3DNicolas%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tatu  Pantsar</span>. </span><span class="cited-content_cbyCitation_article-title">KRAS(G12C)–AMG 510 interaction dynamics revealed by all-atom molecular dynamics simulations. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-020-68950-y" title="DOI URL">https://doi.org/10.1038/s41598-020-68950-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-020-68950-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-020-68950-y%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DKRAS%252528G12C%252529%2525E2%252580%252593AMG%2525C2%2525A0510%252Binteraction%252Bdynamics%252Brevealed%252Bby%252Ball-atom%252Bmolecular%252Bdynamics%252Bsimulations%26aulast%3DPantsar%26aufirst%3DTatu%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dongsung  Kim</span>, <span class="hlFld-ContribAuthor ">Jenny Yaohua  Xue</span>, <span class="hlFld-ContribAuthor ">Piro  Lito</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting KRAS(G12C): From Inhibitory Mechanism to Modulation of Antitumor Effects in Patients. </span><span class="cited-content_cbyCitation_journal-name">Cell</span><span> <strong>2020,</strong> <em>183 </em>
                                    (4)
                                     , 850-859. <a href="https://doi.org/10.1016/j.cell.2020.09.044" title="DOI URL">https://doi.org/10.1016/j.cell.2020.09.044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cell.2020.09.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cell.2020.09.044%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%26atitle%3DTargeting%252BKRAS%252528G12C%252529%25253A%252BFrom%252BInhibitory%252BMechanism%252Bto%252BModulation%252Bof%252BAntitumor%252BEffects%252Bin%252BPatients%26aulast%3DKim%26aufirst%3DDongsung%26date%3D2020%26volume%3D183%26issue%3D4%26spage%3D850%26epage%3D859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mingming  Sun</span>, <span class="hlFld-ContribAuthor ">Wuhong  Chen</span>, <span class="hlFld-ContribAuthor ">Tao  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhenjun  Liu</span>, <span class="hlFld-ContribAuthor ">Junchao  Wei</span>, <span class="hlFld-ContribAuthor ">Ning  Xi</span>. </span><span class="cited-content_cbyCitation_article-title">19F NMR spectroscopy as a tool to detect rotations in fluorine substituted phenyl compounds. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2020,</strong> <em>76 </em>
                                    (48)
                                     , 131679. <a href="https://doi.org/10.1016/j.tet.2020.131679" title="DOI URL">https://doi.org/10.1016/j.tet.2020.131679</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2020.131679&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2020.131679%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3D19F%252BNMR%252Bspectroscopy%252Bas%252Ba%252Btool%252Bto%252Bdetect%252Brotations%252Bin%252Bfluorine%252Bsubstituted%252Bphenyl%252Bcompounds%26aulast%3DSun%26aufirst%3DMingming%26date%3D2020%26volume%3D76%26issue%3D48%26spage%3D131679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yun  Guo</span>, <span class="hlFld-ContribAuthor ">Xian‐ling  Guo</span>, <span class="hlFld-ContribAuthor ">Shuang  Wang</span>, <span class="hlFld-ContribAuthor ">Xinyu  Chen</span>, <span class="hlFld-ContribAuthor ">Jiaochun  Shi</span>, <span class="hlFld-ContribAuthor ">Jian  Wang</span>, <span class="hlFld-ContribAuthor ">Kai  Wang</span>, <span class="hlFld-ContribAuthor ">Samuel J.  Klempner</span>, <span class="hlFld-ContribAuthor ">Weifeng  Wang</span>, <span class="hlFld-ContribAuthor ">Min  Xiao</span>. </span><span class="cited-content_cbyCitation_article-title">Genomic Alterations of
              
                NTRK
              
              ,
              
                POLE
              
              ,
              
                ERBB2
              
              , and Microsatellite Instability Status in Chinese Patients with Colorectal Cancer. </span><span class="cited-content_cbyCitation_journal-name">The Oncologist</span><span> <strong>2020,</strong> <em>25 </em>
                                    (11)
                                     <a href="https://doi.org/10.1634/theoncologist.2020-0356" title="DOI URL">https://doi.org/10.1634/theoncologist.2020-0356</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1634/theoncologist.2020-0356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1634%2Ftheoncologist.2020-0356%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Oncologist%26atitle%3DGenomic%252BAlterations%252Bof%252BNTRK%252B%25252C%252BPOLE%252B%25252C%252BERBB2%252B%25252C%252Band%252BMicrosatellite%252BInstability%252BStatus%252Bin%252BChinese%252BPatients%252Bwith%252BColorectal%252BCancer%26aulast%3DGuo%26aufirst%3DYun%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hidemasa  Matsuo</span>, <span class="hlFld-ContribAuthor ">Kenichi  Yoshida</span>, <span class="hlFld-ContribAuthor ">Kana  Nakatani</span>, <span class="hlFld-ContribAuthor ">Yutarou  Harata</span>, <span class="hlFld-ContribAuthor ">Moe  Higashitani</span>, <span class="hlFld-ContribAuthor ">Yuri  Ito</span>, <span class="hlFld-ContribAuthor ">Yasuhiko  Kamikubo</span>, <span class="hlFld-ContribAuthor ">Yusuke  Shiozawa</span>, <span class="hlFld-ContribAuthor ">Yuichi  Shiraishi</span>, <span class="hlFld-ContribAuthor ">Kenichi  Chiba</span>, <span class="hlFld-ContribAuthor ">Hiroko  Tanaka</span>, <span class="hlFld-ContribAuthor ">Ai  Okada</span>, <span class="hlFld-ContribAuthor ">Yasuhito  Nannya</span>, <span class="hlFld-ContribAuthor ">June  Takeda</span>, <span class="hlFld-ContribAuthor ">Hiroo  Ueno</span>, <span class="hlFld-ContribAuthor ">Nobutaka  Kiyokawa</span>, <span class="hlFld-ContribAuthor ">Daisuke  Tomizawa</span>, <span class="hlFld-ContribAuthor ">Takashi  Taga</span>, <span class="hlFld-ContribAuthor ">Akio  Tawa</span>, <span class="hlFld-ContribAuthor ">Satoru  Miyano</span>, <span class="hlFld-ContribAuthor ">Manja  Meggendorfer</span>, <span class="hlFld-ContribAuthor ">Claudia  Haferlach</span>, <span class="hlFld-ContribAuthor ">Seishi  Ogawa</span>, <span class="hlFld-ContribAuthor ">Souichi  Adachi</span>. </span><span class="cited-content_cbyCitation_article-title">Fusion partner–specific mutation profiles and KRAS mutations as adverse prognostic factors in MLL-rearranged AML. </span><span class="cited-content_cbyCitation_journal-name">Blood Advances</span><span> <strong>2020,</strong> <em>4 </em>
                                    (19)
                                     , 4623-4631. <a href="https://doi.org/10.1182/bloodadvances.2020002457" title="DOI URL">https://doi.org/10.1182/bloodadvances.2020002457</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1182/bloodadvances.2020002457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1182%2Fbloodadvances.2020002457%26sid%3Dliteratum%253Aachs%26jtitle%3DBlood%2520Advances%26atitle%3DFusion%252Bpartner%2525E2%252580%252593specific%252Bmutation%252Bprofiles%252Band%252BKRAS%252Bmutations%252Bas%252Badverse%252Bprognostic%252Bfactors%252Bin%252BMLL-rearranged%252BAML%26aulast%3DMatsuo%26aufirst%3DHidemasa%26date%3D2020%26date%3D2020%26volume%3D4%26issue%3D19%26spage%3D4623%26epage%3D4631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Russell  Madison</span>, <span class="hlFld-ContribAuthor ">Alexa B.  Schrock</span>, <span class="hlFld-ContribAuthor ">Emily  Castellanos</span>, <span class="hlFld-ContribAuthor ">Jeffrey P.  Gregg</span>, <span class="hlFld-ContribAuthor ">Jeremy  Snider</span>, <span class="hlFld-ContribAuthor ">Siraj M.  Ali</span>, <span class="hlFld-ContribAuthor ">Vincent A.  Miller</span>, <span class="hlFld-ContribAuthor ">Gaurav  Singal</span>, <span class="hlFld-ContribAuthor ">Brian M.  Alexander</span>, <span class="hlFld-ContribAuthor ">Jeffrey M.  Venstrom</span>, <span class="hlFld-ContribAuthor ">Jon H.  Chung</span>. </span><span class="cited-content_cbyCitation_article-title">Retrospective analysis of real-world data to determine clinical outcomes of patients with advanced non-small cell lung cancer following cell-free circulating tumor DNA genomic profiling. </span><span class="cited-content_cbyCitation_journal-name">Lung Cancer</span><span> <strong>2020,</strong> <em>148 </em>, 69-78. <a href="https://doi.org/10.1016/j.lungcan.2020.07.033" title="DOI URL">https://doi.org/10.1016/j.lungcan.2020.07.033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.lungcan.2020.07.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.lungcan.2020.07.033%26sid%3Dliteratum%253Aachs%26jtitle%3DLung%2520Cancer%26atitle%3DRetrospective%252Banalysis%252Bof%252Breal-world%252Bdata%252Bto%252Bdetermine%252Bclinical%252Boutcomes%252Bof%252Bpatients%252Bwith%252Badvanced%252Bnon-small%252Bcell%252Blung%252Bcancer%252Bfollowing%252Bcell-free%252Bcirculating%252Btumor%252BDNA%252Bgenomic%252Bprofiling%26aulast%3DMadison%26aufirst%3DRussell%26date%3D2020%26volume%3D148%26spage%3D69%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohamad Karim  Koleilat</span>, <span class="hlFld-ContribAuthor ">Lawrence N.  Kwong</span>. </span><span class="cited-content_cbyCitation_article-title">Same Name, Different Game: EGFR Drives Intrinsic KRAS
              G12C
              Inhibitor Resistance in Colorectal Cancer. </span><span class="cited-content_cbyCitation_journal-name">Cancer Discovery</span><span> <strong>2020,</strong> <em>10 </em>
                                    (8)
                                     , 1094-1096. <a href="https://doi.org/10.1158/2159-8290.CD-20-0612" title="DOI URL">https://doi.org/10.1158/2159-8290.CD-20-0612</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/2159-8290.CD-20-0612&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F2159-8290.CD-20-0612%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Discovery%26atitle%3DSame%252BName%25252C%252BDifferent%252BGame%25253A%252BEGFR%252BDrives%252BIntrinsic%252BKRAS%252BG12C%252BInhibitor%252BResistance%252Bin%252BColorectal%252BCancer%26aulast%3DKoleilat%26aufirst%3DMohamad%2BKarim%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D8%26spage%3D1094%26epage%3D1096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michele  Mancinelli</span>, <span class="hlFld-ContribAuthor ">Giorgio  Bencivenni</span>, <span class="hlFld-ContribAuthor ">Daniel  Pecorari</span>, <span class="hlFld-ContribAuthor ">Andrea  Mazzanti</span>. </span><span class="cited-content_cbyCitation_article-title">Stereochemistry and Recent Applications of Axially Chiral Organic Molecules. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>2020 </em>
                                    (27)
                                     , 4070-4086. <a href="https://doi.org/10.1002/ejoc.201901918" title="DOI URL">https://doi.org/10.1002/ejoc.201901918</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201901918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201901918%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DStereochemistry%252Band%252BRecent%252BApplications%252Bof%252BAxially%252BChiral%252BOrganic%252BMolecules%26aulast%3DMancinelli%26aufirst%3DMichele%26date%3D2020%26date%3D2020%26volume%3D2020%26issue%3D27%26spage%3D4070%26epage%3D4086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lisa  Goebel</span>, <span class="hlFld-ContribAuthor ">Matthias P.  Müller</span>, <span class="hlFld-ContribAuthor ">Roger S.  Goody</span>, <span class="hlFld-ContribAuthor ">Daniel  Rauh</span>. </span><span class="cited-content_cbyCitation_article-title">KRasG12C inhibitors in clinical trials: a short historical perspective. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2020,</strong> <em>11 </em>
                                    (7)
                                     , 760-770. <a href="https://doi.org/10.1039/D0MD00096E" title="DOI URL">https://doi.org/10.1039/D0MD00096E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0MD00096E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0MD00096E%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DKRasG12C%252Binhibitors%252Bin%252Bclinical%252Btrials%25253A%252Ba%252Bshort%252Bhistorical%252Bperspective%26aulast%3DGoebel%26aufirst%3DLisa%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D7%26spage%3D760%26epage%3D770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Soo-Ryum  Yang</span>, <span class="hlFld-ContribAuthor ">Anne M.  Schultheis</span>, <span class="hlFld-ContribAuthor ">Helena  Yu</span>, <span class="hlFld-ContribAuthor ">Diana  Mandelker</span>, <span class="hlFld-ContribAuthor ">Marc  Ladanyi</span>, <span class="hlFld-ContribAuthor ">Reinhard  Büttner</span>. </span><span class="cited-content_cbyCitation_article-title">Precision medicine in non-small cell lung cancer: Current applications and future directions. </span><span class="cited-content_cbyCitation_journal-name">Seminars in Cancer Biology</span><span> <strong>2020,</strong> <em>68 </em><a href="https://doi.org/10.1016/j.semcancer.2020.07.009" title="DOI URL">https://doi.org/10.1016/j.semcancer.2020.07.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.semcancer.2020.07.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.semcancer.2020.07.009%26sid%3Dliteratum%253Aachs%26jtitle%3DSeminars%2520in%2520Cancer%2520Biology%26atitle%3DPrecision%252Bmedicine%252Bin%252Bnon-small%252Bcell%252Blung%252Bcancer%25253A%252BCurrent%252Bapplications%252Band%252Bfuture%252Bdirections%26aulast%3DYang%26aufirst%3DSoo-Ryum%26date%3D2020%26volume%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kei  Kunimasa</span>, <span class="hlFld-ContribAuthor ">Shingo  Matsumoto</span>, <span class="hlFld-ContribAuthor ">Kazumi  Nishino</span>, <span class="hlFld-ContribAuthor ">Harumi  Nakamura</span>, <span class="hlFld-ContribAuthor ">Hanako  Kuhara</span>, <span class="hlFld-ContribAuthor ">Motohiro  Tamiya</span>, <span class="hlFld-ContribAuthor ">Takako  Inoue</span>, <span class="hlFld-ContribAuthor ">Takahisa  Kawamura</span>, <span class="hlFld-ContribAuthor ">Hayato  Kawachi</span>, <span class="hlFld-ContribAuthor ">Kika  Kuno</span>, <span class="hlFld-ContribAuthor ">Toru  Kimura</span>, <span class="hlFld-ContribAuthor ">Tomohiro  Maniwa</span>, <span class="hlFld-ContribAuthor ">Jiro  Okami</span>, <span class="hlFld-ContribAuthor ">Shin-ichi  Nakatsuka</span>, <span class="hlFld-ContribAuthor ">Koichi  Goto</span>, <span class="hlFld-ContribAuthor ">Toru  Kumagai</span>. </span><span class="cited-content_cbyCitation_article-title">Improvement strategies for successful next-generation sequencing analysis of lung cancer. </span><span class="cited-content_cbyCitation_journal-name">Future Oncology</span><span> <strong>2020,</strong> <em>142 </em><a href="https://doi.org/10.2217/fon-2020-0332" title="DOI URL">https://doi.org/10.2217/fon-2020-0332</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2217/fon-2020-0332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2217%2Ffon-2020-0332%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Oncology%26atitle%3DImprovement%252Bstrategies%252Bfor%252Bsuccessful%252Bnext-generation%252Bsequencing%252Banalysis%252Bof%252Blung%252Bcancer%26aulast%3DKunimasa%26aufirst%3DKei%26date%3D2020%26date%3D2020%26volume%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ping-Chih  Hsu</span>, <span class="hlFld-ContribAuthor ">Cheng-Ta  Yang</span>, <span class="hlFld-ContribAuthor ">David M.  Jablons</span>, <span class="hlFld-ContribAuthor ">Liang  You</span>. </span><span class="cited-content_cbyCitation_article-title">The Crosstalk between Src and Hippo/YAP Signaling Pathways in Non-Small Cell Lung Cancer (NSCLC). </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (6)
                                     , 1361. <a href="https://doi.org/10.3390/cancers12061361" title="DOI URL">https://doi.org/10.3390/cancers12061361</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12061361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12061361%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DThe%252BCrosstalk%252Bbetween%252BSrc%252Band%252BHippo%25252FYAP%252BSignaling%252BPathways%252Bin%252BNon-Small%252BCell%252BLung%252BCancer%252B%252528NSCLC%252529%26aulast%3DHsu%26aufirst%3DPing-Chih%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D6%26spage%3D1361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ruben Mercado  Santos</span>, <span class="hlFld-ContribAuthor ">Cerena  Moreno</span>, <span class="hlFld-ContribAuthor ">Wen Cai  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Non-Coding RNAs in Lung Tumor Initiation and Progression. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (8)
                                     , 2774. <a href="https://doi.org/10.3390/ijms21082774" title="DOI URL">https://doi.org/10.3390/ijms21082774</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21082774&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21082774%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DNon-Coding%252BRNAs%252Bin%252BLung%252BTumor%252BInitiation%252Band%252BProgression%26aulast%3DSantos%26aufirst%3DRuben%2BMercado%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D8%26spage%3D2774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mirjam  Steingruber</span>, <span class="hlFld-ContribAuthor ">Manfred  Marschall</span>. </span><span class="cited-content_cbyCitation_article-title">The Cytomegalovirus Protein Kinase pUL97: Host Interactions, Regulatory Mechanisms and Antiviral Drug Targeting. </span><span class="cited-content_cbyCitation_journal-name">Microorganisms</span><span> <strong>2020,</strong> <em>8 </em>
                                    (4)
                                     , 515. <a href="https://doi.org/10.3390/microorganisms8040515" title="DOI URL">https://doi.org/10.3390/microorganisms8040515</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/microorganisms8040515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmicroorganisms8040515%26sid%3Dliteratum%253Aachs%26jtitle%3DMicroorganisms%26atitle%3DThe%252BCytomegalovirus%252BProtein%252BKinase%252BpUL97%25253A%252BHost%252BInteractions%25252C%252BRegulatory%252BMechanisms%252Band%252BAntiviral%252BDrug%252BTargeting%26aulast%3DSteingruber%26aufirst%3DMirjam%26date%3D2020%26date%3D2020%26volume%3D8%26issue%3D4%26spage%3D515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Walter V.  Velasco</span>, <span class="hlFld-ContribAuthor ">Marco  Ramos-Castaneda</span>, <span class="hlFld-ContribAuthor ">Michael J.  Clowers</span>, <span class="hlFld-ContribAuthor ">Shanshan  Deng</span>, <span class="hlFld-ContribAuthor ">Seyed Javad  Moghaddam</span>. </span><span class="cited-content_cbyCitation_article-title">KRAS: The Art of Understanding a Complex Gene. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,<a href="https://doi.org/10.1016/B978-0-08-102723-3.00003-2" title="DOI URL">https://doi.org/10.1016/B978-0-08-102723-3.00003-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-102723-3.00003-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-102723-3.00003-2%26sid%3Dliteratum%253Aachs%26atitle%3DKRAS%25253A%252BThe%252BArt%252Bof%252BUnderstanding%252Ba%252BComplex%252BGene%26aulast%3DVelasco%26aufirst%3DWalter%2BV.%26date%3D2020%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BBiomedical%252BSciences%26date%3D2020%26volume%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kristen K  Ciombor</span>, , <span class="hlFld-ContribAuthor ">Tanios  Bekaii-Saab</span>, . </span><span class="cited-content_cbyCitation_article-title">Precision Medicine in Metastatic Colorectal Cancer—Finding and Hitting the Right Targets. </span><span class="cited-content_cbyCitation_journal-name">Oncology & Hematology Review (US)</span><span> <strong>2020,</strong> <em>16 </em>
                                    (1)
                                     , 36. <a href="https://doi.org/10.17925/OHR.2020.16.1.36" title="DOI URL">https://doi.org/10.17925/OHR.2020.16.1.36</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.17925/OHR.2020.16.1.36&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.17925%2FOHR.2020.16.1.36%26sid%3Dliteratum%253Aachs%26jtitle%3DOncology%2520%2526%2520Hematology%2520Review%2520%2528US%2529%26atitle%3DPrecision%252BMedicine%252Bin%252BMetastatic%252BColorectal%252BCancer%2525E2%252580%252594Finding%252Band%252BHitting%252Bthe%252BRight%252BTargets%26aulast%3DCiombor%26aufirst%3DKristen%2BK%26date%3D2020%26volume%3D16%26issue%3D1%26spage%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/medium/jm9b01180_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/large/jm9b01180_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01180&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/medium/jm9b01180_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/large/jm9b01180_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Comparison of the GDP-KRAS<sup>G12C</sup> binding modes of ARS-1620 (blue, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5V9U">5V9U</a>)<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> and the internally identified indole lead <b>1</b> (pink, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6P8Z">6P8Z</a>)<sub>.</sub><a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> The tetrahydroisoquinoline portion of indole <b>1</b> engages a “cryptic pocket” (magenta) not exploited by prior inhibitors, which is induced by side chain rotation of H95 and comprises the residues Y96, H95, and Q99. Inhibitor activity on downstream ERK phosphorylation (p-ERK IC<sub>50</sub>, 2 h incubation) is indicated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/large/jm9b01180_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01180&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/medium/jm9b01180_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/large/jm9b01180_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Overlay of the GDP-KRAS<sup>G12C</sup>-bound conformations of ARS-1620 (blue) and indole lead <b>1</b> (pink), suggesting potential access to the Y96/H95/Q99 cryptic pocket by substitution of the N1 position of the ARS-1620 scaffold. Conceptual hybrid structure is shown at right.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/large/jm9b01180_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01180&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/medium/jm9b01180_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/large/jm9b01180_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. X-ray crystallography confirms hybrid scaffolds <b>2</b> (a; tan, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6PGO">6PGO</a>) and <b>9</b> (b; violet, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6PGP">6PGP</a>) access the cryptic pocket. Additional van der Waals contacts between the isopropyl moiety of <b>9</b> and H95, Y96, and Q99 account for the increased biochemical and cellular potency of <b>9</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/large/jm9b01180_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01180&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/medium/jm9b01180_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/large/jm9b01180_0004.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Compound <b>18</b> atropisomers are not configurationally stable at 25 °C.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/large/jm9b01180_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01180&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/medium/jm9b01180_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/large/jm9b01180_0005.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. VT NMR method for determining atropisomer interconversion free energy barriers (Δ<i>G</i><sup>⧧</sup>). Coalescence of the H5 <sup>1</sup>H NMR resonance was monitored at elevated temperature, and the coalescences temperature (<i>T</i><sub>c</sub>) and chemical shift difference (Δν; slow exchange limit) were used for calculation of Δ<i>G</i><sup>⧧</sup>. (Compensation applied for minor temperature dependence in the H5 chemical shift.) <sup>1</sup>H spectra (DMSO-<i>d</i><sub>6</sub>) for compound <b>27</b> are depicted. At 298 K, methylpiperazine conformational exchange causes H5 line broadening, which is averaged out at <i>T</i> > 320 K.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/large/jm9b01180_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01180&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/medium/jm9b01180_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/large/jm9b01180_0006.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (<i>R</i>)-<b>24</b> inhibits ERK1/2 phosphorylation in <i>KRAS p.G12C</i> tumors (MIA PaCa-2 T2) and causes tumor regression at QD po doses of ≥60 mg/kg. (a) Mice bearing MIA PaCa-2 T2 tumors were given a single oral dose of vehicle (black bar), (<i>R</i>)-<b>24</b> (blue bars), or ARS-1620 (red bar); tumors were harvested 2 h later and assessed for p-ERK levels. Plasma and tumor concentrations of (<i>R</i>)-<b>24</b> are indicated by red triangles and blue open circles, respectively. Data are presented as percent of control versus vehicle ± SEM (<i>n</i> = 3/group): ****<i>p</i> < 0.0001; *<i>p</i> < 0.05 by one-way ANOVA with Dunnett’s post hoc analysis. (b) Effect of (<i>R</i>)-<b>24</b> on MIA PaCa-2 T2 tumor growth in nude mice (QD po dosing). Data represent mean tumor volume ± SEM (<i>n</i> = 10/group): ****<i>p</i> < 0.0001 by RMANOVA followed by Dunnett’s post hoc analysis, <sup>#</sup><i>p</i> < 0.0001 regression by paired <i>t</i> test. (c) Mean unbound plasma concentrations + SEM (<i>n</i> = 3) following 30 mg/kg po dosing in nude mice. p-ERK IC<sub>50,u</sub> = in vitro cellular IC<sub>50</sub>·<i>f</i><sub>u,media</sub> (fraction unbound in cell culture media).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/large/jm9b01180_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01180&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/medium/jm9b01180_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/large/jm9b01180_0007.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Data are initially published in ref <a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a>. p-ERK (a) dose–response and (b) time-course (MSD) data with plasma and tumor exposures for compound (<i>R</i>)-<b>38</b>. Mice bearing MIA PaCa-2 T2 tumors were given a single oral dose of either vehicle (black bars) or (<i>R</i>)-<b>38</b> (blue bars) and harvested at the indicated time. Data represent percent of control versus vehicle ± SEM (<i>n</i> = 3/group). Plasma and tumor concentrations of (<i>R</i>)-<b>24</b> are indicated by red triangles and blue open circles, respectively: ****<i>p</i> < 0.0001; ***<i>p</i> < 0.001; *<i>p</i> < 0.05 by one-way ANOVA with Dunnett’s post hoc analysis. (c) p-ERK POC (MSD) and percent KRAS<sup>G12C</sup> covalent modification (MS) time-course in MIA PaCa-2 T2 mouse xenografts. Markers represent mean p-ERK1/2 levels (percent of basal ERK1/2) ± SEM and mean % covalent modification ± SEM (<i>n</i> = 3/group).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/large/jm9b01180_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01180&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/medium/jm9b01180_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/large/jm9b01180_0008.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Data are initially published in ref <a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Compound (<i>R</i>)-<b>38</b> dosed orally once daily results in regression of <i>KRAS p.G12C</i> tumor xenografts. (a) Effect of compound (<i>R</i>)-<b>38</b> on MIA PaCa-2 T2 xenograft growth in nude mice (QD PO dosing). Data represent the mean tumor volume ± SEM (<i>n</i> = 10/group): ****<i>p</i> < 0.0001 by Dunnett’s post hoc analysis; <sup>#</sup><i>p</i> < 0.05 regression by paired <i>t</i> test. (b) Mean unbound plasma concentrations ± SEM (<i>n</i> = 2/group). p-ERK IC<sub>50,u</sub> = in vitro cellular IC<sub>50</sub>·<i>f</i><sub>u,media</sub> (fraction unbound in cell culture media).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/large/jm9b01180_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01180&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/medium/jm9b01180_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/large/jm9b01180_0009.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. X-ray crystal structure of compound (<i>R</i>)-<b>38</b> bound to GDP-KRAS<sup>G12C</sup> (cyan, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6OIM">6OIM</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/large/jm9b01180_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01180&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i27">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85321" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85321" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 35 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cox, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimmelman, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Der, C. J.</span></span> <span> </span><span class="NLM_article-title">Drugging the Undruggable RAS: Mission Possible?</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">828</span>– <span class="NLM_lpage">851</span>, <span class="refDoi"> DOI: 10.1038/nrd4389</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=10.1038%2Fnrd4389" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=25323927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslKmu7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=828-851&author=A.+D.+Coxauthor=S.+W.+Fesikauthor=A.+C.+Kimmelmanauthor=J.+Luoauthor=C.+J.+Der&title=Drugging+the+Undruggable+RAS%3A+Mission+Possible%3F&doi=10.1038%2Fnrd4389"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Drugging the undruggable RAS: Mission Possible?</span></div><div class="casAuthors">Cox, Adrienne D.; Fesik, Stephen W.; Kimmelman, Alec C.; Luo, Ji; Der, Channing J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">828-851</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Despite more than three decades of intensive effort, no effective pharmacol. inhibitors of the RAS oncoproteins have reached the clinic, prompting the widely held perception that RAS proteins are 'undruggable'.  However, recent data from the lab. and the clinic have renewed our hope for the development of RAS-inhibitory mols.  In this Review, we summarize the progress and the promise of five key approaches.  Firstly, we focus on the prospects of using direct inhibitors of RAS.  Secondly, we address the issue of whether blocking RAS membrane assocn. is a viable approach.  Thirdly, we assess the status of targeting RAS downstream effector signalling, which is arguably the most favorable current approach.  Fourthly, we address whether the search for synthetic lethal interactors of mutant RAS still holds promise.  Finally, RAS-mediated changes in cell metab. have recently been described and we discuss whether these changes could be exploited for new therapeutic directions.  We conclude with perspectives on how addnl. complexities, which are not yet fully understood, may affect each of these approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvWzW1JqxN4LVg90H21EOLACvtfcHk0lj21k4lIYh5Qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslKmu7zE&md5=6c8645293b079023de7d31011ae1a192</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrd4389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4389%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DA.%2BD.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DKimmelman%26aufirst%3DA.%2BC.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DDer%26aufirst%3DC.%2BJ.%26atitle%3DDrugging%2520the%2520Undruggable%2520RAS%253A%2520Mission%2520Possible%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2014%26volume%3D13%26spage%3D828%26epage%3D851%26doi%3D10.1038%2Fnrd4389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hobbs, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Der, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossman, K. L.</span></span> <span> </span><span class="NLM_article-title">RAS Isoforms and Mutations in Cancer at a Glance</span>. <i>J. Cell Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">1287</span>– <span class="NLM_lpage">1292</span>, <span class="refDoi"> DOI: 10.1242/jcs.182873</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=10.1242%2Fjcs.182873" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=26985062" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVKltr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2016&pages=1287-1292&author=G.+A.+Hobbsauthor=C.+J.+Derauthor=K.+L.+Rossman&title=RAS+Isoforms+and+Mutations+in+Cancer+at+a+Glance&doi=10.1242%2Fjcs.182873"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">RAS isoforms and mutations in cancer at a glance</span></div><div class="casAuthors">Hobbs, G. Aaron; Der, Channing J.; Rossman, Kent L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1287-1292</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">RAS proteins (KRAS4A, KRAS4B, NRAS and HRAS) function as GDP-GTP-regulated binary on-off switches, which regulate cytoplasmic signaling networks that control diverse normal cellular processes.  Gain-of-function missense mutations in RAS genes are found in ∼ 25% of human cancers, prompting interest in identifying anti-RAS therapeutic strategies for cancer treatment.  However, despite more than three decades of intense effort, no anti-RAS therapies have reached clin. application.  Contributing to this failure has been an underestimation of the complexities of RAS.  First, there is now appreciation that the four human RAS proteins are not functionally identical.  Second, with >130 different missense mutations found in cancer, there is an emerging view that there are mutation-specific consequences on RAS structure, biochem. and biol., and mutation-selective therapeutic strategies are needed.  In this Cell Science at a Glance article and accompanying poster, we provide a snapshot of the differences between RAS isoforms and mutations, as well as the current status of anti-RAS drug-discovery efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNufX89IRJk7Vg90H21EOLACvtfcHk0lj21k4lIYh5Qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVKltr7I&md5=bf50d212b900fb437cad2b650a9dc07a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1242%2Fjcs.182873&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.182873%26sid%3Dliteratum%253Aachs%26aulast%3DHobbs%26aufirst%3DG.%2BA.%26aulast%3DDer%26aufirst%3DC.%2BJ.%26aulast%3DRossman%26aufirst%3DK.%2BL.%26atitle%3DRAS%2520Isoforms%2520and%2520Mutations%2520in%2520Cancer%2520at%2520a%2520Glance%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2016%26volume%3D129%26spage%3D1287%26epage%3D1292%26doi%3D10.1242%2Fjcs.182873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prior, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattos, C.</span></span> <span> </span><span class="NLM_article-title">A Comprehensive Survey of Ras Mutations in Cancer</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">2457</span>– <span class="NLM_lpage">2467</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-11-2612</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=10.1158%2F0008-5472.CAN-11-2612" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=22589270" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=1%3ACAS%3A528%3ADC%252BC38XmvF2ntL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=2457-2467&author=I.+A.+Priorauthor=P.+D.+Lewisauthor=C.+Mattos&title=A+Comprehensive+Survey+of+Ras+Mutations+in+Cancer&doi=10.1158%2F0008-5472.CAN-11-2612"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">A Comprehensive Survey of Ras Mutations in Cancer</span></div><div class="casAuthors">Prior, Ian A.; Lewis, Paul D.; Mattos, Carla</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2457-2467</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  All mammalian cells express 3 closely related Ras proteins, termed H-Ras, K-Ras, and N-Ras, that promote oncogenesis when they are mutationally activated at codon 12, 13, or 61.  Although there is a high degree of similarity among the isoforms, K-Ras mutations are far more frequently obsd. in cancer, and each isoform displays preferential coupling to particular cancer types.  We examd. the mutational spectra of Ras isoforms curated from large-scale tumor profiling and found that each isoform exhibits surprisingly distinctive codon mutation and amino-acid substitution biases.  These findings were unexpected given that these mutations occur in regions that share 100% amino-acid sequence identity among the 3 isoforms.  Of importance, many of these mutational biases were not due to differences in exposure to mutagens, because the patterns were still evident when compared within specific cancer types.  We discuss potential genetic and epigenetic mechanisms, as well as isoform-specific differences in protein structure and signaling, that may promote these distinct mutation patterns and differential coupling to specific cancers.  Cancer Res; 72(10); 2457-67.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqg2lqiicosOLVg90H21EOLACvtfcHk0lj21k4lIYh5Qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmvF2ntL4%253D&md5=6d1894847015468f77c8b08b57c6d62a</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-11-2612&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-11-2612%26sid%3Dliteratum%253Aachs%26aulast%3DPrior%26aufirst%3DI.%2BA.%26aulast%3DLewis%26aufirst%3DP.%2BD.%26aulast%3DMattos%26aufirst%3DC.%26atitle%3DA%2520Comprehensive%2520Survey%2520of%2520Ras%2520Mutations%2520in%2520Cancer%26jtitle%3DCancer%2520Res.%26date%3D2012%26volume%3D72%26spage%3D2457%26epage%3D2467%26doi%3D10.1158%2F0008-5472.CAN-11-2612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holderfield, M.</span></span> <span> </span><span class="NLM_article-title">Efforts to Develop KRAS Inhibitors</span>. <i>Cold Spring Harbor Perspect. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">a031864</span>, <span class="refDoi"> DOI: 10.1101/cshperspect.a031864</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=10.1101%2Fcshperspect.a031864" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=29101115" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhs1Ogu7bP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=a031864&author=M.+Holderfield&title=Efforts+to+Develop+KRAS+Inhibitors&doi=10.1101%2Fcshperspect.a031864"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Efforts to develop KRAS inhibitors</span></div><div class="casAuthors">Holderfield, Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Cold Spring Harbor Perspectives in Medicine</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">a031864/1-a031864/9</span>CODEN:
                <span class="NLM_cas:coden">CSHPFV</span>;
        ISSN:<span class="NLM_cas:issn">2157-1422</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">The high prevalence of KRAS mutations in human cancers and the lack of effective treatments for patients ranks KRAS among the most highly sought-after targets for preclin. oncologists.  Pharmaceutical companies and academic labs. have tried for decades to identify small mol. inhibitors of oncogenic KRAS proteins, but little progress has been made and many have labeled KRAS undruggable.  However, recent progress in in silico screening, fragmentbased drug design, disulfide tethered screening, and some emerging themes in RAS biol. have caused the field to reconsider previously held notions about targeting KRAS.  This review will cover some of the historical efforts to identify RAS inhibitors, and some of the most promising efforts currently being pursued.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo79VAhwaV0c7Vg90H21EOLACvtfcHk0liA-k9OxOJgbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhs1Ogu7bP&md5=7b55a0a4a9a8a18253ed804967be1b13</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1101%2Fcshperspect.a031864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fcshperspect.a031864%26sid%3Dliteratum%253Aachs%26aulast%3DHolderfield%26aufirst%3DM.%26atitle%3DEfforts%2520to%2520Develop%2520KRAS%2520Inhibitors%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Med.%26date%3D2018%26volume%3D8%26spage%3Da031864%26doi%3D10.1101%2Fcshperspect.a031864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ostrem, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sos, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shokat, K. M.</span></span> <span> </span><span class="NLM_article-title">K-Ras(G12C) Inhibitors Allosterically Control GTP Affinity and Effector Interactions</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>503</i></span>,  <span class="NLM_fpage">548</span>– <span class="NLM_lpage">551</span>, <span class="refDoi"> DOI: 10.1038/nature12796</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=10.1038%2Fnature12796" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=24256730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVGqs7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=503&publication_year=2013&pages=548-551&author=J.+M.+Ostremauthor=U.+Petersauthor=M.+L.+Sosauthor=J.+A.+Wellsauthor=K.+M.+Shokat&title=K-Ras%28G12C%29+Inhibitors+Allosterically+Control+GTP+Affinity+and+Effector+Interactions&doi=10.1038%2Fnature12796"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions</span></div><div class="casAuthors">Ostrem, Jonathan M.; Peters, Ulf; Sos, Martin L.; Wells, James A.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">503</span>
        (<span class="NLM_cas:issue">7477</span>),
    <span class="NLM_cas:pages">548-551</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Somatic mutations in the small GTPase K-Ras are the most common activating lesions found in human cancer, and are generally assocd. with poor response to std. therapies.  Efforts to target this oncogene directly have faced difficulties owing to its picomolar affinity for GTP/GDP and the absence of known allosteric regulatory sites.  Oncogenic mutations result in functional activation of Ras family proteins by impairing GTP hydrolysis.  With diminished regulation by GTPase activity, the nucleotide state of Ras becomes more dependent on relative nucleotide affinity and concn.  This gives GTP an advantage over GDP and increases the proportion of active GTP-bound Ras.  Here we report the development of small mols. that irreversibly bind to a common oncogenic mutant, K-Ras(G12C).  These compds. rely on the mutant cysteine for binding and therefore do not affect the wild-type protein.  Crystallog. studies reveal the formation of a new pocket that is not apparent in previous structures of Ras, beneath the effector binding switch-II region.  Binding of these inhibitors to K-Ras(G12C) disrupts both switch-I and switch-II, subverting the native nucleotide preference to favor GDP over GTP and impairing binding to Raf.  Our data provide structure-based validation of a new allosteric regulatory site on Ras that is targetable in a mutant-specific manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokkgcVXuBn_rVg90H21EOLACvtfcHk0liA-k9OxOJgbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVGqs7jO&md5=27c1e7d8ef6b7e4b2919e9f00a073923</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnature12796&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12796%26sid%3Dliteratum%253Aachs%26aulast%3DOstrem%26aufirst%3DJ.%2BM.%26aulast%3DPeters%26aufirst%3DU.%26aulast%3DSos%26aufirst%3DM.%2BL.%26aulast%3DWells%26aufirst%3DJ.%2BA.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DK-Ras%2528G12C%2529%2520Inhibitors%2520Allosterically%2520Control%2520GTP%2520Affinity%2520and%2520Effector%2520Interactions%26jtitle%3DNature%26date%3D2013%26volume%3D503%26spage%3D548%26epage%3D551%26doi%3D10.1038%2Fnature12796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Janes, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babbar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firdaus, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darjania, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, Y. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thach, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarieh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ely, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kucharski, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessler, L. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarrinkar, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brehmer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhanak, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorenzi, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu-Lowe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patricelli, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span> <span> </span><span class="NLM_article-title">Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>172</i></span>,  <span class="NLM_fpage">578</span>– <span class="NLM_lpage">589</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2018.01.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=10.1016%2Fj.cell.2018.01.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=29373830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=1%3ACAS%3A528%3ADC%252BC1cXislyisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2018&pages=578-589&author=M.+R.+Janesauthor=J.+Zhangauthor=L.-S.+Liauthor=R.+Hansenauthor=U.+Petersauthor=X.+Guoauthor=Y.+Chenauthor=A.+Babbarauthor=S.+J.+Firdausauthor=L.+Darjaniaauthor=J.+Fengauthor=J.+H.+Chenauthor=S.+Liauthor=S.+Liauthor=Y.+O.+Longauthor=C.+Thachauthor=Y.+Liuauthor=A.+Zariehauthor=T.+Elyauthor=J.+M.+Kucharskiauthor=L.+V.+Kesslerauthor=T.+Wuauthor=K.+Yuauthor=Y.+Wangauthor=Y.+Yaoauthor=X.+Dengauthor=P.+P.+Zarrinkarauthor=D.+Brehmerauthor=D.+Dhanakauthor=M.+V.+Lorenziauthor=D.+Hu-Loweauthor=M.+P.+Patricelliauthor=P.+Renauthor=Y.+Liu&title=Targeting+KRAS+Mutant+Cancers+with+a+Covalent+G12C-Specific+Inhibitor&doi=10.1016%2Fj.cell.2018.01.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor</span></div><div class="casAuthors">Janes, Matthew R.; Zhang, Jingchuan; Li, Lian-Sheng; Hansen, Rasmus; Peters, Ulf; Guo, Xin; Chen, Yuching; Babbar, Anjali; Firdaus, Sarah J.; Darjania, Levan; Feng, Jun; Chen, Jeffrey H.; Li, Shuangwei; Li, Shisheng; Long, Yun O.; Thach, Carol; Liu, Yuan; Zarieh, Ata; Ely, Tess; Kucharski, Jeff M.; Kessler, Linda V.; Wu, Tao; Yu, Ke; Wang, Yi; Yao, Yvonne; Deng, Xiaohu; Zarrinkar, Patrick P.; Brehmer, Dirk; Dhanak, Dashyant; Lorenzi, Matthew V.; Hu-Lowe, Dana; Patricelli, Matthew P.; Ren, Pingda; Liu, Yi</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">578-589.e17</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">KRASG12C was recently identified to be potentially druggable by allele-specific covalent targeting of Cys 12 in vicinity to an inducible allosteric switch II pocket (S-IIP).  Success of this approach requires active cycling of KRASG12C between its active-GTP and inactive-GDP conformations as accessibility of the S-IIP is restricted only to the GDP-bound state.  This strategy proved feasible for inhibiting mutant KRAS in vitro; however, it is uncertain whether this approach would translate to in vivo.  Here, the authors describe structure-based design and identification of ARS-1620, a covalent compd. with high potency and selectivity for KRASG12C.  ARS-1620 achieves rapid and sustained in vivo target occupancy to induce tumor regression.  The authors use ARS-1620 to dissect oncogenic KRAS dependency and demonstrate that monolayer culture formats significantly underestimate KRAS dependency in vivo.  This study provides in vivo evidence that mutant KRAS can be selectively targeted and reveals ARS-1620 as representing a new generation of KRASG12C-specific inhibitors with promising therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVmv4KAl4_dLVg90H21EOLACvtfcHk0liA-k9OxOJgbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXislyisb8%253D&md5=d0883bde981b51e41a794179ffae87be</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2018.01.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2018.01.006%26sid%3Dliteratum%253Aachs%26aulast%3DJanes%26aufirst%3DM.%2BR.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DL.-S.%26aulast%3DHansen%26aufirst%3DR.%26aulast%3DPeters%26aufirst%3DU.%26aulast%3DGuo%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DBabbar%26aufirst%3DA.%26aulast%3DFirdaus%26aufirst%3DS.%2BJ.%26aulast%3DDarjania%26aufirst%3DL.%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DJ.%2BH.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DLong%26aufirst%3DY.%2BO.%26aulast%3DThach%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZarieh%26aufirst%3DA.%26aulast%3DEly%26aufirst%3DT.%26aulast%3DKucharski%26aufirst%3DJ.%2BM.%26aulast%3DKessler%26aufirst%3DL.%2BV.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DYu%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26aulast%3DBrehmer%26aufirst%3DD.%26aulast%3DDhanak%26aufirst%3DD.%26aulast%3DLorenzi%26aufirst%3DM.%2BV.%26aulast%3DHu-Lowe%26aufirst%3DD.%26aulast%3DPatricelli%26aufirst%3DM.%2BP.%26aulast%3DRen%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DY.%26atitle%3DTargeting%2520KRAS%2520Mutant%2520Cancers%2520with%2520a%2520Covalent%2520G12C-Specific%2520Inhibitor%26jtitle%3DCell%26date%3D2018%26volume%3D172%26spage%3D578%26epage%3D589%26doi%3D10.1016%2Fj.cell.2018.01.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wurz, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Achanta, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arvedson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartberger, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campuzano, I. D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fucini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingersoll, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwig, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipford, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopecky, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">San Miguel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohr, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saiki, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawayama, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sethofer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tegley, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volak, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanman, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erlanson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cee, V. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of <i>N</i>-(1-Acryloylazetidin-3-yl)-2-(1<i>H</i>-indol-1-yl)acetamides as a Covalent Inhibitor of KRAS<sup>G12C</sup></span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1302</span>– <span class="NLM_lpage">1308</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.9b00258</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.9b00258" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsF2qs73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=1302-1308&author=Y.+Shinauthor=J.+W.+Jeongauthor=R.+P.+Wurzauthor=P.+Achantaauthor=T.+Arvedsonauthor=M.+D.+Bartbergerauthor=I.+D.+G.+Campuzanoauthor=R.+Fuciniauthor=S.+K.+Hansenauthor=J.+Ingersollauthor=J.+Iwigauthor=J.+R.+Lipfordauthor=V.+Maauthor=D.+J.+Kopeckyauthor=J.+McCarterauthor=T.+San+Miguelauthor=C.+Mohrauthor=S.+Sabetauthor=A.+Y.+Saikiauthor=A.+Sawayamaauthor=S.+Sethoferauthor=C.+M.+Tegleyauthor=L.+P.+Volakauthor=K.+Yangauthor=B.+A.+Lanmanauthor=D.+A.+Erlansonauthor=V.+J.+Cee&title=Discovery+of+N-%281-Acryloylazetidin-3-yl%29-2-%281H-indol-1-yl%29acetamides+as+a+Covalent+Inhibitor+of+KRASG12C&doi=10.1021%2Facsmedchemlett.9b00258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of N-(1-Acryloylazetidin-3-yl)-2-(1H-indol-1-yl)acetamides as Covalent Inhibitors of KRASG12C</span></div><div class="casAuthors">Shin, Youngsook; Jeong, Joon Won; Wurz, Ryan P.; Achanta, Pragathi; Arvedson, Tara; Bartberger, Michael D.; Campuzano, Iain D. G.; Fucini, Ray; Hansen, Stig K.; Ingersoll, John; Iwig, Jeffrey S.; Lipford, J. Russell; Ma, Vu; Kopecky, David J.; McCarter, John; San Miguel, Tisha; Mohr, Christopher; Sabet, Sudi; Saiki, Anne Y.; Sawayama, Andrew; Sethofer, Steven; Tegley, Christopher M.; Volak, Laurie P.; Yang, Kevin; Lanman, Brian A.; Erlanson, Daniel A.; Cee, Victor J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1302-1308</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Discovery of N-(1-Acryloylazetidin-3-yl)-2-(1H-indol-1-yl)acetamides as Covalent Inhibitors of KRASG12C.  KRAS regulates many cellular processes including proliferation, survival, and differentiation.  Point mutants of KRAS have long been known to be mol. drivers of cancer.  KRAS p.G12C, which occurs in approx. 14% of lung adenocarcinomas, 3-5% of colorectal cancers, and low levels in other solid tumors, represents an attractive therapeutic target for covalent inhibitors.  Herein, we disclose the discovery of a class of novel, potent, and selective covalent inhibitors of KRASG12C identified through a custom library synthesis and screening platform called Chemotype Evolution and structure-based design.  Identification of a hidden surface groove bordered by H95/Y96/Q99 side chains was key to the optimization of this class of mols.  Best-in-series exemplars exhibit a rapid covalent reaction with cysteine 12 of GDP-KRASG12C with submicromolar inhibition of downstream signaling in a KRASG12C-specific manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSOlO88sogkLVg90H21EOLACvtfcHk0lj41yYMerCe1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsF2qs73P&md5=ec097c0fb0e018a2d86f024117f8008f</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.9b00258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.9b00258%26sid%3Dliteratum%253Aachs%26aulast%3DShin%26aufirst%3DY.%26aulast%3DJeong%26aufirst%3DJ.%2BW.%26aulast%3DWurz%26aufirst%3DR.%2BP.%26aulast%3DAchanta%26aufirst%3DP.%26aulast%3DArvedson%26aufirst%3DT.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DCampuzano%26aufirst%3DI.%2BD.%2BG.%26aulast%3DFucini%26aufirst%3DR.%26aulast%3DHansen%26aufirst%3DS.%2BK.%26aulast%3DIngersoll%26aufirst%3DJ.%26aulast%3DIwig%26aufirst%3DJ.%26aulast%3DLipford%26aufirst%3DJ.%2BR.%26aulast%3DMa%26aufirst%3DV.%26aulast%3DKopecky%26aufirst%3DD.%2BJ.%26aulast%3DMcCarter%26aufirst%3DJ.%26aulast%3DSan%2BMiguel%26aufirst%3DT.%26aulast%3DMohr%26aufirst%3DC.%26aulast%3DSabet%26aufirst%3DS.%26aulast%3DSaiki%26aufirst%3DA.%2BY.%26aulast%3DSawayama%26aufirst%3DA.%26aulast%3DSethofer%26aufirst%3DS.%26aulast%3DTegley%26aufirst%3DC.%2BM.%26aulast%3DVolak%26aufirst%3DL.%2BP.%26aulast%3DYang%26aufirst%3DK.%26aulast%3DLanman%26aufirst%3DB.%2BA.%26aulast%3DErlanson%26aufirst%3DD.%2BA.%26aulast%3DCee%26aufirst%3DV.%2BJ.%26atitle%3DDiscovery%2520of%2520N-%25281-Acryloylazetidin-3-yl%2529-2-%25281H-indol-1-yl%2529acetamides%2520as%2520a%2520Covalent%2520Inhibitor%2520of%2520KRASG12C%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D10%26spage%3D1302%26epage%3D1308%26doi%3D10.1021%2Facsmedchemlett.9b00258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patricelli, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janes, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessler, L. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kucharski, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ely, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firdaus, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babbar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span> <span> </span><span class="NLM_article-title">Selective Inhibition of Oncogenic KRAS Output with Small Molecules Targeting the Inactive State</span>. <i>Cancer Discovery</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">316</span>– <span class="NLM_lpage">329</span>, <span class="refDoi"> DOI: 10.1158/2159-8290.CD-15-1105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=10.1158%2F2159-8290.CD-15-1105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=26739882" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=1%3ACAS%3A528%3ADC%252BC28XktVyru7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=316-329&author=M.+P.+Patricelliauthor=M.+R.+Janesauthor=L.-S.+Liauthor=R.+Hansenauthor=U.+Petersauthor=L.+V.+Kesslerauthor=Y.+Chenauthor=J.+M.+Kucharskiauthor=J.+Fengauthor=T.+Elyauthor=J.+H.+Chenauthor=S.+J.+Firdausauthor=A.+Babbarauthor=P.+Renauthor=Y.+Liu&title=Selective+Inhibition+of+Oncogenic+KRAS+Output+with+Small+Molecules+Targeting+the+Inactive+State&doi=10.1158%2F2159-8290.CD-15-1105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Inhibition of Oncogenic KRAS Output with Small Molecules Targeting the Inactive State</span></div><div class="casAuthors">Patricelli, Matthew P.; Janes, Matthew R.; Li, Lian-Sheng; Hansen, Rasmus; Peters, Ulf; Kessler, Linda V.; Chen, Yuching; Kucharski, Jeff M.; Feng, Jun; Ely, Tess; Chen, Jeffrey H.; Firdaus, Sarah J.; Babbar, Anjali; Ren, Pingda; Liu, Yi</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Discovery</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">316-329</span>CODEN:
                <span class="NLM_cas:coden">CDAIB2</span>;
        ISSN:<span class="NLM_cas:issn">2159-8274</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">KRAS gain-of-function mutations occur in approx. 30% of all human cancers.  Despite more than 30 years of KRAS-focused research and development efforts, no targeted therapy has been discovered for cancers with KRAS mutations.  Here, we describe ARS-853, a selective, covalent inhibitor of KRASG12C that inhibits mutant KRAS-driven signaling by binding to the GDP-bound oncoprotein and preventing activation.  Based on the rates of engagement and inhibition obsd. for ARS-853, along with a mutant-specific mass spectrometry-based assay for assessing KRAS activation status, we show that the nucleotide state of KRASG12C is in a state of dynamic flux that can be modulated by upstream signaling factors.  These studies provide convincing evidence that the KRASG12C mutation generates a "hyperexcitable" rather than a "statically active" state and that targeting the inactive, GDP-bound form is a promising approach for generating novel anti-RAS therapeutics.  Significance: A cell-active, mutant-specific, covalent inhibitor of KRASG12C is described that targets the GDP-bound, inactive state and prevents subsequent activation.  Using this novel compd., we demonstrate that KRASG12C oncoprotein rapidly cycles bound nucleotide and responds to upstream signaling inputs to maintain a highly active state.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJJA-9IIHeN7Vg90H21EOLACvtfcHk0lj41yYMerCe1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktVyru7s%253D&md5=41db2f02006e8f0be7a9bb47354addcd</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-15-1105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-15-1105%26sid%3Dliteratum%253Aachs%26aulast%3DPatricelli%26aufirst%3DM.%2BP.%26aulast%3DJanes%26aufirst%3DM.%2BR.%26aulast%3DLi%26aufirst%3DL.-S.%26aulast%3DHansen%26aufirst%3DR.%26aulast%3DPeters%26aufirst%3DU.%26aulast%3DKessler%26aufirst%3DL.%2BV.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DKucharski%26aufirst%3DJ.%2BM.%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DEly%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DJ.%2BH.%26aulast%3DFirdaus%26aufirst%3DS.%2BJ.%26aulast%3DBabbar%26aufirst%3DA.%26aulast%3DRen%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DY.%26atitle%3DSelective%2520Inhibition%2520of%2520Oncogenic%2520KRAS%2520Output%2520with%2520Small%2520Molecules%2520Targeting%2520the%2520Inactive%2520State%26jtitle%3DCancer%2520Discovery%26date%3D2016%26volume%3D6%26spage%3D316%26epage%3D329%26doi%3D10.1158%2F2159-8290.CD-15-1105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Janes, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babbar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firdaus, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darjania, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, Y. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thach, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarieh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ely, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kucharski, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessler, L. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarrinkar, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brehmer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhanak, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorenzi, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu-Lowe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patricelli, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span> <span> </span><span class="NLM_article-title">Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>172</i></span>,  <span class="NLM_fpage">578</span>– <span class="NLM_lpage">589</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2018.01.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=10.1016%2Fj.cell.2018.01.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=29373830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=1%3ACAS%3A528%3ADC%252BC1cXislyisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2018&pages=578-589&author=M.+R.+Janesauthor=J.+Zhangauthor=L.-S.+Liauthor=R.+Hansenauthor=U.+Petersauthor=X.+Guoauthor=Y.+Chenauthor=A.+Babbarauthor=S.+J.+Firdausauthor=L.+Darjaniaauthor=J.+Fengauthor=J.+H.+Chenauthor=S.+Liauthor=S.+Liauthor=Y.+O.+Longauthor=C.+Thachauthor=Y.+Liuauthor=A.+Zariehauthor=T.+Elyauthor=J.+M.+Kucharskiauthor=L.+V.+Kesslerauthor=T.+Wuauthor=K.+Yuauthor=Y.+Wangauthor=Y.+Yaoauthor=X.+Dengauthor=P.+P.+Zarrinkarauthor=D.+Brehmerauthor=D.+Dhanakauthor=M.+V.+Lorenziauthor=D.+Hu-Loweauthor=M.+P.+Patricelliauthor=P.+Renauthor=Y.+Liu&title=Targeting+KRAS+Mutant+Cancers+with+a+Covalent+G12C-Specific+Inhibitor&doi=10.1016%2Fj.cell.2018.01.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor</span></div><div class="casAuthors">Janes, Matthew R.; Zhang, Jingchuan; Li, Lian-Sheng; Hansen, Rasmus; Peters, Ulf; Guo, Xin; Chen, Yuching; Babbar, Anjali; Firdaus, Sarah J.; Darjania, Levan; Feng, Jun; Chen, Jeffrey H.; Li, Shuangwei; Li, Shisheng; Long, Yun O.; Thach, Carol; Liu, Yuan; Zarieh, Ata; Ely, Tess; Kucharski, Jeff M.; Kessler, Linda V.; Wu, Tao; Yu, Ke; Wang, Yi; Yao, Yvonne; Deng, Xiaohu; Zarrinkar, Patrick P.; Brehmer, Dirk; Dhanak, Dashyant; Lorenzi, Matthew V.; Hu-Lowe, Dana; Patricelli, Matthew P.; Ren, Pingda; Liu, Yi</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">578-589.e17</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">KRASG12C was recently identified to be potentially druggable by allele-specific covalent targeting of Cys 12 in vicinity to an inducible allosteric switch II pocket (S-IIP).  Success of this approach requires active cycling of KRASG12C between its active-GTP and inactive-GDP conformations as accessibility of the S-IIP is restricted only to the GDP-bound state.  This strategy proved feasible for inhibiting mutant KRAS in vitro; however, it is uncertain whether this approach would translate to in vivo.  Here, the authors describe structure-based design and identification of ARS-1620, a covalent compd. with high potency and selectivity for KRASG12C.  ARS-1620 achieves rapid and sustained in vivo target occupancy to induce tumor regression.  The authors use ARS-1620 to dissect oncogenic KRAS dependency and demonstrate that monolayer culture formats significantly underestimate KRAS dependency in vivo.  This study provides in vivo evidence that mutant KRAS can be selectively targeted and reveals ARS-1620 as representing a new generation of KRASG12C-specific inhibitors with promising therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVmv4KAl4_dLVg90H21EOLACvtfcHk0lg4NvDNAmLJVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXislyisb8%253D&md5=d0883bde981b51e41a794179ffae87be</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2018.01.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2018.01.006%26sid%3Dliteratum%253Aachs%26aulast%3DJanes%26aufirst%3DM.%2BR.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DL.-S.%26aulast%3DHansen%26aufirst%3DR.%26aulast%3DPeters%26aufirst%3DU.%26aulast%3DGuo%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DBabbar%26aufirst%3DA.%26aulast%3DFirdaus%26aufirst%3DS.%2BJ.%26aulast%3DDarjania%26aufirst%3DL.%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DJ.%2BH.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DLong%26aufirst%3DY.%2BO.%26aulast%3DThach%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZarieh%26aufirst%3DA.%26aulast%3DEly%26aufirst%3DT.%26aulast%3DKucharski%26aufirst%3DJ.%2BM.%26aulast%3DKessler%26aufirst%3DL.%2BV.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DYu%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26aulast%3DBrehmer%26aufirst%3DD.%26aulast%3DDhanak%26aufirst%3DD.%26aulast%3DLorenzi%26aufirst%3DM.%2BV.%26aulast%3DHu-Lowe%26aufirst%3DD.%26aulast%3DPatricelli%26aufirst%3DM.%2BP.%26aulast%3DRen%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DY.%26atitle%3DTargeting%2520KRAS%2520Mutant%2520Cancers%2520with%2520a%2520Covalent%2520G12C-Specific%2520Inhibitor%26jtitle%3DCell%26date%3D2018%26volume%3D172%26spage%3D578%26epage%3D589%26doi%3D10.1016%2Fj.cell.2018.01.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, S.</span>; <span class="NLM_string-name">Erlanson, D.</span>; <span class="NLM_string-name">Cancilla, M.</span></span> <span> </span><span class="NLM_article-title">Methods of Chemotype Evolution</span>. U.S. Patent <span class="NLM_patent">10,107,798</span>, October 23, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=S.+Hansen&author=D.+Erlanson&author=M.+Cancilla&title=Methods+of+Chemotype+Evolution"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHansen%26aufirst%3DS.%26atitle%3DMethods%2520of%2520Chemotype%2520Evolution%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span> For independent identification
of the H95/Y96/Q99 groove from a KRAS M72C screen, see<span class="NLM_contrib-group"><span class="NLM_string-name">Gentile, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rathinaswamy, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moss, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siempelkamp, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renslo, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shokat, K. M.</span></span> <span> </span><span class="NLM_article-title">Ras Binder Induces a Modified Switch-II Pocket in GTP and GDP States</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1455</span>– <span class="NLM_lpage">1466</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2017.08.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=10.1016%2Fj.chembiol.2017.08.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=29033317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Gjs7zK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2017&pages=1455-1466&author=D.+R.+Gentileauthor=M.+K.+Rathinaswamyauthor=M.+L.+Jenkinsauthor=S.+M.+Mossauthor=B.+D.+Siempelkampauthor=A.+R.+Rensloauthor=J.+E.+Burkeauthor=K.+M.+Shokat&title=Ras+Binder+Induces+a+Modified+Switch-II+Pocket+in+GTP+and+GDP+States&doi=10.1016%2Fj.chembiol.2017.08.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Ras Binder Induces a Modified Switch-II Pocket in GTP and GDP States</span></div><div class="casAuthors">Gentile, Daniel R.; Rathinaswamy, Manoj K.; Jenkins, Meredith L.; Moss, Steven M.; Siempelkamp, Braden D.; Renslo, Adam R.; Burke, John E.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1455-1466.e14</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Covalent inhibitors of K-Ras(G12C) have been reported that exclusively recognize the GDP state.  Here, we utilize disulfide tethering of a non-natural cysteine (K-Ras(M72C)) to identify a new switch-II pocket (S-IIP) binding ligand (2C07) that engages the active GTP state.  Co-crystal structures of 2C07 bound to H-Ras(M72C) reveal binding in a cryptic groove we term S-IIG.  In the GppNHp state, 2C07 binding to a modified S-IIP pushes switch I away from the nucleotide, breaking the network of polar contacts essential for adopting the canonical GTP state.  Biochem. studies show that 2C07 alters nucleotide preference and inhibits SOS binding and catalyzed nucleotide exchange. 2C07 was converted to irreversible covalent analogs, which target both nucleotide states, inhibit PI3K activation in vitro, and function as occupancy probes to detect reversible engagement in competition assays.  Targeting both nucleotide states opens the possibility of inhibiting oncogenic mutants of Ras, which exist predominantly in the GTP state in cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqfzb5EFJWK7Vg90H21EOLACvtfcHk0lg4NvDNAmLJVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Gjs7zK&md5=082a1311777fc813b312d5a60430433e</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2017.08.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2017.08.025%26sid%3Dliteratum%253Aachs%26aulast%3DGentile%26aufirst%3DD.%2BR.%26aulast%3DRathinaswamy%26aufirst%3DM.%2BK.%26aulast%3DJenkins%26aufirst%3DM.%2BL.%26aulast%3DMoss%26aufirst%3DS.%2BM.%26aulast%3DSiempelkamp%26aufirst%3DB.%2BD.%26aulast%3DRenslo%26aufirst%3DA.%2BR.%26aulast%3DBurke%26aufirst%3DJ.%2BE.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DRas%2520Binder%2520Induces%2520a%2520Modified%2520Switch-II%2520Pocket%2520in%2520GTP%2520and%2520GDP%2520States%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2017%26volume%3D24%26spage%3D1455%26epage%3D1466%26doi%3D10.1016%2Fj.chembiol.2017.08.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="note"><p class="first last">It should be noted that covalent inhibitors derive their potency not only from noncovalent protein binding affinity (which facilitates protein–ligand preassociation) but also from features of the protein–ligand complex that accelerate covalent bond formation. Improved ligand “potencies” as described in this manuscript should be understood as arising from varying contributions of these two factors.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span>For details,
see <a href="https://www.perkinelmer.com/Content/RelatedMaterials/Brochures/BRO_AlphaScreen2004.pdf" class="extLink">https://www.perkinelmer.com/Content/RelatedMaterials/Brochures/BRO_AlphaScreen2004.pdf</a> (accessed Sep 7, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=For+details%2C%0Asee+https%3A%2F%2Fwww.perkinelmer.com%2FContent%2FRelatedMaterials%2FBrochures%2FBRO_AlphaScreen2004.pdf+%28accessed+Sep+7%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span>For details,
see <a href="https://www.mesoscale.com/en/products/phospho-total-erk1-2-whole-cell-lysate-kit-k15107d/" class="extLink">https://www.mesoscale.com/en/products/phospho-total-erk1-2-whole-cell-lysate-kit-k15107d/</a> (accessed Sep 7, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=For+details%2C%0Asee+https%3A%2F%2Fwww.mesoscale.com%2Fen%2Fproducts%2Fphospho-total-erk1-2-whole-cell-lysate-kit-k15107d%2F+%28accessed+Sep+7%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="note"><p class="first last">A 5 min incubation represented the shortest incubation time that could be practically executed.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="note"><p class="first last">A 2 h incubation was estimated to be the minimum time required to achieve “complete” (∼95%) covalent modification of KRAS<sup>G12C</sup> based on the GTP hydrolysis rate reported in ref <a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="note"><p class="first last">Possible reasons for the increased activity of compound <b>9</b> include more optimal orientation of the isopropylphenyl substituent in the cryptic pocket (a B3LYP/6-31G* quantum mechanical model predicts compound <b>8</b> to adopt a ground-state biaryl torsion angle of 65°, whereas the quinazolinone and phenyl rings are nearly perpendicular in compound <b>9</b>, enhancing contacts with the cryptic pocket residues) and enhanced contacts between the quinazolinone carbonyl group and proximal protein residues and water molecules.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span> For IUPAC naming
conventions,
see<span class="NLM_contrib-group"><span class="NLM_string-name">Moss, G. P.</span></span> <span> </span><span class="NLM_article-title">Basic Terminology of Stereochemistry (IUPAC Recommendations 1996)</span>. <i>Pure Appl. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">2193</span>– <span class="NLM_lpage">2222</span>, <span class="refDoi"> DOI: 10.1351/pac199668122193</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=10.1351%2Fpac199668122193" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=1%3ACAS%3A528%3ADyaK2sXot1Wruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=1996&pages=2193-2222&author=G.+P.+Moss&title=Basic+Terminology+of+Stereochemistry+%28IUPAC+Recommendations+1996%29&doi=10.1351%2Fpac199668122193"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Basic terminology of stereochemistry</span></div><div class="casAuthors">Moss, G. P.</div><div class="citationInfo"><span class="NLM_cas:title">Pure and Applied Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2193-2222</span>CODEN:
                <span class="NLM_cas:coden">PACHAS</span>;
        ISSN:<span class="NLM_cas:issn">0033-4545</span>.
    
            (<span class="NLM_cas:orgname">Blackwell</span>)
        </div><div class="casAbstract">This is a glossary of the more important, and most widely-used stereochem. terms.  It extends the list of those defined in the IUPAC Nomenclature of Org. Chem., Section E: Stereochem. (Recommendations 1974) and includes some terms from the Glossary of Terms used in Phys. Org. Chem. (Recommendations 1994).  Addnl. terms have been added from inorg. and macromol. chem.  Some misleading terms are included together with guidance on correct usage or acceptable alternatives.  Many of the symbols used in stereochem. nomenclature are mentioned but details of their assignment or their incorporation into chem. names are left to the appropriate recommendations.  Terminol. related to techniques used in the detn. of stereochem. are largely excluded as well as terms used to describe reaction mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplnwq600kNP7Vg90H21EOLACvtfcHk0lg4NvDNAmLJVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXot1Wruw%253D%253D&md5=81b14a1d5cf6be717cd467808d644af0</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1351%2Fpac199668122193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1351%252Fpac199668122193%26sid%3Dliteratum%253Aachs%26aulast%3DMoss%26aufirst%3DG.%2BP.%26atitle%3DBasic%2520Terminology%2520of%2520Stereochemistry%2520%2528IUPAC%2520Recommendations%25201996%2529%26jtitle%3DPure%2520Appl.%2520Chem.%26date%3D1996%26volume%3D68%26spage%3D2193%26epage%3D2222%26doi%3D10.1351%2Fpac199668122193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="note"><p class="first last">(<i>R</i>)<i>-</i><b>9</b> was ∼20-fold more potent than (<i>S</i>)-<b>9</b> in the ERK phosphorylation assay (MSD, 4 h incubation).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span>For details,
see <a href="https://www.promega.com/products/cell-health-assays/cell-viability-and-cytotoxicity-assays/celltiter_glo-luminescent-cell-viability-assay/?catNum=G7570" class="extLink">https://www.promega.com/products/cell-health-assays/cell-viability-and-cytotoxicity-assays/celltiter_glo-luminescent-cell-viability-assay/?catNum=G7570</a> (accessed Sep 7, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=For+details%2C%0Asee+https%3A%2F%2Fwww.promega.com%2Fproducts%2Fcell-health-assays%2Fcell-viability-and-cytotoxicity-assays%2Fcelltiter_glo-luminescent-cell-viability-assay%2F%3FcatNum%3DG7570+%28accessed+Sep+7%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span> Intramolecular hydrogen
bonding has previously been demonstrated to enhance passive membrane
permeability:<span class="NLM_contrib-group"><span class="NLM_string-name">Rezai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bock, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalyanaraman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lokey, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, M. P.</span></span> <span> </span><span class="NLM_article-title">Conformational Flexibility, Internal Hydrogen Bonding, and Passive Membrane Permeability: Successful In Silico Prediction of the Relative Permeabilities of Cyclic Peptides</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">14073</span>– <span class="NLM_lpage">14080</span>, <span class="refDoi"> DOI: 10.1021/ja063076p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja063076p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVCmur3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2006&pages=14073-14080&author=T.+Rezaiauthor=J.+E.+Bockauthor=M.+V.+Zhouauthor=C.+Kalyanaramanauthor=R.+S.+Lokeyauthor=M.+P.+Jacobson&title=Conformational+Flexibility%2C+Internal+Hydrogen+Bonding%2C+and+Passive+Membrane+Permeability%3A+Successful+In+Silico+Prediction+of+the+Relative+Permeabilities+of+Cyclic+Peptides&doi=10.1021%2Fja063076p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Conformational Flexibility, Internal Hydrogen Bonding, and Passive Membrane Permeability: Successful in Silico Prediction of the Relative Permeabilities of Cyclic Peptides</span></div><div class="casAuthors">Rezai, Taha; Bock, Jonathan E.; Zhou, Mai V.; Kalyanaraman, Chakrapani; Lokey, R. Scott; Jacobson, Matthew P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">14073-14080</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report an atomistic phys. model for the passive membrane permeability of cyclic peptides.  The computational modeling was performed in advance of the expts. and did not involve the use of "training data".  The model explicitly treats the conformational flexibility of the peptides by extensive conformational sampling in low (membrane) and high (water) dielec. environments.  The passive membrane permeabilities of 11 cyclic peptides were obtained exptl. using a parallel artificial membrane permeability assay (PAMPA) and showed a linear correlation with the computational results with R2 = 0.96.  In general, the results support the hypothesis, already well established in the literature, that the ability to form internal hydrogen bonds is crit. for passive membrane permeability and can be the distinguishing factor among closely related compds., such as those studied here.  However, we have found that the no. of internal hydrogen bonds that can form in the membrane and the solvent-exposed polar surface area correlate more poorly with PAMPA permeability than our model, which quant. ests. the solvation free energy losses upon moving from high-dielec. water to the low-dielec. interior of a membrane.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofxfL018o86rVg90H21EOLACvtfcHk0lgRuq5Nd3HhmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVCmur3I&md5=78d4b4082e6a72b288d4b6dac933ca35</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fja063076p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja063076p%26sid%3Dliteratum%253Aachs%26aulast%3DRezai%26aufirst%3DT.%26aulast%3DBock%26aufirst%3DJ.%2BE.%26aulast%3DZhou%26aufirst%3DM.%2BV.%26aulast%3DKalyanaraman%26aufirst%3DC.%26aulast%3DLokey%26aufirst%3DR.%2BS.%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26atitle%3DConformational%2520Flexibility%252C%2520Internal%2520Hydrogen%2520Bonding%252C%2520and%2520Passive%2520Membrane%2520Permeability%253A%2520Successful%2520In%2520Silico%2520Prediction%2520of%2520the%2520Relative%2520Permeabilities%2520of%2520Cyclic%2520Peptides%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2006%26volume%3D128%26spage%3D14073%26epage%3D14080%26doi%3D10.1021%2Fja063076p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span>Atropisomer
interconversion was monitored by <sup>1</sup>H NMR. Exchange
rates were calculated from line-shape analysis, coalescence temperatures,
or half-lives. Free energy barriers (Δ<i>G</i><sup>⧧</sup>) were calculated from exchange rates using Eyring’s
equation. For details, see <span class="NLM_contrib-group"><span class="NLM_string-name">Claridge, T. D. W.</span></span> <i>High-Resolution NMR Techniques in Organic Chemistry</i>, <span class="NLM_edition">3</span>rd ed.; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">Amsterdam, The Netherlands</span>, <span class="NLM_year">2016</span>; p  <span class="NLM_fpage">50</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&pages=50&author=T.+D.+W.+Claridge&title=High-Resolution+NMR+Techniques+in+Organic+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DClaridge%26aufirst%3DT.%2BD.%2BW.%26btitle%3DHigh-Resolution%2520NMR%2520Techniques%2520in%2520Organic%2520Chemistry%26pub%3DElsevier%26date%3D2016%26spage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laplante, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fader, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fandrick, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fandrick, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hucke, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemper, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, P. J.</span></span> <span> </span><span class="NLM_article-title">Assessing Atropisomer Axial Chirality in Drug Discovery and Development</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">7005</span>– <span class="NLM_lpage">7022</span>, <span class="refDoi"> DOI: 10.1021/jm200584g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200584g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFygu7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7005-7022&author=S.+R.+Laplanteauthor=L.+D.+Faderauthor=K.+R.+Fandrickauthor=D.+R.+Fandrickauthor=O.+Huckeauthor=R.+Kemperauthor=S.+P.+Millerauthor=P.+J.+Edwards&title=Assessing+Atropisomer+Axial+Chirality+in+Drug+Discovery+and+Development&doi=10.1021%2Fjm200584g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Assessing Atropisomer Axial Chirality in Drug Discovery and Development</span></div><div class="casAuthors">LaPlante, Steven R.; Fader, Lee D.; Fandrick, Keith R.; Fandrick, Daniel R.; Hucke, Oliver; Kemper, Ray; Miller, Stephen P. F.; Edwards, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7005-7022</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQ8uS-SDx68bVg90H21EOLACvtfcHk0lh0Se0AxDoinw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFygu7zN&md5=6b44135b3871d2460fba4b3246b899e3</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm200584g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200584g%26sid%3Dliteratum%253Aachs%26aulast%3DLaplante%26aufirst%3DS.%2BR.%26aulast%3DFader%26aufirst%3DL.%2BD.%26aulast%3DFandrick%26aufirst%3DK.%2BR.%26aulast%3DFandrick%26aufirst%3DD.%2BR.%26aulast%3DHucke%26aufirst%3DO.%26aulast%3DKemper%26aufirst%3DR.%26aulast%3DMiller%26aufirst%3DS.%2BP.%26aulast%3DEdwards%26aufirst%3DP.%2BJ.%26atitle%3DAssessing%2520Atropisomer%2520Axial%2520Chirality%2520in%2520Drug%2520Discovery%2520and%2520Development%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7005%26epage%3D7022%26doi%3D10.1021%2Fjm200584g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rotzler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gsellinger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bihlmeier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gantenbein, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vonlanthen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Häussinger, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klopper, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayor, M.</span></span> <span> </span><span class="NLM_article-title">Atropisomerization of di-<i>para</i>-Substituted Propyl-Bridged Biphenyl Cyclophanes</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">110</span>– <span class="NLM_lpage">118</span>, <span class="refDoi"> DOI: 10.1039/C2OB26243F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=10.1039%2FC2OB26243F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=23059962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslOjsbnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2013&pages=110-118&author=J.+Rotzlerauthor=H.+Gsellingerauthor=A.+Bihlmeierauthor=M.+Gantenbeinauthor=D.+Vonlanthenauthor=D.+H%C3%A4ussingerauthor=W.+Klopperauthor=M.+Mayor&title=Atropisomerization+of+di-para-Substituted+Propyl-Bridged+Biphenyl+Cyclophanes&doi=10.1039%2FC2OB26243F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Atropisomerization of di-para-substituted propyl-bridged biphenyl cyclophanes</span></div><div class="casAuthors">Rotzler, Juergen; Gsellinger, Heiko; Bihlmeier, Angela; Gantenbein, Markus; Vonlanthen, David; Haeussinger, Daniel; Klopper, Wim; Mayor, Marcel</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">110-118</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The influence of electron donors and electron acceptors of variable strength in the 4 and 4' position of 2 and 2' propyl-bridged axial chiral biphenyl cyclophanes on their atropisomerization process was studied.  Estd. free energies ΔG±(T) of the rotation around the central biphenyl bond which were obtained from 1H-NMR coalescence measurements were correlated to the Hammett parameters σp as a measure for electron donor and acceptor strength.  It is demonstrated that the resulting nice linear correlation is mainly based on the influence of the different substituents on the π-system of the biphenyl cyclophanes.  By lineshape anal. the rate consts. were calcd. and by the use of the Eyring equation the enthalpic and entropic contributions were evaluated.  D. functional theory calcns. show a planar transition state of the isomerization process and the calcd. energy barriers based on this reaction mechanism are in good agreement with the exptl. obtained free energies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWTv2XXtp9XbVg90H21EOLACvtfcHk0lh0Se0AxDoinw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslOjsbnJ&md5=f06d7f8220a05450327283e425c94c04</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1039%2FC2OB26243F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC2OB26243F%26sid%3Dliteratum%253Aachs%26aulast%3DRotzler%26aufirst%3DJ.%26aulast%3DGsellinger%26aufirst%3DH.%26aulast%3DBihlmeier%26aufirst%3DA.%26aulast%3DGantenbein%26aufirst%3DM.%26aulast%3DVonlanthen%26aufirst%3DD.%26aulast%3DH%25C3%25A4ussinger%26aufirst%3DD.%26aulast%3DKlopper%26aufirst%3DW.%26aulast%3DMayor%26aufirst%3DM.%26atitle%3DAtropisomerization%2520of%2520di-para-Substituted%2520Propyl-Bridged%2520Biphenyl%2520Cyclophanes%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2013%26volume%3D11%26spage%3D110%26epage%3D118%26doi%3D10.1039%2FC2OB26243F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="note"><p class="first last">In vitro p-ERK IC<sub>50</sub> values were derived from EGF-stimulated MIA PaCa-2 cells.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="note"><p class="first last">Residual ERK phosphorylation (∼30%) is attributable to nonmutant KRAS activity resulting from stromal contamination of the clonal <i>KRAS p.G12C</i> tumors (confirmed by RNA-seq) and is observed both at later time points and at higher doses.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="note"><p class="first last">No significant body weight loss was observed at any dose level in this study.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span> Data initially published
in<span class="NLM_contrib-group"><span class="NLM_string-name">Canon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rex, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saiki, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohr, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooke, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bagal, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaida, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knutson, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koppada, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanman, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rapaport, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">San Miguel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortiz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osgood, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarter, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volak, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houk, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fakih, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neil, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falchook, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Govindan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouyang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henary, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arvedson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cee, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipford, J. R.</span></span> <span> </span><span class="NLM_article-title">The Clinical KRAS<sup>G12C</sup> Inhibitor AMG 510 Drives Anti-Tumor Immunity</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>575</i></span>,  <span class="NLM_fpage">217</span>– <span class="NLM_lpage">223</span>, <span class="refDoi"> DOI: 10.1038/s41586-019-1694-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=10.1038%2Fs41586-019-1694-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=31666701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitV2hsb7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=575&publication_year=2019&pages=217-223&author=J.+Canonauthor=K.+Rexauthor=A.+Y.+Saikiauthor=C.+Mohrauthor=K.+Cookeauthor=D.+Bagalauthor=K.+Gaidaauthor=T.+Holtauthor=C.+G.+Knutsonauthor=N.+Koppadaauthor=B.+A.+Lanmanauthor=J.+Wernerauthor=A.+S.+Rapaportauthor=T.+San+Miguelauthor=R.+Ortizauthor=T.+Osgoodauthor=J.-R.+Sunauthor=X.+Zhuauthor=J.+D.+McCarterauthor=L.+P.+Volakauthor=B.+E.+Houkauthor=M.+G.+Fakihauthor=B.+H.+O%E2%80%99Neilauthor=T.+J.+Priceauthor=G.+S.+Falchookauthor=J.+Desaiauthor=J.+Kuoauthor=R.+Govindanauthor=D.+S.+Hongauthor=W.+Ouyangauthor=H.+Henaryauthor=T.+Arvedsonauthor=V.+J.+Ceeauthor=J.+R.+Lipford&title=The+Clinical+KRASG12C+Inhibitor+AMG+510+Drives+Anti-Tumor+Immunity&doi=10.1038%2Fs41586-019-1694-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity</span></div><div class="casAuthors">Canon, Jude; Rex, Karen; Saiki, Anne Y.; Mohr, Christopher; Cooke, Keegan; Bagal, Dhanashri; Gaida, Kevin; Holt, Tyler; Knutson, Charles G.; Koppada, Neelima; Lanman, Brian A.; Werner, Jonathan; Rapaport, Aaron S.; San Miguel, Tisha; Ortiz, Roberto; Osgood, Tao; Sun, Ji-Rong; Zhu, Xiaochun; McCarter, John D.; Volak, Laurie P.; Houk, Brett E.; Fakih, Marwan G.; O'Neil, Bert H.; Price, Timothy J.; Falchook, Gerald S.; Desai, Jayesh; Kuo, James; Govindan, Ramaswamy; Hong, David S.; Ouyang, Wenjun; Henary, Haby; Arvedson, Tara; Cee, Victor J.; Lipford, J. Russell</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">575</span>
        (<span class="NLM_cas:issue">7781</span>),
    <span class="NLM_cas:pages">217-223</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">KRAS is the most frequently mutated oncogene in cancer and encodes a key signalling protein in tumors1,2.  The KRAS(G12C) mutant has a cysteine residue that has been exploited to design covalent inhibitors that have promising preclin. activity3-5.  Here we optimized a series of inhibitors, using novel binding interactions to markedly enhance their potency and selectivity.  Our efforts have led to the discovery of AMG 510, which is, to our knowledge, the first KRAS(G12C) inhibitor in clin. development.  In preclin. analyses, treatment with AMG 510 led to the regression of KRASG12C tumors and improved the anti-tumor efficacy of chemotherapy and targeted agents.  In immune-competent mice, treatment with AMG 510 resulted in a pro-inflammatory tumor microenvironment and produced durable cures alone as well as in combination with immune-checkpoint inhibitors.  Cured mice rejected the growth of isogenic KRASG12D tumors, which suggests adaptive immunity against shared antigens.  Furthermore, in clin. trials, AMG 510 demonstrated anti-tumor activity in the first dosing cohorts and represents a potentially transformative therapy for patients for whom effective treatments are lacking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTHdBftQfnhbVg90H21EOLACvtfcHk0lirc_HJzahf9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitV2hsb7F&md5=3819175980905976ba87ff545b9506e1</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fs41586-019-1694-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-019-1694-1%26sid%3Dliteratum%253Aachs%26aulast%3DCanon%26aufirst%3DJ.%26aulast%3DRex%26aufirst%3DK.%26aulast%3DSaiki%26aufirst%3DA.%2BY.%26aulast%3DMohr%26aufirst%3DC.%26aulast%3DCooke%26aufirst%3DK.%26aulast%3DBagal%26aufirst%3DD.%26aulast%3DGaida%26aufirst%3DK.%26aulast%3DHolt%26aufirst%3DT.%26aulast%3DKnutson%26aufirst%3DC.%2BG.%26aulast%3DKoppada%26aufirst%3DN.%26aulast%3DLanman%26aufirst%3DB.%2BA.%26aulast%3DWerner%26aufirst%3DJ.%26aulast%3DRapaport%26aufirst%3DA.%2BS.%26aulast%3DSan%2BMiguel%26aufirst%3DT.%26aulast%3DOrtiz%26aufirst%3DR.%26aulast%3DOsgood%26aufirst%3DT.%26aulast%3DSun%26aufirst%3DJ.-R.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DMcCarter%26aufirst%3DJ.%2BD.%26aulast%3DVolak%26aufirst%3DL.%2BP.%26aulast%3DHouk%26aufirst%3DB.%2BE.%26aulast%3DFakih%26aufirst%3DM.%2BG.%26aulast%3DO%25E2%2580%2599Neil%26aufirst%3DB.%2BH.%26aulast%3DPrice%26aufirst%3DT.%2BJ.%26aulast%3DFalchook%26aufirst%3DG.%2BS.%26aulast%3DDesai%26aufirst%3DJ.%26aulast%3DKuo%26aufirst%3DJ.%26aulast%3DGovindan%26aufirst%3DR.%26aulast%3DHong%26aufirst%3DD.%2BS.%26aulast%3DOuyang%26aufirst%3DW.%26aulast%3DHenary%26aufirst%3DH.%26aulast%3DArvedson%26aufirst%3DT.%26aulast%3DCee%26aufirst%3DV.%2BJ.%26aulast%3DLipford%26aufirst%3DJ.%2BR.%26atitle%3DThe%2520Clinical%2520KRASG12C%2520Inhibitor%2520AMG%2520510%2520Drives%2520Anti-Tumor%2520Immunity%26jtitle%3DNature%26date%3D2019%26volume%3D575%26spage%3D217%26epage%3D223%26doi%3D10.1038%2Fs41586-019-1694-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalvie, D. K.</span></span> <span> </span><span class="NLM_article-title">Drug Discovery for a New Generation of Covalent Drugs</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">561</span>– <span class="NLM_lpage">581</span>, <span class="refDoi"> DOI: 10.1517/17460441.2012.688744</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=10.1517%2F17460441.2012.688744" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=22607458" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=1%3ACAS%3A528%3ADC%252BC38XptFWmt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=561-581&author=A.+S.+Kalgutkarauthor=D.+K.+Dalvie&title=Drug+Discovery+for+a+New+Generation+of+Covalent+Drugs&doi=10.1517%2F17460441.2012.688744"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Drug discovery for a new generation of covalent drugs</span></div><div class="casAuthors">Kalgutkar, Amit S.; Dalvie, Deepak K.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">561-581</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: The design of target-specific covalent inhibitors is conceptually attractive because of increased biochem. efficiency through covalency and increased duration of action that outlasts the pharmacokinetics of the agent.  Although many covalent inhibitors have been approved or are in advanced clin. trials to treat indications such as cancer and hepatitis C, there is a general tendency to avoid them as drug candidates because of concerns regarding immune-mediated toxicity that can arise from indiscriminate reactivity with off-target proteins.Areas covered: The review examines potential reason(s) for the excellent safety record of marketed covalent agents and advanced clin. candidates for emerging therapeutic targets.  A significant emphasis is placed on proteomic techniques and chem./biochem. reactivity assays that aim to provide a systematic rank ordering of pharmacol. selectivity relative to off-target protein reactivity of covalent inhibitors.Expert opinion: While tactics to examine selective covalent modification of the pharmacol. target are broadly applicable in drug discovery, it is unclear whether the output from such studies can prospectively predict idiosyncratic immune-mediated drug toxicity.  Opinions regarding an acceptable threshold of protein reactivity/body burden for a toxic electrophile and a non-toxic electrophilic covalent drug have not been defined.  Increasing confidence in proteomic and chem./biochem. reactivity screens will require a retrospective side-by-side profiling of marketed covalent drugs and electrophiles known to cause deleterious toxic effects via non-selective covalent binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowmXy20mDTPbVg90H21EOLACvtfcHk0lirc_HJzahf9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XptFWmt7k%253D&md5=b7fc8e60b263dda5765dd8380f52df17</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1517%2F17460441.2012.688744&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2012.688744%26sid%3Dliteratum%253Aachs%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DDalvie%26aufirst%3DD.%2BK.%26atitle%3DDrug%2520Discovery%2520for%2520a%2520New%2520Generation%2520of%2520Covalent%2520Drugs%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2012%26volume%3D7%26spage%3D561%26epage%3D581%26doi%3D10.1517%2F17460441.2012.688744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="note"><p class="first last">As determined by stable-isotope labelling (SILAC) experiments; see ref <a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Campuzano, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">San Miguel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onea, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cee, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arvedson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarter, J. D.</span></span> <span> </span><span class="NLM_article-title">High-Throughput Mass Spectrometric Analysis of Covalent Protein-Inhibitor Adducts for the Discovery of Irreversible Inhibitors: A Complete Workflow</span>. <i>J. Biomol. Screening</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">136</span>– <span class="NLM_lpage">144</span>, <span class="refDoi"> DOI: 10.1177/1087057115621288</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=10.1177%2F1087057115621288" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=26676098" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=1%3ACAS%3A528%3ADC%252BC28XmvVSrtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=136-144&author=I.+D.+Campuzanoauthor=T.+San+Miguelauthor=T.+Roweauthor=D.+Oneaauthor=V.+J.+Ceeauthor=T.+Arvedsonauthor=J.+D.+McCarter&title=High-Throughput+Mass+Spectrometric+Analysis+of+Covalent+Protein-Inhibitor+Adducts+for+the+Discovery+of+Irreversible+Inhibitors%3A+A+Complete+Workflow&doi=10.1177%2F1087057115621288"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">High-throughput mass spectrometric analysis of covalent protein-inhibitor adducts for the discovery of irreversible inhibitors: a complete workflow</span></div><div class="casAuthors">Campuzano, Iain D. G.; San Miguel, Tisha; Rowe, Todd; Onea, Daniel; Cee, Victor J.; Arvedson, Tara; McCarter, John D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">136-144</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">We have implemented a solid-phase extn. based time-of-flight mass spectrometer system in combination with novel informatics to rapidly screen and characterize the covalent binding of different irreversible inhibitors to intact proteins.  This high-throughput screening platform can be used to accurately detect and quantitate the extent of formation of different covalent protein-inhibitor adducts between electrophilic inhibitors and nucleophilic residues such as cysteine or lysine.  For a representative 19.5 kDa protein, the anal. time is approx. 20 s per sample, including an efficient sample loading and desalting step.  Accurate protein masses are measured (±0.5 amu of the theor. mol. wt.; measured precision of ±0.02 amu).  The fraction of protein reacted with an electrophilic compd. is detd. relative to an unmodified protein control.  A key element of the workflow is the automated identification and quantitation of the expected masses of covalent protein-inhibitor adducts using a custom routine that obviates the need to manually inspect each individual spectrum.  Parallel screens were performed on a library of approx. 1000 acrylamide contg. compds. (different structures and reactivities) using the solid-phase extn. mass spectrometry based assay and a fluorescence based thiol-reactive probe assay enabling comparison of false positives and false negatives between these orthogonal screening approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5_Meysg0t4LVg90H21EOLACvtfcHk0lirc_HJzahf9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmvVSrtb4%253D&md5=060f56816034d61615584239b8bc14ab</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1177%2F1087057115621288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057115621288%26sid%3Dliteratum%253Aachs%26aulast%3DCampuzano%26aufirst%3DI.%2BD.%26aulast%3DSan%2BMiguel%26aufirst%3DT.%26aulast%3DRowe%26aufirst%3DT.%26aulast%3DOnea%26aufirst%3DD.%26aulast%3DCee%26aufirst%3DV.%2BJ.%26aulast%3DArvedson%26aufirst%3DT.%26aulast%3DMcCarter%26aufirst%3DJ.%2BD.%26atitle%3DHigh-Throughput%2520Mass%2520Spectrometric%2520Analysis%2520of%2520Covalent%2520Protein-Inhibitor%2520Adducts%2520for%2520the%2520Discovery%2520of%2520Irreversible%2520Inhibitors%253A%2520A%2520Complete%2520Workflow%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2016%26volume%3D21%26spage%3D136%26epage%3D144%26doi%3D10.1177%2F1087057115621288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cee, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volak, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartberger, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tegley, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arvedson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tasker, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fotsch, C.</span></span> <span> </span><span class="NLM_article-title">Systematic Study of the Glutathione (GSH) Reactivity of <i>N</i>-Arylacrylamides: 1. Effects of Aryl Substitution</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">9171</span>– <span class="NLM_lpage">9178</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01018</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01018" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFGrsLfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=9171-9178&author=V.+J.+Ceeauthor=L.+P.+Volakauthor=Y.+Chenauthor=M.+D.+Bartbergerauthor=C.+Tegleyauthor=T.+Arvedsonauthor=J.+McCarterauthor=A.+S.+Taskerauthor=C.+Fotsch&title=Systematic+Study+of+the+Glutathione+%28GSH%29+Reactivity+of+N-Arylacrylamides%3A+1.+Effects+of+Aryl+Substitution&doi=10.1021%2Facs.jmedchem.5b01018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Systematic Study of the Glutathione (GSH) Reactivity of N-Arylacrylamides: 1. Effects of Aryl Substitution</span></div><div class="casAuthors">Cee, Victor J.; Volak, Laurie P.; Chen, Yuping; Bartberger, Michael D.; Tegley, Chris; Arvedson, Tara; McCarter, John; Tasker, Andrew S.; Fotsch, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9171-9178</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Success in the design of targeted covalent inhibitors depends in part on a knowledge of the factors influencing electrophile reactivity.  In an effort to further develop an understanding of structure-reactivity relations among N-arylacrylamides, the authors detd. glutathione (GSH) reaction rates for a family of N-arylacrylamides independently substituted at ortho-, meta-, and para-positions with 11 different groups common to inhibitor design.  Substituent effects on reaction rates show a linear Hammett correlation for ortho-, meta-, and para-substitution.  The authors note a correlation between 1H and 13C NMR chem. shifts of the acrylamide with GSH reaction rates, suggesting that NMR chem. shifts may be a convenient surrogate measure of relative acrylamide reactivity.  D. functional theory calcns. reveal a correlation between computed activation parameters and exptl. detd. reaction rates, validating the use of such methodol. for the screening of synthetic candidates in a prospective fashion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAoYRfo0lRj7Vg90H21EOLACvtfcHk0lh1_bU56uy2BA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFGrsLfN&md5=2f3a816446dd73d5be061ad8d2195e2d</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01018%26sid%3Dliteratum%253Aachs%26aulast%3DCee%26aufirst%3DV.%2BJ.%26aulast%3DVolak%26aufirst%3DL.%2BP.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DTegley%26aufirst%3DC.%26aulast%3DArvedson%26aufirst%3DT.%26aulast%3DMcCarter%26aufirst%3DJ.%26aulast%3DTasker%26aufirst%3DA.%2BS.%26aulast%3DFotsch%26aufirst%3DC.%26atitle%3DSystematic%2520Study%2520of%2520the%2520Glutathione%2520%2528GSH%2529%2520Reactivity%2520of%2520N-Arylacrylamides%253A%25201.%2520Effects%2520of%2520Aryl%2520Substitution%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D9171%26epage%3D9178%26doi%3D10.1021%2Facs.jmedchem.5b01018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="note"><p class="first last">Data to be reported separately.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span>Details
of this trial can be found at <a href="https://clinicaltrials.gov/" class="extLink">https://clinicaltrials.gov/</a> (accessed Sep 7, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Details%0Aof+this+trial+can+be+found+at+https%3A%2F%2Fclinicaltrials.gov%2F+%28accessed+Sep+7%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fakih, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neil, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falchook, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Govindan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rasmussen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrow, P. K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henary, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, D. S.</span></span> <span> </span><span class="NLM_article-title">Phase 1 Study Evaluating the Safety, Tolerability, Pharmacokinetics (PK), and Efficacy of AMG 510, a Novel Small Molecule KRASG12C Inhibitor, in Advanced Solid Tumors</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">3003</span>, <span class="refDoi"> DOI: 10.1200/JCO.2019.37.15_suppl.3003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;key=10.1200%2FJCO.2019.37.15_suppl.3003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2019&pages=3003&author=M.+Fakihauthor=B.+O%E2%80%99Neilauthor=T.+J.+Priceauthor=G.+S.+Falchookauthor=J.+Desaiauthor=J.+Kuoauthor=R.+Govindanauthor=E.+Rasmussenauthor=P.+K.+H.+Morrowauthor=J.+Ngangauthor=H.+A.+Henaryauthor=D.+S.+Hong&title=Phase+1+Study+Evaluating+the+Safety%2C+Tolerability%2C+Pharmacokinetics+%28PK%29%2C+and+Efficacy+of+AMG+510%2C+a+Novel+Small+Molecule+KRASG12C+Inhibitor%2C+in+Advanced+Solid+Tumors&doi=10.1200%2FJCO.2019.37.15_suppl.3003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1200%2FJCO.2019.37.15_suppl.3003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2019.37.15_suppl.3003%26sid%3Dliteratum%253Aachs%26aulast%3DFakih%26aufirst%3DM.%26aulast%3DO%25E2%2580%2599Neil%26aufirst%3DB.%26aulast%3DPrice%26aufirst%3DT.%2BJ.%26aulast%3DFalchook%26aufirst%3DG.%2BS.%26aulast%3DDesai%26aufirst%3DJ.%26aulast%3DKuo%26aufirst%3DJ.%26aulast%3DGovindan%26aufirst%3DR.%26aulast%3DRasmussen%26aufirst%3DE.%26aulast%3DMorrow%26aufirst%3DP.%2BK.%2BH.%26aulast%3DNgang%26aufirst%3DJ.%26aulast%3DHenary%26aufirst%3DH.%2BA.%26aulast%3DHong%26aufirst%3DD.%2BS.%26atitle%3DPhase%25201%2520Study%2520Evaluating%2520the%2520Safety%252C%2520Tolerability%252C%2520Pharmacokinetics%2520%2528PK%2529%252C%2520and%2520Efficacy%2520of%2520AMG%2520510%252C%2520a%2520Novel%2520Small%2520Molecule%2520KRASG12C%2520Inhibitor%252C%2520in%2520Advanced%2520Solid%2520Tumors%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2019%26volume%3D37%26spage%3D3003%26doi%3D10.1200%2FJCO.2019.37.15_suppl.3003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5V9U" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5V9U','PDB','5V9U'); return false;">PDB: 5V9U</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6P8Z" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6P8Z','PDB','6P8Z'); return false;">PDB: 6P8Z</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6PGO" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6PGO','PDB','6PGO'); return false;">PDB: 6PGO</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6PGP" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6PGP','PDB','6PGP'); return false;">PDB: 6PGP</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6OIM" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6OIM','PDB','6OIM'); return false;">PDB: 6OIM</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i22"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01180">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_22528"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.9b01180?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01180</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Experimental details for in vitro and in vivo studies, additional crystallographic data for compounds <b>2</b> and <b>9</b>, and synthetic procedures for compounds <b>2</b>–<b>40</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01180/suppl_file/jm9b01180_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01180/suppl_file/jm9b01180_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01180/suppl_file/jm9b01180_si_001.pdf">jm9b01180_si_001.pdf (629.26 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01180/suppl_file/jm9b01180_si_002.csv">jm9b01180_si_002.csv (4.24 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Atomic coordinates for the X-ray structures of compound <b>2</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6PGO">6PGO</a>) and compound <b>9</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6PGP">6PGP</a>) bound to GDP-KRAS<sup>G12C</sup> are available from the RCSB Protein Data Bank (<a href="http://www.rcsb.org" class="extLink">www.rcsb.org</a>).</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b01180&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-1%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b01180" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b01180" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                7MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677a8077c8d23c1c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
